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 ABSTRACT 
Helicobacter pylori causes chronic gastritis, peptic ulceration and gastric cancer. 
This bacterium is one of the most prevalent in the world, but affects mostly the 
populations with a lower socioeconomical status. While it causes gastric and duodenal 
ulcers in only 20% of infected patients, less then 1% will develop gastric adenocarcinoma. 
In fact, H. pylori is the most important risk factor in developing gastric cancer. 
Epidemiological studies have shown that 80% of gastric cancer patients are H. pylori 
positive. The outcome of the infection with this bacterium depends on bacterial factors, 
diet, genetic background of the host, and coinfection with other microorganisms.  The 
most important cofactor in H. pylori induced disease is the host immune response, even 
though the exact mechanism of how the bacterium is causing disease is unknown.  
The structural complexity of Helicobacter bacteria makes us believe that different 
bacterial factors interact with different components of the innate immunity. However, as a 
whole bacterium it may need mainly the TLR2 receptor to trigger an immune response. 
The type of adaptive immunity developed in response to Helicobacter is crucial in 
determining the consequences of infection. It is now known for decades that a susceptible 
host will follow the infection with a strong Th1 immune response. IFNγ, IL-12, IL-1β and 
TNF-α are the key components of a strong adaptive Th1 response. This is further 
supported by our work, where deficient T-bet (a master regulator for Th1 response) mice 
were protected against gastric cancer, despite maintaining an infection at similar levels to 
wild type mice.  On the other hand, a host that is resistant to Helicobacter develops an 
infection that is followed by a Th2 response sparing the mucosa from severe 
inflammation. Human studies looking at single nucleotide polymorphism of cytokines, 
like IL-1β, IL-10 and TNF-α have clearly demonstrated how genotypes that result in high 
levels of IL-1β and TNF-α, but low IL-10 expression may confer a 50-fold higher risk in 
developing gastric cancer.  
The outcome of Helicobacter infection clearly relies on the immune response and 
genetic background, however the coinfection of the host with other pathogens should not 
be ignored as this may result in modulation of the adaptive immunity. In studying this, we 
took advantage of the Balb/C mice that are known to be protected against Helicobacter 
induced inflammation by mounting a strong Th2 polarization. We were able to switch 
their adaptive immunity to Th1 by coinfected them with a T. gondii infection (a well 
known Th1 infection in mice). The dual infected mice developed severe gastritis, parietal 
cell loss and metaplastic changes. These experiments have clearly shown how unrelated 
pathogens may interact and result in different clinical outcomes of the infected host. 
A strong immune response that results in severe inflammation will also cause a 
cascade of apoptotic changes in the mucosa. A strict balance between proliferation and 
apoptosis is needed, as its disruption may result in uncontrolled proliferation, 
transformation and metaplasia. The Fas Ag pathway is the leading cause of apoptosis in 
the Helicobacter-induced inflammation. One mechanism for escaping Fas mediating 
apoptosis is upregulation of MHCII receptor. Fas Ag and MHCII receptor interaction 
inhibits Fas mediated apoptosis by an impairment of the Fas Ag receptor aggregation 
when stimulated by Fas ligand. Because H. pylori infection is associated with an 
upregulation of the MHCII levels on gastric epithelial cells, this indeed may be one 
mechanism by which cells escape apoptosis.  
The link between chronic inflammation and cancer is well known since the past 
century. Helicobacter infection is a prime example how a chronic inflammatory state is 
causing uncontrolled cell proliferation that results in cancer. The cell biology of “cancer” 
is regarded not as an accumulation of cells that divide without any control, but rather as an 
organ formed of cancer stem cells, tumor stromal support cells, myofibroblasts and 
endothelial cells, which function as a group. The properties of the cancer stem cells are to 
self-renew and differentiate into tumor cells thus maintaining the tumor grow, 
emphasizing that a striking similarity exists between cancer stem cells and tissue stem 
cells. 
We looked into what role would BMDCs play in chronic inflammation that causes 
cancer. Using the mouse model of Helicobacter induced adenocarcinoma we discovered 
that gastric cancer originates from a mesenchymal stem cell coming from bone marrow. 
We believe that chronic inflammation, in our case of the stomach, sets up the perfect stage 
for bone marrow stem cells to migrate to the stomach where they are exposed to 
inflammatory stimuli and transform into cancer stem cells. One of the mechanism by 
which the MSC migrate to the inflammation site is the CXCR4/SDF-1 axis.  
Our work sheds new light on Helicobacter induced gastric cancer pathogenesis. I 
hope that our findings will promote the development of new therapies in the fight against 
this deadly disease.  
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1
 1. Gastric cancer: classification and epidemiology. 
 
Gastric adenocarcinoma is the second most common cause of cancer-related 
mortality worldwide and the 14th overall cause of death (1). There are widespread 
geographical differences in gastric cancer rates with the highest rates seen in Japan, China 
and South America, and much lower rates in Western Europe and the United States (1). 
The single most common cause of gastric cancer is infection with Helicobacter pylori: one 
of the most common chronic bacterial infections in man (2). This bacterium colonizes 
over half of the world’s population. Infection is usually acquired in childhood and in the 
absence of antibiotic therapy persists for the life of the host (3).  
H. pylori is a member of a large family of related bacteria that colonize the 
mammalian stomach, and is causally linked to chronic gastritis, peptic ulceration, gastric 
atrophy, gastric adenocarcinoma and rarely non-Hodgkin lymphoma of the stomach (4). In 
the United States, the rate of H. pylori acquisition is less than 1% per year, with 10–15% 
of children less than 12 years of age and 50–60% of people greater than 60 years of age 
infected (5).  
The gastric environment is relatively inhospitable to bacteria and other pathogens. 
As a result of harsh pH conditions, the presence of digestive enzymes and constant 
contractions with sweeping motility designed to clear the gastric contents at regular 
intervals, the stomach is a relatively sterile organ. Indeed, H. pylori is the only known 
bacteria that can persistently colonize the normal stomach, and essentially sets up a 
monoculture within the gastric mucosa.  
Although most infected patients will develop a chronic active gastritis, the 
2
 majorities are asymptomatic. Though the risk varies with age, geographical location and 
ethnicity, overall 15–20% of infected patients will develop gastric or duodenal ulcer 
disease and less than 1% will develop gastric adenocarcinoma (4, 6). Unfortunately, 
symptoms and disease are poorly correlated, and many cases of gastric cancer are detected 
late in disease progression, when the disease is incurable.  
The pattern of gastritis has been shown to correlate strongly with the risk of 
gastric adenocarcinoma. Patients who develop antral-predominant gastritis (the most 
common manifestation) are at a higher risk of developing duodenal ulcers, while those 
that develop corpus-predominant gastritis and multifocal atrophic gastritis are at a higher 
risk of developing gastric ulcers, and of progressing to intestinal metaplasia, dysplasia and 
adenocarcinoma (7). Noncardia gastric cancers (Lauren classification) are divided into 
two histological distinct variants termed intestinal-type adenocarcinoma and diffuse-type 
adenocarcinoma (8). Intestinal-type gastric adenocarcinoma forms gland-like structures 
and primarily involves the distal stomach (9). The development of the intestinal type of 
gastric carcinoma appears to progress through a stepwise transition from normal mucosa 
through atrophic gastritis, atrophy, and intestinal metaplasia. It is in the setting of atrophy 
and metaplasia that dysplasia arises, which may progress to adenocarcinoma (10), though 
the point of transition from a “premalignant” to “malignant” lesion has not been 
identified. Intestinal-type adenocarcinoma has a predilection for the elderly of lower 
socioeconomic status and has a male-to-female ratio of 2:1.  
In contrast, the histology of diffuse type of gastric cancer is one of individual 
neoplastic cells infiltrating the gastric mucosa, without forming glandular structures. 
There is no association with atrophy or intestinal metaplasia, and there is no stepwise 
3
 progression as seen in intestinal-type cancer (11). The diffuse type of gastric cancer 
presents at a younger age, affects men and women equally and there is a stronger genetic 
component. 
 
2. Helicobacter infection in the initiation and promotion of gastric cancer. 
 
H. pylori has been classified by the World Health Organization (WHO) as a class 
1 carcinogen, although the precise mechanism by which this bacterium causes gastric 
cancer is not clear (12). The evidence supporting a role for H. pylori causing gastric 
cancer is very strong. Epidemiological studies link Helicobacter colonization with 
noncardia gastric cancer (13, 14), with the decline in H. pylori infection in industrialized 
counties in the last century correlating closely with decreased morbidity and mortality 
from gastric adenocarcinoma (15, 16). Case controlled studies have established a positive 
link between seropositivity and gastric adenocarcinoma; with a 2.1- to 16.7- fold increase 
risk when compared to seronegative patients (14, 17).  
More recently, the presence of past or present Helicobacter infection has been 
confirmed in the majority (up to 80%) of gastric cancer patients, demonstrating 
conclusively that Helicobacter infection is associated with the majority of gastric cancer 
cases (18, 19). The precise manner in which infection causes cancer is not known; 
however, the present thinking is that cancer arises through the combination of infection 
with a virulent organism, a permissive environment and a genetically susceptible host. 
Candidates for cancer induction include direct H. pylori bacterial factors, components of 
the host immune response, dietary cofactors including high salt and decreased ascorbate, 
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 gastrin hormonal levels, and decreased acid secretion with bacterial overgrowth. Indeed, 
all these factors may interact to alter host cell signaling, derange apoptotic and 
proliferative signaling, and promote the acquisition and maintenance of genetic mutations 
leading to neoplasia. 
 
2.1. H. pylori bacterial factors. 
 
H. pylori is well adapted to the gastric environment, withstanding low pH to gain 
entry to its preferred niche, the mucus layer of the stomach. Once there, the bacterium 
evades local and systemic immune responses that are ineffective at eliminating the 
organism. In the absence of antibiotic therapy, colonization persists for the life of the 
host. The H. pylori genome has 1.65 million base pairs and codes for approximately 1500 
genes (20). Of these, only 2/3 of the genes have been assigned biological roles. The 
function of the remaining 1/3 of the genome remains obscure. A modified signature 
tagged mutagenesis approach, used to detect the genes essential for colonization and 
survival of H. pylori identified 47 genes, including several previously known factors such 
as urease and motilin, thereby validating this method (2). Bacterial factors, which 
contribute to carcinogenesis, include those that enable the bacteria to effectively colonize 
the gastric mucosa, incite a more aggressive host immune response and direct virulence 
factors of the organism. 
 
2.2. Motility. 
Motility toward epithelial cells of the stomach is a vital feature of H. pylori 
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 survival tactics. This function is assured by several factors including spiraling movement 
designed to navigate the thick gastric mucus and through efficient modifications of the 
extracellular matrix and mucus layer thus decreasing viscosity and allowing bacterial 
penetration. The complex flagella filament is composed of two flagellin subspecies, the 
more abundant flaA protein, which comprises the majority of the filament, and a second 
slightly larger protein, flaB, which appears to be exclusively located proximal to the hook 
within the assembled filament (21) (Fig. 1.1A). Both are essential for flagella integrity 
and function to quickly propel the bacterium from the hostile gastric lumen, to the 
protected niche of mucus overlying the gastric mucosal cells. Once safely out of the 
lumen, the bacterium modifies the local environment to allow unhampered movement 
over the surface of epithelial cells. A gene coding for a putative collagenase (HP0169) 
enzyme has been described (2). This enzyme is actively transported to the bacterial cell 
surface where it may remain, or is secreted into the extracellular space and functions to 
digest collagen, allowing freer bacterial movement. Collagen types III and I are important 
components of the extracellular matrix of the gastric epithelium. Secretion by gastric 
cells is induced in areas of ulceration and gastritis where it functions to promote healing. 
Through digestion of collagen, collagenase secreted by H. pylori may be responsible for 
delay of ulcer healing and chronic ulcers. Additionally, components of the mucosal 
immune response, such as IgA antibodies, may be degraded by bacterial collagenase 
further contributing to disease by Helicobacter or other transient organisms within the GI 
(gastrointestinal) tract (2) (Fig. 1.1A). 
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FIGURE 1.1 H. PYLORI BACTERIAL VIRULENCE FACTORS.  
(A) Helicobacter gains access to the epithelial cell surface through a combination of 
spiral motility provided by powerful flagella composed of subunits flagellin A and B 
(FlaA and FlaB), and secretion of a collagenase (Hp 0169) which acts to decrease 
viscosity and allow bacterial movement over the mucosal cell surface. Collagenases 
degrade other host molecules such as immunoglobulin A (IgA) favoring bacterial – host 
cell attachment. (B) Once in contact with the mucosal surface, bacteria can adhere to the 
epithelial cells via an adhesin (BabA) - Lewis B blood group antigen. Urease, produced 
by the bacterium, converts urea to CO2 and NH3, buffering the mucus niche creating a 
neutral pH habitat directly over the cell surface. (C) Using a type IV secretory system, 
Helicobacter proteins and DNA are introduced into host cells. Once inside, CagA 
(cytotoxin-associated gene A) can be phosphorylated by host proteins. Phosphorylated 
CagA, in turn, dephosphorylates host proteins, altering cytoskeletal structure and 
interfering with cell signaling. VacA (vacuolating cytotoxin A) within the cell leads to T-
lymphocyte inactivation through G1/S cell cycle arrest and targets the nuclear factor of 
activated T-cells (NFAT) signaling pathway to hinder cytokine signaling. 
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 2.3. Adhesion factors. 
Adhesins are a large family of 32 related outer membrane proteins (Hop proteins) 
that assures adhesion of the bacteria to the epithelial layer. One of the best-characterized 
adhesin is babA, encoded by the strain specific gene babA2, a member of a highly 
conserved family of outer membrane proteins. babA binds to the fucosylated Lewis B 
blood group antigen on gastric epithelial cells and forms a scaffold apparatus that allows 
bacterial proteins to enter host epithelial cells. Bacterial strains which posses the babA2 
gene adhere more tightly to epithelial cells and promote a more aggressive phenotype, 
and are associated with a higher incidence of gastric adenocarcinoma. Transgenic mice 
carrying the Lewis B blood group antigen challenged with babA+ H. pylori strains are 
more likely to develop severe gastritis, atrophy and antiparietal cell antibodies than the 
same mice challenged with wild-type strains of bacteria (22), via increased bacterial 
adherence to mucosal cells. On the other hand, there are some H. pylori strains that 
produce low levels of babA and have a low binding activity to the gastric mucosa; 
however these strains some times may have a higher likelihood to cause gastric 
inflammation and atrophy. The underlying reason is unclear and needs further 
investigations (23) (Fig. 1.1B). 
 
2.4. Urease. 
 
Urease is produced by all strains of H. pylori and functions to hydrolyze urea into 
CO2 and NH3. NH3 effectively buffers the acid environment immediately surrounding 
the bacterium permitting survival in the acid environment of the stomach. Urease enzyme 
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 activity is tightly controlled by a pH-gated urea channel (ureI), which is open at low pH 
and closed at neutral pH conditions (24), allowing the bacterium a precise level of control 
over its pH environment (Fig. 1.1B). 
 
2.5. The cag (cytotoxin-associated gene) pathogenicity island. 
 
The most important feature, which distinguishes strains of H. pylori is the 
presence or absence of the cag island. The Cag pathogenicity island is approximately 40 
kb, and contains 31 genes. The terminal gene of this island, cagA, is often times used as a 
marker for the entire cag locus. Several genes within the island have homology to genes 
that encode a type IV secretory system. Once the bacteria adhere to the gastric epithelial 
cell, the type IV secretion system functions to export bacterial DNA and/or proteins into 
the host cell cytoplasm. In vitro experiments suggest that once in the cytoplasm, cagA 
undergoes kinase-mediated phosphorylation. Phosphorylated cagA in turn 
dephosphorylates host cell proteins, activating intracellular signaling pathways. 
Alterations in host cell proteins lead to actin-cytoskeleton reorganization and 
morphological changes described in cultured cells as the "hummingbird phenotype”.  
To further study this phenomenon in vivo, Ohnishi et al. generated a wild type 
cagA and a phosphorylation resistant cagA transgenic mouse. The transgenic mouse with 
wild type cagA developed impressive gastric and small intestine adenocarcinoma. 
However, the phosphorylation resistant cagA transgenic mice did not develop these 
pathological findings. This is one of the first evidences of cagA being a bacterial 
oncoprotein acting in mammals (25). Compared to cagA- strains, cagA+ strains are 
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 associated with more severe inflammation, higher degrees of atrophic changes and a 
greater chance of progressing to gastric adenocarcinoma (13, 26-31). Other genes within 
the pathogenicity island are felt to be important for disease (cagE or picB, cagG, cagH, 
cagI, cagL, cagM), as they appear to be required for in vitro epithelial cell cytokine 
release (32-34), though there does not appear to be as great an effect on immune cell 
cytokine activation. These findings may explain the attenuated inflammatory response 
and lower cancer risk with cagA- strains in vivo (28, 35-37) (Fig. 1.1C).  
All strains of H. pylori carry the vacA (vacuolating cytotoxin A) gene, which 
codes for a vacuolating toxin, with expression varying depending on allelic variation. 
Approximately 50% of H. pylori strains express the vacuolating cytotoxin A (vacA 
protein). Although vacA and cagA map to different loci within the H. pylori genome, they 
commonly are found together. The vacuolating toxin, composed of identical 87 kDa 
monomers assembled into a flower-shaped oligomer, alters intracellular vesicular 
trafficking in eukaryotic cells, leading to formation of large vacuoles (38). When 
administered orally to mice, vacA alone is able to induce gastric epithelial erosions, 
resembling erosions found in Helicobacter-infected humans (39).  
It is proposed that VacA binds protein tyrosine phosphatase receptor type Z 
(Ptprz), increases the tyrosine phosphorylation of the G-protein-coupled receptor kinase 
interactor 1 (git1, a Ptprz substrate), inducing mucosal damage. In support of this, the 
endogenous ligand of Ptprz, pleiotropin, induces gastritis in wild-type mice. Ptprz-/- mice 
do not develop vacA-induced mucosal damage, even though vacA successfully 
incorporates into gastric epithelial cells (40). The challenge of Ptprz-/- mice with “full” 
H. pylori was lacking in this study, which would have confirmed the physiological 
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 significance of these findings. In addition to effects on gastric epithelial cells, vacA 
cytotoxin acts to inhibit T lymphocyte activation through induction of a G1/S cell cycle 
arrest, impedes transcription of IL-2 and downregulates IL-2R-alpha through targeting 
the nuclear factor of activated T cells (NFAT) signaling pathway (41) at the level of 
calcineurin (42). Additionally, vacA has been shown to activate MKK3/6 (MAP 
(Mitogen-Activated Protein) Kinase Kinase), p38, and a rac-specific nucleotide exchange 
factor (vav) by presumed interaction with an as of yet unknown receptor (40). This 
aberrant activation of rac stimulates actin polymerization, altering cellular architecture 
and interfering with the formation of the immunological synapse between antigen-
presenting cells (APCs) and T cells (43) (Fig. 1.1C). These effects impair T lymphocyte 
activation and perpetuate an ineffective immune response, permitting chronic 
colonization of the stomach.  
Other bacterial virulence factors, such as cagE, may play a role in the modulation 
of apoptosis and the host inflammatory response thereby contributing to disease 
manifestations. Indeed, “virulent strains” (cagA+, cagE+ and vacA+) appear to be more 
potent inducers of pro-inflammatory mediators than “nonvirulent strains” (cagA-, cagE- 
and vacA-) possibly explaining the higher association of cag+ strains with gastric cancer 
(4). 
H. pylori neutrophil-activating protein (HP-NAP) is another major virulence 
factor, which was initially described as promoter of neutrophil adhesion to the endothelial 
cells and it is known to stimulate the production of oxygen radicals by neutrophils (44). 
Amedei et al. have found HP-NAP to be a TLR2 (Toll-like receptor) agonist, which by 
stimulating the neutrophils increase their expression of IL-12. Furthermore, when HP-
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 NAP stimulates the monocytes it will induce their production of IL-23, and differentiate 
them towards a mature dendritic cell. A T–cell that is undergoing a specific antigen 
challenge has the propensity to polarize towards a Th-1 phenotype, when stimulated with 
HP-NAP in vitro and in vivo (45).  
  
3. Host immune response - an overview. 
 
Evidence to date clearly shows the most important cofactor in the induction of 
Helicobacter-related disease is the host immune response. Indeed, chronic inflammation 
has been linked to a number of gastrointestinal cancers including chronic viral hepatitis 
and hepatocellular carcinoma; Barrett’s adenocarcinoma of the esophagus arising in the 
setting of chronic reflux disease; and colonic adenocarcinoma arising in the setting of 
chronic inflammatory bowel disease, thus setting the stage for the investigation of 
chronic inflammation in the pathogenesis of gastric adenocarcinoma. How the bacterium 
initiates an immune response is not precisely known and likely involves multiple factors. 
Despite the unclear initiating events, it is certain that chronic inflammation is necessary 
for the progression through atrophy to gastric cancer. I will begin by defining what we 
know about the initial events in immune recognition of the bacterium, and outline how 
the polarity and strength of the adaptive response impacts disease outcomes. 
 
3.1 The innate immune response to H. pylori in initial bacterial recognition. 
 
Initiation of the innate immune response to H. pylori is just beginning to be 
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 unraveled. Recent work supports a role for pattern recognition receptors (Toll-like 
receptors or TLRs) in the initial response to Helicobacter colonization, though there is 
not yet a consensus as to which receptor within this group is most important, or which 
cell type expressing the receptor plays the central role in antigen recognition (Fig. 1.2)  
Helicobacter produces a very weak LPS (lipopolysaccharide): up to 10,000- fold 
less active than LPS of other gram-negative bacteria, such as Echerichia coli (46, 47). 
We know that LPS from gram-negative bacteria, such as E. coli, predominantly stimulate 
innate immunity through TLR4 (48). Data regarding H. pylori LPS are contradictory, 
with reports of activation of both TLR4 (49) and TLR2 (50) in gastric epithelial cells. 
These contradictions may be explained by differences in bacterial strain, different 
bacterial concentrations used or trace contaminants in the LPS preparations such as 
peptidoglycan or lipopeptides, both which signal via TLR2 receptor. While the cell type 
responsible for initiation of the immune response has not been identified, it is possible 
that the gastric immune cells themselves act as the first line of recognition. Gastric 
epithelial cells reportedly express TLR4, 5 and 9 on their surface (49). In addition to LPS 
acting locally, it may gain access to the blood stream to be detected by peripheral blood 
monocytes (51).  
Whole Helicobacter bacteria (H. pylori, H. hepaticus and H. felis) activate 
immune response by TLR2, not TLR4 (52), suggesting various components of the 
bacterium (i.e. LPS, proteins, flagella) may activate various members of the TLR family. 
Indeed, expression of human TLR2 has been shown to be sufficient to confer 
responsiveness to intact Helicobacter bacteria, whereas TLR4 was not. Macrophages 
from both wild-type and TLR4-deficient mice produce a robust cytokine secretion 
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FIGURE 1.2 INNATE IMMUNITY IN HELICOBACTER INFECTION.
peptidoglycan
NOD1
IFN type1
15
FIGURE 1.2 INNATE IMMUNITY IN HELICOBACTER INFECTION.  
Multiple members of the family of Toll-like receptors (TLR) have been implicated in 
innate recognition of Helicobacter species. LPS (lipopolysaccharide) may activate the 
immune response through TLR2 and/or TLR4. Whole bacteria appear to be recognized 
by TLR2 exclusively. TLR5 may recognize bacterial flagella. Bacterial DNA containing 
CpG islands (high frequency CpG sites in DNA) may be recognized by intracellular 
TLR9. Helicobacter peptidoglycans may bind the intracytoplasmic NOD1 (nucleotide-
binding oligomerization domain) and activate interferon type 1 pathway. 
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 response (IL-6 and MCP1 (Monocyte chemotactic protein-1)) when stimulated with 
intact Helicobacter bacteria, while macrophages from TLR2-deficient mice were 
profoundly unresponsive to intact bacteria, failing to secretion cytokines even at high 
(100:1) bacteria-to-macrophage ratios. Because the quantity and strength of bacterial LPS 
is so weak, the involvement of TLR4 in clinical disease is unclear; in vitro and in vivo 
studies suggest that TLR2 may be the dominant innate immune receptor for recognition 
of gastrointestinal Helicobacter species (52). TLR5 recognizes flagellin proteins; 
however, a role for TLR5 in Helicobacter recognition is not clear. Gastric mucosal cells 
in culture express low but detectable amounts of TLR5 (53). TLR9 recognizes CpG 
(cytosine-phosphate-guanosine) molecules and distinguishes bacterial DNA from 
vertebrate DNA (54), inducing a very potent systemic Th1 response as a result (Fig. 1.2). 
CpG oligodinucleotides (ODNs) may be phagocytosed by antigen-presenting cells 
(APCs) or injected directly into the cytoplasm using the bacterial type IV secretory 
system. Interaction between TLR9 and CpG molecules intracellular recruits the MyD88 
(myeloid differentiation primary response gene 88) adapter protein and triggers a strong 
Th1 immune response (55).  
TLR signaling is required only for Th1 type of adaptive immunity, not for the 
development of Th2 type lymphocyte subsets. Th2 cells are most likely activated by 
another distinctive (but presently unknown) pathway. In the absence of induced IL-12 
production by dendritic cells, a Th2 response appears to the “default” pathway (56).  
 H. pylori peptidoglycan also activates the intracellular cytoplasmic nucleotide-
binding oligomerization domain (NOD) 1 in gastric epithelial cells promoting a Th1 
response (57). NOD domains are linked to a leucine-rich repeat domain at the C-terminus 
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 and to a caspase-recruitment domain (CARD) at the N-terminus.  NOD1 and its family 
member, NOD2 recognize peptidoglycans of the bacterial cell wall. NOD1 is expressed 
in APCs and most of the gastrointestinal epithelial cell proving their role as a defense 
mechanism in the gastrointestinal tract (Watanabe T. 2010 in press). It is known that 
NOD1 activation induces a potent IL-8 secretion in the epithelial cells of the stomach 
(58).  
Recently, Watanabe et al. have demonstrated clearly that NOD1 activation by 
Helicobacter is using its type IV secretion system.  This stimulates IP-10 secretion, 
which attracts Th1 cells to the infected mucosa, resulting in epithelial cells and incoming 
Th1 cells to produce IFN-γ in large amounts that will enhance the magnitude of the 
inflammatory response (Watanabe T. 2010 in press) (Fig. 1.2). 
 
3.2 Adaptive immunity to Helicobacter infection. 
 
Genetic manipulation of immune cell constituents has been used to evaluate the 
role of the inflammatory response in the pathogenesis of gastric cancer. For example, 
infection in recombinase activating gene (RAG)-deficient mice, severe combined 
immunodeficiency (SCID), and T cell deficient mice fail to produce tissue damage or 
recreate the metaplasia–dysplasia–carcinoma sequence (59, 60). In contrast, infection in 
B cell deficient mice (which retain a normal T cell response) is indistinguishable from 
infection in the wild type mice, stressing a crucial role for CD4 T lymphocytes in 
orchestrating disease (62). In order to understand what it is about the CD4 T lymphocyte 
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 that is related to disease, Th1/Th2 patterns were evaluated between susceptible and 
resistant strains. A susceptible strain (such as the C57BL/6 mice) is able to mount a 
strong immune response (Th1) which results in mucosal disease (61, 62), while a 
resistant strain (such as the Balb/C mice) develops an infection, but responds with a 
polarized Th2 response and appear protected from mucosal damage despite maintaining 
bacterial colonization (61). Interestingly, strains such as the C3H, which have a mixed 
Th1/Th2 cytokine profile, develop a mild mucosal disease. Although the composite 
immune picture most likely determines how disease is manifest, there may be a role for 
individual cytokines in both the predisposition to and protection from disease. 
More recently, Shi et al. have described elegantly how H. pylori infection 
promotes the secretion of IL-17, which results in the development of a Th17 immune 
response. Th17 will modulate the Th1 polarization in response to H. pylori, helping in 
bacterial colonization and resulting in gastric mucosal inflammation (63). 
Several studies have examined the role of individual cytokines in disease 
progression. For example, the IFN-γ knockout mouse is protected from Helicobacter-
induced atrophy (61, 62), while IFN-γ infusion into the infected C57BL/6 mouse 
accelerates disease progression (64). In contrast, the IL-10 knockout develops severe 
atrophic gastritis (61, 62), possibly due to the inability to modulate the immune response. 
While these studies provide useful information, one must be cautious in interpreting the 
data. The effect of over- or underexpressing a single cytokine has widespread impact on 
other signaling pathways, and effects may be secondary and not due to direct action of 
the cytokine that has been manipulated. To further address this issue, others and we have 
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 manipulated the immune response within wild-type strains. For example, infection with 
the intestinal helminth, Heligmosomoides polygyrus, skews the immune response toward 
Th2 polarization and protects the C57BL/6 host from Helicobacter induced atrophy and 
preneoplasia (65). Conversely, our group published how induction of a Th1 response in 
the Balb/C induces atrophy, metaplasia and dysplasia (66) and converts this formerly 
resistant strain to a susceptible host (CHAPTER IV).  
In humans, the designation of an immune response as Th1 or Th2 is somewhat 
artificial and simplistic as the adaptive response in humans can more accurately be 
described as falling somewhere on a continuum between these two extremes. 
The first cytokine studied in detail in humans was interleukin-1β, a pro-
inflammatory cytokine shown to induce gastrin release, inhibit acid secretion, and 
promote apoptosis. Studies by El-Omar looking at single nucleotide polymorphisms 
(SNPs) within the IL-1β gene suggested that high-expressing IL-1β genotypes increase 
the risk of developing both atrophy and gastric cancer secondary to Helicobacter 
infection (67). A combination of IL-1β, TNF-α (tumor necrosis factor alpha) and IL-10 
SNPs, which potentially result in a phenotype of elevated IL-1β and TNF-α; and 
decreased IL-10 has been shown to confer a 50-fold increased risk of gastric cancer (68, 
69). More recently, Erzin et al. analyzed a cohort of 93 H. pylori positive Turkish patients 
in tandem with their host genetic factors and established that bacterial factor babA2 is the 
most important predictor of a malignant outcome of an H. pylori infection, but the 
presence of the IL-1β-31T/T genotype is as a protective factor against it (70). There is 
also a synergistic effect between IL-10-592A/A and IL-8-251A/A in regards to 
20
 developing gastric cancer, after an analysis of a cohort of 1187 Korean patients (71).  
 Recent evidence describes the role of other cytokines in the H. pylori 
pathogenesis. For example, following an H. pylori infection, gastric epithelial cells will 
produce IL-18, a potent Th-1 cytokine. Patients infected with Helicobacter pylori who 
have a high IL-18 expression genotype (IL-18-607C/C and IL-18-137G/G) will develop a 
more severe gastritis (72).   
 
4. Inflammation, stem cells and carcinoma development. 
  
Helicobacter pylori has gone from an unknown organism ”contaminating” 
pathology slides to the celebrity of the past century. Once passed over, it is now 
recognized as the leading cause of gastric cancer worldwide, largely through its effects on 
the host immune response. Thus Helicobacter has become an important tool for the study 
of inflammation-induced cancers, and has provided for us a glimpse into the turmoil of 
chronically infected tissues. Over the last several years there has been a resurgence of 
interest in the association of inflammation and cancer. While inflammation was initially 
felt to be a beneficial response, we now recognize that in many situations inflammation 
may in fact drive malignancy.  
The concept of a cancer stem cell, or a cancer-initiating cell has regained attention 
in recent years. What years ago started as a theory, is now supported by solid 
experimental data derived from multiple models and multiple cancer types.   It is believed 
that all tumors contain a subset of cells (termed the cancer stem cell or cancer initiating 
cell) responsible for the growth, differentiation, invasion and metastasis of the tumor.  
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 The exact proportion of these cells within the tumor itself is controversial and likely 
varies widely.  The surface marker profile and gene expression pattern of these cells is 
beginning to be delineated, and while there is seemingly a different signature for each 
tumor type evaluated, there are also significant similarities, suggesting a common origin 
may exist for these cells.   Now that we recognize a cancer stem cell as the soul of a 
tumor- responsible for it’s very existence- we must address the next question- from where 
does this cancer stem cell originate?  Throughout the history of cancer research, virtually 
every cell type has at one time or another been considered as a candidate for the cancer-
initiating cell.  Our recent thinking however assigns this task to a cell with inherent 
progenitor or stem cell function. I will discuss the history of the cancer stem cell 
hypothesis, and present the arguments and data to support a role for a bone marrow 
derived cell as an additional candidate cell type to the more widely held peripheral stem 
cell candidate. 
The traditional model of cancer development suggests that genetic instability and/or 
environmental factors affect the differentiated cells of the tissue, inducing mutations that 
will lead to carcinogenesis. The tumor cell progresses through preneoplastic into a 
neoplastic stage that may, at later times, metastasize (73, 74).  The majority of cancer 
research in the last century has focused on tumor cell properties, with less attention 
dedicated to understanding what type of cells are affected by these mutations, leaving the 
question – what is the source of the cancer stem cell- unanswered.   
In order to understand where cancer stem cells come from, we must first 
understand the potential sources for this cell, and the growth properties inherent of each 
of these cell types. 
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 Most tissues in the mammalian body have a population of adult stem cells or 
progenitor stem cells.  Tissue specific stem cells have two main properties: the ability of 
self-renewal and the ability to differentiate into all cell types of the tissue of origin. Adult 
stem cells are believed to be capable of an unlimited number of cell divisions.  During 
cell division, the stem cell is thought to divide asymmetrically, producing an identical 
daughter stem cell, which remains relatively quiescent, and a transit-amplifying cell. The 
transit-amplifying (TA) cell is highly proliferative and gives rise to various differentiated 
mature cell types specific to the tissue they reside in.  These unique biological properties 
of the adult stem cell allows it to supply the tissues indefinitely with mature differentiated 
cells, ensuring homeostatic control in the face of continuous turnover, such as occurs in 
the gut, skin, blood etc., yet delegating the actual work of proliferation to a more 
“transient” cell (TA) (75). The majority of DNA damage is acquired during cell 
replication, putting a replicating cell population at risk for malignant transformation.  
This burst of proliferative activity in a cell with a finite life span may ensure cell 
proliferation while maintaining the safe guard of TA elimination prior to accumulating 
genetic damage. In most tissues the true stem cells are rare and relatively quiescent, 
making them less likely to accumulate genetic damage, but also making them difficult to 
prospectively identify and study. While the progenitor cell is considered a strong 
candidate in becoming the first cancer stem cell, it remains unclear if this is still valid 
when its population is completely exhausted in a severe inflammation case. 
The other potential source of stem cells is the bone marrow. Within the bone marrow, 
there are at least two populations of stem cells, hematopoietic and mesenchymal stem 
cells (known as bone marrow derived cells, BMDCs).  The hematopoietic stem cell is 
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 responsible for producing all the formed elements of the blood.  The mesenchymal stem 
cell was originally recognized as essential for the production of stromal support cells 
necessary for hematopoiesis, and later recognized as having tri-lineage potential, with the 
ability to differentiate to bone, cartilage and fat.  The mesenchymal stem cell has been 
shown to possess the plasticity to differentiate down most all cell lineages in the body 
and participate in tissue restoration and healing as epithelial cells as well as stromal cells. 
Under normal physiologic conditions, multiple types of epithelial cells are shown to be 
derived from bone marrow cells, including epithelium of the lung, gastrointestinal tract 
and skin (76, 77). These data strongly support the existence of a single pluripotent stem 
cell rather than multiple committed progenitor cells as the cell of origin. Thus, bone 
marrow is an excellent candidate for a continuous resource of stem cells.  
Taking advantage of the chronic infection of C57BL/6 mice with Helicobacter as a 
model of chronic inflammation and carcinogenesis, we will examine if BMDCs have any 
role in promoting gastric malignancy (CHAPTER VI).  
 
5. Alterations in gastric mucosal signaling: regulation of apoptotic and proliferative 
pathways. 
 
The host response to infection induces multiple changes within the gastric mucosa 
leading to the formation of adenocarcinoma. The balance between apoptosis (Fig. 1.3) 
and proliferation (Fig. 1.4) is severely altered and the cellular composition distorted as 
parietal and chief cells are depleted and metaplastic lineages emerge. These changes are 
likely due to effects of Th1 type cytokines, which act at several levels including induction 
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FIGURE 1.3 APOPTOTIC PATHWAYS IN HELICOBACTER INFECTION.
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FIGURE 1.3 APOPTOTIC PATHWAYS IN HELICOBACTER INFECTION. 
Several pathways for initiation of apoptosis, and of apoptosis control are active during 
Helicobacter infection. Fas Ag on the mucosal cell surface, and FasL on invading 
immune cells are upregulated by inflammatory cytokines. The Fas Ag pathway may be 
inhibited by major histocompatibility class II (MHCII) expression, which impairs Fas Ag 
receptor aggregation and DISC (death-inducing signaling complex) formation, via nitric 
oxide (NO) -induced nitrosylation of caspases, and through p38 and kinase 
Ras/MEK/ERK (mitogen-activated protein kinase /extracellular signal–regulated kinases) 
inhibition of apoptosis downstream of the Fas receptor. Helicobacter may bind to MHCII 
directly and induce apoptosis. VacA may directly induce cytochrome c release from 
mitochondria, inducing apoptosis. 
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FIGURE 1.4. PROLIFERATION PATHWAYS IN HELICOBACTER INFECTION. 
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FIGURE 1.4 PROLIFERATION PATHWAYS IN HELICOBACTER INFECTION.  
Infection with Helicobacter organisms can induce host cell proliferation through several 
pathways, including Fas-mediated proliferation through MEK/ERK (mitogen-activated 
protein kinase /extracellular signal–regulated kinases) activation of NFκB (nuclear factor 
κ-light-chain-enhancer of activated B cells); activation of the MAPK/ERK pathway 
separate from Fas signaling, through the effects of the hormone gastrin, or via the 
arachidonic acid pathway. 
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 of hypochlorhydria and atrophy (68), direct cytokine signaling, or secondary effects 
through modulation of other growth promoting signaling cascades. H. pylori in humans 
has been associated with both an increase and a decrease in apoptosis, dependent upon 
the population studied (78, 79). Increase in proliferation is seen in all cases of mucosal 
damage due to infection. Apoptosis and proliferation are intimately associated, and 
regulations of these pathways are more effectively discussed together. Apoptosis is a 
physiological safeguard against perpetuating acquired DNA damage. While increased 
apoptosis in the setting of Helicobacter infection may contribute to ulcer formation and 
cell lineage depletion, inhibition of apoptosis may lead to transformation of cells leading 
to gastric adenocarcinoma. Mouse models of infection combined with human and rat cell 
culture systems have provided a great deal of insight into the interactions of the 
bacterium with various host cell proliferative and apoptotic pathways and have allowed 
detailed study of individual signaling cascades not possible in human systems. 
The Fas Ag pathway of apoptosis is recognized as a leading cause of tissue 
destruction during Helicobacter infection. More recently, however, a role for Fas Ag 
signaling in proliferation has been recognized (80, 81). H. pylori can both directly and 
indirectly (through cytokine production) induce Fas Ag and Fas ligand expression (78, 
82-84). In transformed cell lines, H. pylori can directly induce and activate the Fas 
pathway (83). In nontransformed cell cultures, direct bacterial contact does not appear 
sufficient for induction and activation, but requires components of the immune response. 
Our laboratory has shown that IL-1β, TNF-α and IFN-γ are produced during infection 
increase surface Fas Ag expression on gastric mucosal cells resulting in increased 
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 proliferation at low receptor abundance, and increased susceptibility to Fas L-induced 
apoptosis at high receptor abundance (80, 85).  
In the wild-type C57BL/6 mouse model, levels of Fas-mediated apoptosis 
increase early in infection in a nonrandom fashion, with parietal and chief cells 
preferentially affected (81, 85). Subsequently, proliferation is increased and homeostasis 
is maintained at the cost of increased cell turnover. As infection persists and metaplastic 
and dysplastic populations arise, cells become resistant to Fas-mediated apoptosis (86, 
87) and may use the Fas pathway instead for proliferative signaling (80). Nitric oxide, 
while usually discussed in the context of DNA damage and mutagenesis, can directly 
influence mitochondrial pathways of apoptosis (88), and potentially plays a role in 
multiple levels of cell signal transduction during infection. Additionally, bacterial factors 
may directly induce apoptosis. VacA has been reported to insert directly into the 
membrane of mitochondria, inducing cytochrome c release and apoptosis (89) (Fig. 1.3). 
This is described in more details in CHAPTER III. 
 
6. Cell cycle regulation. 
 
Several bacterial factors have been directly implicated in altering apoptotic and 
proliferative signaling. For instance, Helicobacter infection alters expression of the cell 
cycle regulatory protein p27, which appears to confer an apoptosis- resistant phenotype to 
cells in culture and alters the cellular response to chemotherapeutic agents (90-92). 
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 7. Cell - cell cross talk and signal disruption. 
 
Parietal cell loss is temporally associated with atrophy, mucous cell metaplasia 
and initiation of dysplastic changes (93), suggesting a cause and effect relationship. In 
addition to production of acid, the parietal cell regulates key differentiation decisions in 
the fundic oxyntic glands with ablation of parietal cells associated with the appearance 
and expansion of undifferentiated cell types. Deregulated proliferation of poorly 
differentiated precursor cells is often associated with the appearance of a mucus neck cell 
lineage expressing trefoil factor 2 (TFF2) or spasmolytic polypeptide (SP). TFF2 is felt to 
have a physiological role in cytoprotection and maintenance of mucosal integrity and 
repair (94, 95), because it is usually expressed at the edges of healing ulcers, with 
downregulation of expression once restitution and healing are complete. Continued 
expression, as is seen in mucous cell metaplasia, is associated with dysplasia and 
progression to cancer; however, causality has not been shown. Another effect of parietal 
cell loss is hypochlorhydria, hypergastrinemia, and bacterial overgrowth, which may 
contribute independently to tissue damage and abnormal cell signaling. 
 
8. Summary. 
 
H. pylori remains one of the most common chronic bacterial infections in the 
world. Fifteen to twenty percent of infected patients will develop gastric or duodenal 
ulcer disease and up to 1% will develop gastric adenocarcinoma (30). Unfortunately, 
symptoms and disease are poorly correlated and many cases of gastric cancer are detected 
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 late in disease progression, when they are incurable. Evidence to date clearly stresses that 
a vital factor in the induction of Helicobacter-related disease is the host immune 
response. Bacterial factors most responsible for initiating and continuing the immune 
response continue to be evaluated. Our understanding of the bacterial interactions with 
components of the innate immune response continues to evolve. Additionally, we are 
expanding our understanding regarding the components of the adaptive immune response 
responsible for disease initiation and progression. A multitude of host and environmental 
factors, including interaction with other infectious agents and dietary factors, affect the 
immune response to Helicobacter organisms and may impact disease presentation over 
the life of the host. The presence of sophisticated analytical tools such as human and 
mouse genome sequence data, mouse models of infection and gastric cancer and the 
complete genome and evolving functional analysis of the H. pylori genome will prove 
extremely valuable as we address still unanswered questions on the pathogenesis of H. 
pylori induced gastric cancer. 
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 CHAPTER II. MATERIALS AND METHODS 
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 1. Mice. 
 
The University of Massachusetts Institutional Animal Care and Use Committee 
approved all animal work. Six- to 8-week-old male C57BL/6 mice which were viral 
antibody (Ab) free, parasite free, and bacterial pathogen free, inclusive of Helicobacter 
species, were purchased from Jackson Laboratories (Bar Harbor, ME) and housed in 
microisolator cages, fed standard chow, and allowed free access to water.  
T-bet (Th1-specific T box transcription factor) KO (knockout) mice in a C57BL/6 
background were certified free of H. felis, Helicobacter hepaticus, and Helicobacter bilis, 
were purchased from The Jackson Laboratory and crossed with C57BL/6 mice and 
heterozygous mice mated to produce T-bet KO and C57BL/6 wild type littermates as 
controls. Male and female mice were genotyped according to company protocol before 
initiation of any experiments and again at euthanasia. An equal number of male and 
female mice were used for each study.  
 
2. Helicobacter and Toxoplasma infections. 
 
Helicobacter felis (strain 49179 from the American Type Culture Collection, 
Manassas, VA) and Helicobacter pylori Sydney strain (a kind gift from Timothy Wang 
MD) were grown on Trypticase soy agar with 5% sheep blood under microaerophilic 
conditions at 37° for 4 days. Bacteria were harvested and the number of CFU (colony 
forming units) determined as previously described (85). Mice were restrained by hand 
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 and gavaged with Helicobacter felis or H. pylori (1 X 107 CFU suspended in 400 µl total 
volume) via a 20-gauge feeding tube (Popper and Sons, New Hyde Park, N.Y.) three 
times at 2-day intervals. 
The 76K strain of T. gondii was maintained by continuous oral passage of cysts in 
female C57L/J mice. After 2 months of infection, mice were euthanized, brains removed, 
and cysts counted. To induce T. gondii infection, 100 T. gondii cysts suspended in 250 µl 
PBS were given by oral gavage. For the effects of chronic Helicobacter infection, mice 
were infected with H. felis 20 wk before infection with T. gondii. For acute Helicobacter 
infection, mice were first infected with T. gondii, and on days 5, 7, and 9 post infection 
(to coincide with the maximum IFN-γ levels induced by T. gondii), mice were infected 
with H. felis. Control mice were infected with T. gondii alone, H. felis alone, or mock 
infected with vehicle alone. Mice were euthanized before predetermined time points if 
they became moribund or showed evidence of severe dehydration or distress. 
 
3. Bone marrow transplantation. 
 
Bone marrow was isolated from the femurs and tibias of 6-8 week old 
C57BL/6JGtrosa26 (ROSA26) or C57BL/6-TgN [ACTbEGFP] (Green Fluorescent 
Protein) mice. Total bone marrow was washed, triturated using a 20-gauge needle and 
passed through a 40µm nylon mesh cell strainer (Becton Dickson, Franklin Lakes, NJ) to 
produce a single cell suspension in PBS. Recipient C57BL/6J mice were irradiated with 
900 rads from a cesium 137-gamma cell irradiator, reconstituted with 3 x 106 donor 
35
 marrow cells via a single tail vein injection, and used for experiments after 4 weeks of 
recovery. The overall level of engraftment was 60-80% as assessed by analysis of beta-
galactosidase or GFP in peripheral leukocytes. Non-transplanted C57BL/6 mice and 
C57BL/6 transplanted with C57BL/6 marrow from liter mates served as controls for all 
injury models. C57BL/6 mice transplanted with marrow from ROSA26 or GFP 
transgenic mice without further intervention served as controls for baseline engraftment. 
All mice received a single 1 mg/kg BrdU intraperitoneal injection prior to euthanasia. 
 
4. Acute stomach alcohol injury. 
 
Mice were gavaged with a dose of 200µl of 50% ethanol in normal saline (NaCl 
0.9%, pH 7.2), as per Andrade et al. (96). Each mouse was given one dose a day for four 
successive days, then sacrificed at day 5. This corresponds to a dose of 5gm of alcohol/kg 
of mouse weight. Each mouse weighed 30gm. 
 
5. Bone marrow culture. 
 
Total marrow was collected as described above into PBS containing 
penicillin/streptomycin 1% and 5% fetal calf serum. Red Blood Cells were lysed. Bone 
marrow was depleted of differentiated cells using an antibody cocktail of TER, 
YW25.12.7, MAC-1, GR-1, LYT-2, L3T4, B220 and separated using Dynal™ magnetic 
bead. Depleted bone marrow was stained with Rhodamine and Hoechst dye and a lineage 
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 depleted, Rhodamine dull, Hoechst dull (lin-RhodullHodull) population isolated as the HSC 
population (76) using the Cytomation MoFlo (Dakocytomation, Carpenteria CA). 
Culturing whole marrow in complete medium isolated mesenchymal stem cells (DMEM, 
FBS 10%, L-glutamine 1%, penicillin/streptomycin 1%, sodium pyruvate 1%, and 
nonessential amino acids 1%) for 3 days, discarding non-adherent cells, and retaining 
adherent cells as MSC (mesenchymal stem cells). HSC or MSC (2000 cells) were plated 
into the upper well of a 0.4µm pore 6.5 mm Transwell culture dish with polycarbonate 
membrane (Corning Costar Corporation, Cambridge MA). The bottom dish contained 
either complete medium or complete medium containing gastric mucosa (see above). 
Cells were cultured at 37°, 5% CO2 for 24 or 48 hours.  
 
6. RT-PCR of bone marrow cells. 
 
RNA was isolated using RNeasy Protect Mini kit, and reverse transcribed using 
equivalent amounts of RNA using Omniscript Reverse Transcriptase and PCR with 
HotStarTaq Master Mix kit as per manufacturers instructions (Qiagen, Valencia, CA, 
USA). Primer sequences were as follows: Keratin19 (KRT1-19) 189bp, Annealing temp 
59°C, forward primer 5′- CCGCGGTGGAAGTTTTAGTGG-3′, reverse primer 5′-
GGTCCGGGTCCCTGCTTCTGGTA-3′. CD45 277bp, annealing temperature 51°C, 
forward primer 5′-GCACAC CAAAAGAAAAGGCTAATA-3′, reverse primer; 5′-
GGAATCCCCAAATCTGTCTGC-3′. GAPDH 210bp, Annealing temperature 57°C, 
forward primer 5’GACATCAAGAAGGTGGTGAAGC-3′, reverse primer 5′-
GTCCACCACCCTGTTGCTGTAG-3′. TFF2 annealing temperature 58°, forward primer 
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 5′-CTGGTAGAGGGCGAGAAA-3′, reverse primer 5′- AGAAACACCAGGGCACTT-
3′ all for 45 cycles and product resolved on a 2% agarose gel with ethidium bromide. 
 
7. Culture and characterization of culture adapted Mesenchymal stem cells 
(MSC). 
 
Total marrow was isolated as described above. Once confluent, cells were cultured 
with DMEM/20% FCS. At each passage, cultures were split as follows: one plate was 
held in culture at confluence for detection of foci, one plate was split into the next 
passage culture, and the remainder of the plates was frozen. Surface expression of CD44 
and CD45 (BD PharMingen) was assessed by fluorescence-activated cell sorting (FACS) 
analysis. Assessment of lineage specific markers, cytokeratin, vimentin, desmin, CD34, 
CD31, S100, and smooth muscle actin (SMA)(BD PharMingen), was determined by 
immunohistochemistry or reverse transcription-PCR (RT-PCR). Selected MSCs were 
stably transfected with the plasmid pDS-Red-monomer-hyg-C1, red fluorescent protein 
(RFP) expression was verified by RT-PCR and FACS, and single-cell clones were 
isolated.  
 
8. Mesenchymal stem cells injection in mice. 
 
106 RFP labeled MSC were injected in mice by a single tail vein injection on day 3 
after the 3rd dose of alcohol was given. Prior to injection, the cells were washed in PBS, 
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 strained through a 40µm strainer and suspended in 500µl of PBS.  
 
9. Necropsy and histology. 
 
Mice were euthanized, the stomach removed, opened longitudinally along the greater 
curvature, and gently washed with PBS (phosphate buffered saline). Strips of gastric 
tissue along the lesser curvature from the squamocolumnar junction through the pylorus 
were taken, fixed in 10% neutral buffered formalin for 4 h, processed by standard 
methods, embedded in paraffin, cut into 5-µm sections, stained with H&E, and examined 
for inflammation and architectural distortion.  
Sections were scored in a blinded fashion as follows: Inflammation 0: Normal; 1: 
Small multifocal leukocyte accumulations in mucosa; 2: Coalescing mucosal 
inflammation; early submucosal extension; 3: Coalescing mucosal inflammation with 
prominent multifocal submucosal extension ± follicle formation; 4: Severe diffuse 
inflammation of mucosa, submucosa, with or without deeper layers. Hyperplasia 0: 
Normal; 1: one and one-half times normal thickness; 2: two times normal thickness with 
mitotic figures one-third way up to surface; 3: three times normal thickness with mitotic 
figures half way up to surface; 4: four times normal thickness or greater with mitotic 
figures greater than half way up to the surface. Parietal cell loss and mucous cell 
hypertrophy and metaplasia 0: no substantial alterations; 1: <5% alteration; 2: 25–50% 
alteration; 3: 50–75% alteration; 4: >75% alteration. 
For enumeration of parietal cells, five high-power fields in each H&E 
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 (hematoxylin & eosin) - stained section were examined; beginning at the junction 
between the forestomach and fundus, with two well-oriented gastric glands counted per 
field for a total of 10 glands per mouse (97) and reported as the average number of 
parietal cells per gland ± 1 SD. 
 
10.  Preparation of tissue for immunohistochemistry. 
 
Mice were euthanized by CO2 inhalation; gastric tissue was removed, washed, 
sectioned as described above and fixed in 10% neutral-buffered formalin, 100% ethanol, 
or Prefer (Anatech, Ltd., Battle Creek, MI), followed by standard histological processing. 
Sections were stained using routine H&E. For immunohistochemistry, sections were 
deparafinized and hydrated. Permeabilixation with PBST (0.2% Tween) was done at 
room temperature for 10 min, followed by antigen retrival with urea (1M) at 100°C in 
microwave. Next, H2O2 quench (H2O2-3% in methanol) for 20 min at room 
temperature. After a three times wash with PBST (phosphate buffered saline Tween), 
avidin/biotin block was applied (Vector Laboratories, Burlingame, CA). Serum blocking 
applied for 1 h at room temperature with 5% solution of the host of secondary antibody. 
Primary antibody was applied overnight at 4°C in prior determined concentrations. The 
next day, after a quick wash the secondary antibody was applied at room temperature for 
1 hour. If the secondary antibody was biotinilated, an ABC mixture was applied as per 
manufacturer’s instructions (Vector Laboratories, Burlingame, CA), followed by DAB 
developing. Sections were labeled using antibodies directed against BrdU (Zymed, San 
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 Francisco, CA), bacterial betagalactosidase (Promega, Madison, WI), GFP (Abcam, 
Cambridge, UK), RFP (Rockland, Gilbertsville, PA).  
For immunostaining using mouse antibodies on mouse tissue the ARK kit (DAKO, 
Carpinetera, CA) was employed. For dual fluorescence immunohistochemistry, cell 
phenotype markers were indirectly labeled with streptavidin-fluorescein using antibodies 
directed towards pan-cytokeratin (AE1/AE3; DAKO) or CD45 (leukocyte common 
antigen, Ly-5, BD Biosciences, San Diego, CA) followed by a biotin block and serial 
application of anti-beta-galactosidase antibody labeled indirectly with streptavidin-Cy3. 
Sections were mounted with anti-fade Vectashield with DAPI (Vector Laboratories, 
Burlingame, CA), fields viewed and captured with the Zeiss Axiopath system 
(Thornwood, NY), and serial 3-color images were overlaid using Photoshop 6.0 (Adobe 
Systems, San Jose, CA). 
 
11. Direct fluorescence on stomach frozen sections. 
 
Tissue was first fixed in 4% paraformaldehyde for 4h at room temperature, then 
embedded in OTC compound (SAKURA, Torrance, USA) and immediately frozen. 5µm 
frozen sections were then cut, fixed in methanol/acetic acid (3:1 ration) for 10 min. After 
a quick air dry the slides were mounted with DAPI solution and examined for 
fluorescence under a microscope.  
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12. Co-localization of Y-chromosome and cytokeratin in paraffin tissue sections. 
 
Collected 5µm paraffin tissue section were coated on slides, and then dried overnight 
at 37°C. Slides were the dewaxed in xylene and rehydrated in graded alcohols to water. 
After incubating the slides in sodium thiocyanate (1M) for 10 min at 80°C, they were 
washed in water and digested in pepsin solution (50 mg in 100 ml of NaCl at pH of 1.5 of 
HCl) at 37°C for 10 min. It was followed by a glycine solution (2 mg/ml) treatment at 
room temperature for 5 min to neutralize the pepsin effect. Slides were then fixed in 4% 
paraformaldehyde for 2 min at room temperature. After washing in PBS three times of 15 
min each, the tissue was dehydrated in graded alcohols, then air dry. The slides were then 
aged at 65°C for 1 hour. After the StarFishTM Y chromosome-FITC conjugated probes 
(purchased from Cambio, UK) were applied on the slides, they were denatured for 10 min 
at 65°C, then incubated at 37°C for overnight. The next day, slides were washed and 
exposed to the FITC amplification kit as per manufacturer’s protocol (Cambio, UK). For 
cytokeratin detection, tissue was then exposed to anti-pankeratin PE conjugated antibody 
(clone C11, Abcam, Cambridge) at a concentration of 1/50 for 20 min at 37°C. After a 
quick wash, slides were mounted with DAPI (4',6-diamidino-2-phenylindole) antifade 
and cover slips applied; then immediately viewed with a fluorescent microscope 
(Olympus, Japan). 
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 13. Determination of enzyme (X-gal) activity. 
 
After intracardiac perfusion (4% paraformaldehyde, 2% glutaraldehyde in 0.1 M 
Sorensen’s phosphate buffer (pH 7.4) with 2 mM MgCl2 and 5 mM EGTA), stomachs 
were removed, opened along the greater curvature, washed, and linear longitudinal 
sections from the squamocolumnar junction through the pylorus collected. Tissue was 
embedded in OCT compound (SAKURA Torrance USA), snap frozen, and sectioned on 
a cryostat for enzyme histochemistry. Frozen sections (10µm) were washed in Sorensen’s 
buffer containing 0.01 % sodium deoxycholate and 0.02 % Nonidet P-40 and incubated 
for 4 hours at 37°C in a 0.1 % X-gal solution (4 % 4-chloro-5-bromo-3- indolyl-D 
galactopyranoside (X-gal) dissolved in dimethylformamide, 5 mM K3Fe (CN) 6.5 mM 
K4Fe(CN)6.6H2O in 0.1 M Sorensen’s phosphate buffer) and counterstained with nuclear 
fast red. Additional sections had nuclear fast red omitted, and cells were instead labeled 
using antibodies directed against TFF2 (a kind gift from N. A. Wright). 
 
14. Laser capture microdissection of beta-galactosidase positive glands. 
 
Frozen sections were prepared and stained with X-gal as outlined above. Individual 
gastric cells within positive glands, individual lymphocytes within an area of submucosal 
infiltrate or negative glands (control) were captured using the Laser Capture Microscope 
PixCell II, (Arcturus Engineering Inc., Mountain View, CA, U.S.A). Twenty to 30 cells 
were captured for each area of interest. DNA was extracted using the PicoPure DNA 
extraction kit (Arcturus Engineering Inc., Mountain View, CA, USA) and GAPDH (210 
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 bp) (2) or 140 bp of the LacZ/NEO fusion gene sequence amplified as follows: Annealing 
temperature 56°, forward primer 5′-CGGGCTGCAGCCAATATGGGATCG- 3′, reverse 
primer 5′-GCCGGAACACGGCGGCATCAGAGC-3′ Using HotStarTaq Master Mix 
(Qiagen, Valencia, CA, USA). Primer sequence for LacZ/NEO was a kind gift from D.K. 
Kotton. 
 
15. Mouse gastric mucosal cell culture. 
 
The entire stomach was removed from C57BL/6 mice, opened along the greater 
curvature and washed extensively in sterile PBS, 20% FCS (fetal calf serum), 
supplemented with penicillin/streptomycin and amphothericin. The fundic mucosa was 
scraped free from the serosa using a sterile scalpel, minced, manually disaggregated using 
a pipette, and the cell suspension equally divided into the bottom wells of the 
Transwell™ culture plate. Medium was changed after 24 hours to remove dead cells. 
 
16. Single stomach cell preparation for FACS analysis and FISH (fluorescent in situ 
hybridization). 
 
Stomachs were removed, opened and extensively washed. A small longitudinal 
section from the squamocolumnar junction through the antrum was processed as outlined 
above with standard H&E, anti-beta galactosidase or cytokeratin IHC. The fundic mucosa 
was gently scraped free from the serosa, minced and digested for 2 hours in 1mM EDTA, 
2% BSA and 0.1% pronase in PBS at 37° and filtered through a 40 µm nylon mesh 
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 strainer. For determination of DNA content, cells were fixed in 70% ethanol for 48 hours, 
stained with PI, and DNA content determined by FACS. For X and Y chromosome 
determination, single cell preparations from stomachs of sex-mismatched, GFP marrow 
transplanted mice were prepared as detailed above. Cells were washed twice in PBS on 
ice, resuspended in 0.5 ml of staining buffer (2% FBS, 0.01% sodium azide in PBS) and 
stained with anti-CD45-PE Ab (BD Pharmingen) according to manufacturer protocol. 
FACS sorted cells, which were GFP+ and CD45-, GFP+ and CD45+, GFP- and CD45+ 
and GFP- and CD45- were collected. An aliquot of each was prepared and analyzed for 
DNA content as described above and analyzed using FloJo software. For cytokeratin 
immunocytochemistry, an aliquot of cells were spun onto slides (Thermo Shandon) at a 
speed of 500 rpm for 5 minutes at a density of 5,000 cells per slide, fixed in 4% 
paraformaldehyde pH of 7.4 for 1 hour and incubated with the primary Ab for AE1/AE2 
keratin complex (DAKO Corporation, Carpinteria, CA) at a dilution of 1/50 using the 
Animal Research kit (DAKO corporation, Carpinteria, CA) followed by incubation with 
diaminobenzidine/hydrogen peroxidase as chromogen-substrate and counterstained with 
hematoxylin. X- and Y-chromosomes were detected using the Dual Color Detection kit 
(ID Labs) according to the manufacturer’s protocol (DAPI for nuclear staining, FITC for 
Y chromosomes and Texas Red for X chromosomes) and immediately viewed with a 
fluorescent microscope (Olympus, Japan). 
 
17. Cytokeratin staining of stomach single cells after FACS sorting. 
 
Fluorescence-activated cell sorter (FACS)-sorted cells were spun onto slides (Thermo 
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 Shandon, Pittsburgh, PA) at a speed of 500 rpm for 5 min at a density of 5,000 cells per 
slide, fixed in 4% paraformaldehyde, pH 7.4, for 1 h, and incubated with the primary Ab 
for AE1/AE2 keratin complex (DAKO Corporation, Carpinteria, CA) at a dilution of 1/50 
using the Animal Research kit (DAKO Corporation, Carpinteria, CA), followed by 
incubation with diaminobenzidine/hydrogen peroxidase as a chromogen substrate and 
counterstaining with hematoxylin. 
 
18. Serum IFN-γ determination in mice. 
 
Blood was collected before euthanasia and immediately spun; aliquots of serum 
frozen at -80°C. IFN-γ ELISA detection kit (Pierce Endogen, Rockford, IL) was used 
according to manufacture’s protocol. Samples were run in duplicate, compared with a 
standard curve generated with known values, and reported as the mean ±SD for each 
group.  
 
19. ELISA for IgG1 and IgG2a Abs against H. felis. 
 
The 96-well plates were coated overnight at 4°C with 100 µl of a 10 µg/ml H. felis 
protein in carbonate buffer (pH 9.6) as previously described (65). The blocked washed 
plates were incubated for 1.5 h at room temperature with diluted serum samples in 
triplicate. Biotinylated monoclonal secondary Abs produced by clones G1-6.5 and R19-
15 (BD Pharmingen, San Diego, CA) for detecting mouse IgG1 and IgG2a, respectively, 
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 were used. Incubation with streptavidin peroxidase (Sigma-Aldrich, St. Louis, MO) was 
followed by ABTS substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) for 
color development. Absorbance at wavelength 405 nm was recorded on an ELISA plate 
reader (DynatechMR7000; Dynatech Laboratories, Chantilly, VA) and reported at a 
sample dilution of 1/100. 
 
20. ELISA for anti-T. gondii IgG-total, and IgG1 and IgG2a isotypes. 
 
Sera from mice were tested for T. gondii-specific IgG and IgG subtypes as previously 
described (98). Briefly, 96 microwell plates were coated with T. gondii tachyzoites (5 X 
104 parasites per well), dried overnight then blocked with PBS-BSA 4% at 37°C for 1 h. 
Serial dilutions of the sera (1/200 to 1/512,000 for total IgG and 1/1000 to 1/1,024,000 
for isotype analysis) were incubated for 1 h at 37°C followed by incubation with anti-
mouse IgG conjugated to alkaline phosphatase (1/1000 dilution; Sigma- Aldrich) or anti-
mouse IgG1 or IgG2a conjugated with HRP (1/8000 dilution; Southern Biotechnology 
Associates, Birmingham, AL) for 1 h at 37°C and detected by p-nitrophenyl phosphate or 
tetramethylbenzidine substrate (Sigma-Aldrich), respectively. OD was measured at 450 
nm with an ELISA plate reader (Bio-Rad, Hercules, CA). The Ab titer for each sample 
was calculated as described by (99) and expressed as the reciprocal of the highest dilution 
for which the absorbance was 2.5 times greater than the absorbance of control sera at the 
same dilution. Results are given as the means of log2 titer ± SD. 
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21. Quantitative analysis of H. felis colonization. 
 
A 2 mm X 2 mm piece of gastric mucosa taken at the fundus/antral border was snap 
frozen at the time of necropsy. All samples were processed together as follows: DNA was 
extracted using High Pure PCR Template Preparation kit (Roche Molecular 
Biochemicals, Indianapolis, IN) according to manufacture’s protocol. The 2 µl of 
extracted DNA was used for RealTime PCR (SmartCycler; Cepheid, Sunnyvale, CA) 
using QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA). Standards were made by 
sequential 10-fold dilutions of purified H. felis DNA producing a range from 500,000 to 5 
copies per reaction. This is based on the premise that 2 Fg of H. felis chromosomal DNA 
is equivalent to 1 copy of the H. felis genome. Each sample was analyzed in triplicate. 
Primers sequences for a 225 fragment of the flaB gene were as follows: 5’-TTCG 
ATTGGTCCTACAGGCTCAGA-3’ and 5’TTCTTGTTGATGACATTGACCA 
ACGCA- 3’. Annealing temperature was 55°C. 
 
22. Quantification of splenic T. gondii tachyzoite DNA. 
 
One-half of each spleen was snap frozen at the time of necropsy and all samples 
processed together. A 5 µl of genomic DNA was used for Real- Time PCR (SmartCycler; 
Cepheid) using QuantiTect SYBR Green PCR kit (Qiagen) according to manufacturers 
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 directions. Results were analyzed using relative quantification with 2-ΔΔCT method (100) 
using GAPDH as the internal control. Primers amplifying a 183 bp fragment of the T. 
gondii B1 gene were as follows: 5’-CATTCTTGTGCTGCCTCCTCTCAT-3’, 5’- 
AGCGGCAGCGTCTCTTCCTCTTT-3’, annealing temperature at 57°C. The other half 
of the spleen was fixed in 10% buffered formalin and processed as previously described. 
T. gondii tachyzoites were enumerated in spleen sections stained with H&E. 
 
23. Spleen cell assays. 
 
Spleen cells were isolated using Lymphocyte Separation Medium-M (Cellgro). For 
anti-CD3 stimulation, High Protein binding plates (Corning) were coated with anti-CD3 
Ab at 400 ng/ml. Spleen cells were plated at 1 X 106 per well together with anti-CD28 at 
100 ng/ml (BD Pharmingen) and incubated for 18 h. Cytokine levels were measured in 
culture supernatants by ELISA. Statistical analysis was performed using Student’s t test 
(JMP Software). For FACS analysis, spleen cells were harvested and RBCs were lysed 
with Tris-ammonium chloride. Cells were incubated with allophycocyanin- or PE-labeled 
Abs specific for FasL, CD3, CD4, CD8, CD11b, CD19, and CD69 (BD Pharmingen) and 
analyzed using a FACS scan analyzer (BD Biosciences). 
 
24. RT-PCR of stomach sorted cells. 
 
Populations (MHCII+ Fas Ag+ CD45-, MHCII+ Fas Ag- CD45-, and mouse stomach) 
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 were subjected to reverse transcription-PCR (RT-PCR) for the following genes: Fas Ag, 
MHCII, TFF2, gastric intrinsic factor (GIF), hydrogen potassium ATPase (HK ATPase), 
MUC5, MUC6, and 18S rRNA. RNA was isolated using the RNeasy kit (QIAGEN, 
Valencia, CA), purified, and DNase treated using a DNA-free RNA kit (Zymo Research, 
Orange, CA). Reverse transcription was done with the Omniscript RT kit (QIAGEN, 
Valencia, CA) using the manufacturer’s protocol. PCR was done with the HotStarTag 
Master Mix kit (QIAGEN, Valencia, CA) using the manufacturer’s protocol, and the 
PCR products were run on an agarose gel (2%). RT-PCR was carried out in a 
programmed thermal Eppendorf Mastercycler (Eppendorf AG, Hamburg, Germany) 
using primer sequences and conditions listed in Table 1. 
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 Table 1. Mouse primers. 
 
Primer name Primer sequences 
(Forward and Reverse) 
Product 
size (bp) 
 
Annealing 
Temp (°C) 
 
Fas Ag AAGGGAAGGAGTACATGGACAAGA 
GAGGCGCAGCGAACACAG 
184 55 
MHC class II GACATTGGCCAGTACACATTTGAA  
TTGGGGAACACAGTCGCTTGAG 
230 55 
TFF2 GCTTCCCGGGCATCACCAG 
AAACACCAGGGCACTTCAAA 
229 56 
GIF TTGCCCAAATTCTCCCTTCCTT 
CCCCTCTCAGCTGGTTGTTTATGG 
171 55 
HK ATPase CCCCCAATGGCACCTTCAGTCTCC 
TTCGTAGGGGTCATGGGGGTTGTT 
182 59 
MUC5 ACGGGGATGGCCACTTTGTTACCT 
TCTCCGCTTGGCCCTTGCTCTAC 
253 59 
MUC6 ACTGGCCAGCCTGTCCGAAACT 
GGGGCCATAAACCATACCATTGAG 
255 60 
18S rRNA AAAATAGCCTTCGCCATCACTG  
GGCTGTACTTCCCATCCTTCAC 
217 56 
IFN-γ CATGGCTGTTTCTGGCTGTTACTG 
GTTGCTGATGGCCTGATTGTCTTT  
226 54.5 
IL-12 CTGCCTGCCCCCACAGAAGA 
GCGCAGAGTCTCGCCATTATG  
208 57 
IL-1β CAGGATGAGGACATGAGCACC 
CTCTGCAGACTCAAACTCCAC 
446 60 
IL-4 ATCGGCATTTTGAACGAGGTCA 
CATCGAAAAGCCCGAAAGAGTCT 
221 56 
IL-10 CCTAGAGCTGCGGACTGCCTTCA 
CAGCCGCATCCTGAGGGTCTTC 
247 58 
GAPDH GACATCAAGAAGGTGGTGAAGC 
GTCCACCACCCTGTTGCT GTAG 
210 57 
IL-5 GGCTTCCTGTCCCTACTCATAAAA 
AGCCTTCCATTGCCCACTCT 
252 55 
IL-13 ATGGCGCTCTGGGTGACTGC 
ATTTTGGTATCGGGGAGGCTGGAG 
326 60.1 
CXCR4 GACCGCCTTTACCCCGATAGC 
ACCCCCAAAAGGATGAAGGAGTC 
248 57.9 
β actin CCTAAGGCCAACCGTGAAAAGATG 
GTCCCGGCCAGCCAGGTCCAG 
219 59.7 
SDF-1 GAGAGCCACATCGCCAGAGC 
GGATCCACTTTAATTTCGGGTCAA 
123 60 
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 25. Real-time PCR for gastric mucosal cytokines. 
 
Total RNA was extracted from the fundus of the stomach using RNAeasy kit 
(Qiagen). A 5 µg of total RNA was DNase treated using RNase-Free DNase set (Qiagen) 
and reverse transcribed using OmniScript RT kit (Qiagen). A total of 2 µl of cDNA was 
used for RealTime PCR (SmartCycler; Cepheid) using QuantiTect SYBR Green PCR kit 
(Qiagen) and results analyzed using Relative Quantification with the 2-ΔΔCT method (100). 
GAPDH or β-actin was used as the internal control. Primers were designed using 
DNASTAR software (Madison, WI). Primer sequences are listed in Table 1. 
 
26. Cell culture of RGM1 cells. 
 
Rat gastric mucosal cells (RGM-1 cell line; RIKEN cell bank, Tsukuba Science City, 
Japan) were cultured in Dulbecco’s modified Eagle medium with 20% fetal bovine 
serum, 1% L-glutamine, and 1% penicillin-streptomycin (Invitrogen, Grand Island, NY) 
at 37°C (with 5% CO2) and grown to 50 to 70% confluence. Cell lines were cultured as 
described above with 100ng/ml rat gamma interferon (IFN-γ) (PeproTech, Rocky Hill, 
NJ) for 48 h, with 0.5 µg/ml cytochalasin D (CytoD) (Calbiochem, San Diego, CA) for 
18 h, and/or with 12.5, 25, or 50 ng/ml human recombinant Fas L for times ranging from 
30 min to 48 h (50% lethal dose = 50 ng/ml; Alexis Corporation, San Diego, CA). The 
parent cell line and cell lines expressing Fas Ag with or without MHCII were exposed to 
cytochalasin D prior to exposure to Fas L. The dose used in this study (0.5 µg/ml) 
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 inhibits actin polymerization without being cytotoxic, as assessed by analytical cytology 
analysis (101). 
 
27. Characterization of RGM-1 cells. 
 
Total RNA was extracted from RGM1 and MHCII-Fas Ag cells and rat stomach (as a 
positive control) by using TRIzol (Invitrogen, Life Technologies, Carlsbad, CA) 
according to the manufacturer’s directions. Two micrograms of RNA was purified, 
DNase treated, and reverse transcribed as previously described. Primer sequences for rat 
TFF2, GIF, TFF2, HK ATPase β subunit, MUC, MUC1, MUC5, MUC6, and 18S rRNA 
are given in Table 2.  
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Table 2. Rat primers. 
 
Primer name Primer sequences 
(Forward and Reverse) 
Product 
size (bp) 
 
Annealing 
Temp (°C) 
 
TFF2 CTGGCGGAAGGCGAGAAAC 
ATGCCCGGGTATCCACAAT 
230 57 
GIF ATTGCCCAGATTCTCCCTTCCT 
CCCCCTCAGCTGGTTGTGTTTATG 
171 55 
HK ATPase TCACGGCGGACATGCTACAGAAT 
TCCGGGGCTTTTGGGGGTCATC 
174 58 
MUC CACCCCCATCTCCACCACCATTAC 
AGCCCCTCTGAGACATTACACTG 
240 56 
MUC1 CCAGTGCCGCCGAAAGAGC 
CAGCCGGGTTGGTGTAAGAGA 
191 58 
MUC5 CCAAGGGCCTCCACCAACAC 
TCCAGGCCTGAGCACACACC 
201 57 
MUC6 ACACCTGTGGGCCCCTCCTACTTG 
ACTGTGGGCCTTGTGGGTGTTGAC 
209 59 
18S rRNA TCCCCGAGAAGTTTCAGCACATCC 
CTTCCCATCCTTCACGTCCTTCTG 
269 59 
MHC class II TCCCTGCGGCGGCTTGAG 
TCTGACGCTTGTGACGGATGAAAA 
406 60 
Ii (invariant chain) CCCGATGCGCATGGCTACTCC 
CCCGCGGCTCTTGGTGTGA 
487 60 
CIITA (major 
histocompatibility 
class II 
transactivator) 
TGCCCACGAAACACAGGAACC 
GACGGGGCCCAATGCAAACTCTA 
466 60 
GAPDH TCTTCACCACCATGGAGAA 
ACTGTGGTCATGAGTCCTT 
231 60 
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 Periodic acid-Schiff (PAS) staining was performed on cytospun cells by using a PAS 
staining system from Sigma (St. Louis, MO) according to the manufacturer’s protocol. 
Alcian blue staining was performed using alcian blue solution (alcian blue 8GX [Sigma, 
St. Louis, MO] at 1 g in 100ml 3% acetic acid, pH 2.5) for 30 min, followed by a tap 
water wash for 2 min and counterstaining with Nuclear Fast Red (DAKO, Carpinteria, 
CA) for 5 min. Slides were dehydrated and mounted with Permount (Fisher Scientific, 
Fair Lawn, NJ). 
 
28. RGM-1 cells as a model for MHCII signaling in gastric mucosa. 
 
Total RNA was extracted from RGM1 cells exposed to 100 ng/ml rat IFN-γ 
(PeproTech, Rocky Hill, NJ) or control medium and was reverse transcribed and 
analyzed as previously described, using primers for MHCII RT1B-beta chain, MHCII 
transactivator (CIITA), and GAPDH (glyceraldehyde-3-phosphate dehydrogenase). 
Control reactions were done without the addition of reverse transcriptase. 
 
29. Fas Ag- and MHCII - expressing clones. 
 
RGM-1 cells expressing high levels of surface Fas Ag, MHCII complex alone, both 
Fas Ag and MHCII complex, or empty vector were made as follows. Total RNA was 
isolated from mouse thymus and reverse transcribed, and specific sequences were 
amplified using the following primers: I-A alpha sense, 5’-
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 CTAGCTAGCACCATGCCGCGCAGCAGAGCT-3’; I-A alpha antisense, 5’-
CCGGAATTCTCATAAAGGCCCTGGGTGTC-3’; I-A beta sense, 5’-
TGCTCTAGAACCATGGCTCTGCAGATCCCCA- 3’; and I-A beta antisense, 5’-
ATAAGAATGCGGCCGCTCACTGCAGGAGCCCTG-3’. After sequencing 
(University of Massachusetts Nucleic Acid Facility; ABI Prism model 377 version 3.4.1, 
ABI200), the 771-bp MHCII   αchain was inserted into the NheI/EcoRI site of multiple 
cloning site A and the 791-bp MHCII β chain was inserted into the XbaI/NotI site of 
multiple cloning site B of the pIRES cloning vector (Clontech, Palo Alto, CA), and stable 
clones were selected in neomycin. The 1-kb Fas Ag fragment was cloned using the sense 
primer 5’-GAAGATCTGCAGACATGCTGTGGATCTGGGCTGTC-3’ and antisense 
primer 5’-CTCGAATTCTCACTCCAGACATTGTCCTTCATTTTC- 3’, sequenced, and 
inserted into the BglII/EcoRI site of pMSCV-puro (BD Clontech), and stable clones were 
selected in puromycin. Membrane surface receptor expression was confirmed by FACS 
analysis (anti-CD95-FITC or MHCII [I-Akα-FITC and I-Akβ-PE]; PharMingen, San 
Diego, CA). Expression of MHCII and Fas Ag was analyzed as a percentage of positive 
cells over background staining. Before these studies, expression of Fas Ag or MHCII on 
CD45- depleted, H. felis-infected (4 to 8 weeks) mouse gastric mucosa was determined 
by FACS, and populations were classified as high- or low-expressing populations based 
on surface receptor abundance. The average receptor expression level in the high-
abundance population was quantitated relative to GAPDH and 18S rRNA. We then chose 
our high-Fas-Ag-expressing cell lines and our dual Fas Ag/MHCII cell lines based on the 
numbers derived from these studies. A cell line was considered a high expressor if it 
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 expressed 1.5 to 2.0 times the average level of Fas Ag, or of Fas Ag and MHCII, of the 
mouse gastric mucosal cells. Three to five representative clones of each group were used 
to confirm experiments. 
 
30. RGM1 cell growth assays. 
 
For proliferation, 1 X 104 cells per well were incubated in 96-well plates with or 
without 12.5 ng/ml Fas L for 24 h. The plates were harvested and [3H] thymidine 
incorporation measured as counts per minute. For apoptosis assessment, 1 X 104 cells 
were seeded into each well of a six-well plate and incubated with or without Fas L at 25 
ng/ml for 4 h. Cells were visualized, stained with annexin V and propidium iodide by 
using an annexin V-FITC kit (Oncogene, Boston, MA) according to the manufacturer’s 
protocol, and analyzed via flow cytometry. Cells that were annexin V positive and PI 
(propidium iodine) negative or annexin V positive and PI positive were determined to be 
apoptotic. Experiments were repeated three times. 
 
31. Caspase 8 activity assay. 
 
Cells (1 X 106) were stimulated for 1 h with Fas L at 25 ng/ml. Stimulated and control 
cells were collected and analyzed using a Caspase-8 Fluorometric Activity Assay kit 
(Oncogene, Boston, MA) according to the manufacturer’s directions. Caspase 8 activity 
was measured using a fluorescent plate reader (Perkin-Elmer Life Sciences, Boston, MA) 
at an excitation wavelength of 400 nm and an emission wavelength of 510 nm. 
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 Comparisons were made in relative fluorescence units. Experiments were repeated three 
times. 
 
32. DISC immunoprecipitation and analysis. 
 
Cells were grown to 70 to 80% confluence and then stimulated with human 
recombinant FLAG-tagged-Fas L (Alexis Biochemicals) (50 ng/ml) or control vehicle for 
30 min. Cells were harvested, washed in cold buffer, pelleted, and lysed in ice-cold lysis 
buffer (30 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40, 1 mM 
phenylmethylsulfonyl fluoride) with 2 µg/ml small peptide inhibitors (pepstatin, 
chymostatin, antipain, and leupeptin; Sigma, St. Louis, Missouri) for 30 min. Control 
cells had FLAG-tagged Fas ligand added after lysis. Cell debris was pelleted by 
centrifugation for 10 min at 13,000 X g. FLAG-Fas L-CD95-DISC complexes were 
immunoprecipitated with an affinity column and anti-FLAG M1 affinity gel (Sigma, St. 
Louis, MO) according to the manufacture’s protocol. The multimeric status of Fas 
Ag/CD95 was determined by fractionating immunoprecipitated complexes under non 
reducing conditions on a 4 to 20% gradient gel (Gradipore Ltd., French Forest, Australia) 
at 4°C. Proteins were transferred to a polyvinylidene difluoride membrane (Amersham 
Biosciences Corp, Piscataway, NJ) and blocked overnight in 5% nonfat dry milk in 0.1% 
Tris-buffered saline–Tween 20. Anti-CD95 mouse monoclonal Ab at a 1:2,000 dilution 
(BD PharMingen, San Diego, CA) was used as the primary Ab, and donkey anti-mouse 
horseradish peroxidase-conjugated Ab (Santa Cruz Biotechnology Inc., Santa Cruz, CA) 
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 at a 1:3,000 dilution was used as the secondary Ab. To verify components of DISCs, 
aliquots were run on reducing gels and blotted using anti-Fas Ag monoclonal antibody at 
a 1:2,000 dilution (BD PharMingen, San Diego, CA) and rabbit anti-mouse caspase 8 
polyclonal antibody at a 1:1,000 dilution (BD PharMingen, San Diego, CA), which 
detects both noncleaved (inactive) and cleaved forms of caspase 8. Detection was done 
using the ECL Plus System kit (Amersham Biosciences Corp., Piscataway, NJ) according 
to the manufacturer’s directions. 
 
33. CXCR4 knock down in mesenchymal stem cells. 
 
shCXCR4-GFP construct (clones 1, 2, 3) was purchased from GeneCopoeia 
(Rockville, MD). The cells were transfected with this constructs using a letiviral system. 
293FT cells were used for virus production using Virapower (Invitrogen, Carlsbad, CA) 
as per manufacture’s instruction manual, under collaboration with Dr. John Mordes.  
Cells were infected with clones 1, 2 and 3 in succession, using 50µl of viral culture per 
well of a 6 well plate at a 70% cell confluence. The infection efficiency was checked by 
GFP fluorescence.  
 
34. cAMP (cyclic adenosine monophosphate) ELISA assay. 
 
50,000 cells per well were seeded in a 96 well plate, precoated with anti-cAMP 
antibodies, purchased from Applied Biosystems (Bedford, MA). After letting the cells to 
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 grow in culture overnight, they were stimulated with SDF-1 at 100ng/ml concentration 
for 10 min at 37°C. Cell media was then aspirated and the cells were lysed in a buffer 
provided in the kit. The remaining protocol was followed as per manufacturer’s 
instructions. The results were read by a plate luminometer at an emission of 470nm 
(Perkin-Elmer, Waltham, MA). The results were plotted against the standards, provided 
in the kit. 
 
35. Transwell cell migration assay. 
 
Transwell plates with an 8µm pore size inserts were purchased from Corning (Lowell, 
MA). Mesenchymal cells were seeded in the well insert at a 10,000-cells/100µl of 0.1% 
fetal calf serum concentration media. After a 6-hour incubation, the bottom well media 
was changed to new media with or without 100ng/ml of SDF-1 and incubated for 
overnight. The next day, the inserts and the media were discarded. The cells that migrated 
through the Transwell were fixed with methanol/acetic acid (3:1 ratio) for 10 min, and 
then stained with Giemsa solution (1/20 concentration) for 10 min. After a wash with 
PBS, the plate was air-dried and the cells were counted under a microscope. The results 
of migrated cells were plotted as a ratio of its nonstimulated control group (given a value 
of 1).  
 
 
 
60
 36. Western blotting on cultured cell lines. 
 
Cells were grown at 80% confluence overnight, seeded in equal numbers. Cells were 
then lysed by adding 1xSDS sample buffer (500µl per a 100mm plate). Sonication was 
done for 10-15 seconds to shear DNA and reduce sample viscosity. After a 5 min heating 
done at 100°C, cell lysates were centrifuged for min and the supernatant was loaded on a 
SDS-PAGE gel. Transfer was done on PFDF (Biorad, Hercules, CA) membrane for 65 
min at 110 volts. Blocking was done with 5% nonfat milk at room temperature for 1 hour. 
Primary antibody at appropriate concentrations (CXCR4 – 1/250 (Abcam, UK); β-actin 
HRP conjugated, 1/1000 (Santa Cruz, CA)) was incubated overnight at 4°C. The next 
day, secondary antibody was incubated for 1 hour at room temperature. Detection was 
done using SuperSignal (Pierce Endogen, Rockford, IL). 
 
37. Statistical analysis. 
 
Survival after T. gondii/H. felis infection is shown using the Kaplan-Meier curve. 
Data for serum IFN-γ, T. gondii gene expression, tachyzoite quantitation, and H. felis 
copy number are reported as the mean ± 1 SD. Results for T. gondii Ab response are 
given as the mean of log2 titer ±SD. H. felis IgG1 and IgG2a are reported as a mean ± 1 
SE and compared using the Student t test. A value of p < 0.05 was considered statistically 
significant for differences between groups. Pathology data are compared using the Mann-
Whitney analysis of nonparametric data and considered significant at a value of p < 0.05. 
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 Statistical analysis of real-time RT-PCR was done using REST 2009 software (Technical 
University Munich, Germany).  
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CHAPTER III. MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II 
INHIBITS FAS ANTIGEN-MEDIATED GASTRIC MUCOSAL CELL 
APOPTOSIS THROUGH ACTIN-DEPENDENT INHIBITION OF RECEPTOR 
AGGREGATION 
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 Introduction 
 
Escape from normal apoptotic control is thought to be essential for the 
development of cancer. During Helicobacter pylori infection, the leading cause of gastric 
cancer, activation of the Fas antigen (Fas Ag) apoptotic pathway is responsible for early 
atrophy and tissue loss. As disease progresses, metaplastic and dysplastic glands arise, 
which express Fas Ag, but are resistant to apoptosis and are believed to be the precursor 
cells for adenocarcinoma. The C57BL/6 mouse model of Helicobacter infection is a 
powerful tool with which to study the initiation and progression of gastric cancer. 
Infection in the C57BL/6 mouse recapitulates human disease, progressing from atrophy 
and metaplasia through dysplasia to intraepithelial neoplasia with invasion through the 
muscularis mucosae (102). Using this mouse model to understand the mechanism(s) by 
which gastric mucosal cells acquires a transformed phenotype is critical to our efforts to 
prevent and treat gastric cancer. Initiation of cancer requires that cells escape from normal 
apoptotic controls (103). The extension of cell viability through inhibition of apoptosis is 
a hallmark of human tumors and appears necessary for cells to acquire a transformed 
phenotype (103). While inhibition of apoptosis per se is not carcinogenic, failure to 
remove genetically damaged cells which otherwise would have been eliminated allows 
unchecked accumulation of potentially transforming mutations. Helicobacter has been 
shown to induce apoptosis both directly and indirectly in gastric mucosal cells (104-111). 
One apoptotic pathway is the Fas antigen (Fas Ag) signal cascade. Under normal, 
noninflamed conditions, Fas Ag is expressed at minimal levels throughout the gastric 
mucosa (112). However, with Helicobacter infection there is a marked upregulation of 
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 mucosal Fas Ag receptor expression (81, 84), and an increase in Fas Ag expression in both 
mouse experimental systems and in vitro tissue culture systems results in an increase in 
apoptotic signaling (80, 83-85). Fas signaling is crucial for gastric mucosal alterations 
under inflammatory conditions (81, 83, 113-115). As the time of infection increases, a 
subset of cells within the gastric mucosa appear which are resistant to Fas mediated 
apoptosis as evidenced by continued survival in the face of persistent Fas Ag expression 
and available ligand. The Fas Ag-expressing population of cells increases as architectural 
alterations progress through metaplasia to dysplasia to cancer (87, 112). The mechanism 
of Fas-apoptosis resistance is not known, but has been suggested to include expression of 
FAP-1 (Fas associated phosphatase-1), an inhibitor of Fas-mediated apoptosis (86) and 
FLIP (FLICE inhibitory protein), a dominant- negative caspase 8 (87). In general, Fas-
mediated cell death is controlled by an abundance of independent mechanisms allowing 
cells to integrate a variety of intracellular and extracellular signals to respond in a highly 
flexible manner towards Fas stimulation. Regulation of the Fas pathway in gastric cells is 
complex and, at present, incompletely defined.  
Fas Ag is a cell surface receptor. When Fas ligand (Fas L) binds to Fas Ag, 
receptors aggregate and recruit adaptor proteins, forming the death-inducing signaling 
complex (DISC) (consisting of Fas L, Fas Ag, FADD (Fas-Associated protein with Death 
Domain) and FLICE [procaspase 8]). Once the DISC is formed, a caspase cascade is 
activated directly (type I signaling) or activated using a mitochondrial amplification loop 
(type II signaling). Both pathways converge at the level of caspase 3, resulting in 
apoptosis. There are multiple levels at which this cascade can be regulated, including 
regulation by parallel signaling pathways and receptor-receptor interactions.  
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 Major histocompatibility complex class II (MHCII) molecules are heterodimeric 
cell surface glycoproteins whose expression is critical for the development of CD4 T 
cells and the ability to mount an adaptive immune response. These molecules are 
expressed on professional antigen-presenting cells, such as B cells, macrophages, and 
dendritic cells, which function in the uptake, processing, and presentation of antigen to 
CD4 T cells. In addition, these molecules are constitutively expressed on epithelial cells 
of the thymus, macrophages, Langerhans cells of the skin (116), and Kupffer cells in the 
liver (117). Under permissive conditions, MHCII expression can be induced in a variety 
of cell types, including cells of the gastrointestinal tract (104, 118).  
During Helicobacter infection, gastric mucosal cells upregulate surface MHCII 
expression and costimulatory molecules (119-121) and have the ability to weakly present 
antigens (119, 122). Additionally, there is evidence that Helicobacter pylori may bind the 
gastric cell via the MHCII complex and regulate apoptotic responses (120). We show that 
during Helicobacter infection there is a small but distinct population of gastric mucosal 
cells, which coexpress Fas Ag and MHCII, setting up a scenario where these receptors 
may interact, akin to what we see in immune cells. Our examination of cells in culture 
demonstrates that MHCII prevents Fas receptor aggregation at the level of the actin 
cytoskeleton and renders Fas-expressing gastric mucosal cells resistant to Fas L-mediated 
apoptosis. These findings support that MHCII coexpression may be one of the 
mechanisms by which gastric mucosal cells escape Fas-mediated apoptosis. 
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 Results 
 
1. RGM-1 cells resemble immature gastric mucus cells. 
 
Metaplastic and dysplastic cells express both MHCII and Fas Ag and are Fas 
apoptosis resistant. In order to test the interaction of these two receptors in vitro, we used 
a cell line derived from mucus cells that resembles cells early in the metaplasia-dysplasia 
sequence. RGM-1 cells are cytokeratin positive but do not express lineage-specific 
markers such as GIF (expressed in chief cells), hydrogen potassium ATPase (expressed 
in parietal cells), MUC5 or MUC6 (expressed in neck and surface epithelial cells), or 
TFF2 (expressed in metaplastic cells) (Fig. 3.1A) and do not stain with alcian blue, pH 
2.5 (indicative of intestinal type mucin) (data not shown). RGM-1 cells are weakly PAS 
positive (Fig. 3.1B to G), indicating glycogen stores. 
 
2. A population of gastric mucosal cells expresses both Fas Ag and MHCII receptors 
under conditions of inflammation. 
 
During Helicobacter infection and inflammation, Fas Ag (81, 83, 85, 113-115) 
and MHCII (119-121, 123) expression on the gastric mucosal cell surface is increased. 
Representative histological sections from sham-infected (Fig. 3.2A), H. felis-infected 
(Fig. 3.2B), and H. pylori-infected (Fig. 3.2C) mice at 6 months show preserved normal 
architecture in the sham-infected mouse, with a paucity of inflammatory cells and no 
metaplasia or dysplasia (Fig. 3.2A). At 6 months (Fig. 3.2B and C), the chronically 
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FIGURE 3.1 RGM-1 CELLS RESEMBLE IMMATURE MUCUS CELLS.
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FIGURE 3.1 RGM-1 CELLS RESEMBLE IMMATURE MUCUS CELLS.  
(A) RT-PCR for a panel of gastric mucosa-expressed genes in RGM-1 and RGM-1 
MHCII/Fas Ag cell lines. Total rat stomach was used as a positive control (top row). 
RGM-1 cells without reverse transcriptase were used as a negative control (bottom row). 
RGM1 and RGM-1 MHCII/Fas Ag cells do not express any of the gastric mucosa genes 
showing that they are immature cells. (B and C) PAS-hematoxylin staining of primary 
hepatocyte culture is positive (purple staining of cytoplasm) (positive control) (B) and 
primary lymphocyte culture is negative for PAS staining (negative control) (C). (D and 
E) Hematoxylin staining of RGM-1 (D) and MHCII/Fas Ag (E) cells. (F and G) PAS - 
hematoxylin staining of RGM-1 (F) and MHCII/Fas Ag (G) cells. Both cell lines are 
positive for PAS staining (arrows). 
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FIGURE 3.2 HISTOLOGICAL CHANGES DUE TO HELICOBACTER INFECTION.
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FIGURE 3.2 HISTOLOGICAL CHANGES DUE TO HELICOBACTER 
INFECTION.  
Six- to eight-week-old male C57BL/6 mice were infected with control medium (sham 
infected), H. felis, or H. pylori and euthanatized at 6 months. The gastric mucosa of 
sham-infected mice (A) had normal architecture, with preservation of parietal cells and a 
paucity of inflammatory cells. The gastric mucosa of mice infected with H. felis (B) or H. 
pylori (C) had antralization of glands (thin arrow), loss of parietal cells, and chronic 
inflammatory infiltrate in the submucosa (thick arrows) and above the muscularis 
mucosa, between glands. Hematoxylin and eosin staining was used; magnification, X40. 
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 infected mice have developed moderate submucosal plasma-lymphocytic infiltrates, with 
lymphocytes invading the mucosal layer and intercalating between glandular units. There 
is a decrease in the number of parietal and chief cells, antralization of glands and early 
metaplasia. There was no evidence of dysplasia at this early time point. The findings 
were similar for both the H. felis- and H. pylori-infected groups; however, the range of 
mucosal alterations was broader with H. pylori infection. H. felis infection, which showed 
less mouse-to-mouse variation, was used for the remainder of the experiments. To 
determine both the percentage of cells expressing Fas Ag and MHCII and whether 
expression occurred within the same gastric mucosal cell, we examined single-cell 
preparations of the gastric mucosa that had been depleted of immune cells (CD45+) by 
FACS. Under control conditions, MHCII is expressed on a small minority of gastric 
mucosal cells, and only 0.12% of cells coexpressed Fas Ag and MHCII. In contrast, mice 
infected with Helicobacter felis expressed both MHCII and Fas Ag on the surface of 
greater than 6% of the gastric mucosal cells isolated (representative data from one 
experiment are shown in Fig. 3.3A). Cytokeratin staining confirmed that these dual-
receptor-expressing cells were epithelial cells (Fig. 3.3B and C). We further determined 
the nature of these dual-receptor expressing cells. We analyzed whole gastric mucosa 
(containing all gastric cell lineages and inflammatory cells) and two populations of 
CD45-negative gastric cells, a double-positive population expressing both Fas Ag and 
MHCII and a double negative population that expressed neither Fas Ag nor MHCII, for 
the expression of lineage specific markers. Fas Ag and MHCII are coexpressed on cells 
expressing a wide range of lineage markers, suggesting that this double-receptor-
expressing population is a heterogeneous mixture of parietal, chief, mucous, and 
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FIGURE 3.3 FAS AG AND MHCII ARE COEXPRESSED ON GASTRIC EPITHELIAL
CELLS DURING HELICOBACTER INFECTION.
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FIGURE 3.3 FAS AG AND MHCII ARE COEXPRESSED ON GASTRIC 
EPITHELIAL CELLS DURING HELICOBACTER INFECTION.  
(A) Single-cell preparations from control or H. felis-infected mice were stained with anti-
CD45-Cy5 conjugated, anti-Fas Ag-PE conjugated, and anti-MHCII-FITC conjugated 
antibodies and FACS (fluorescent acquisition cell sorting) sorted into CD45 (-) 
populations expressing Fas Ag, MHCII, or Fas Ag/MHCII. Results of one representative 
experiment are shown. The experiment was performed three times with similar results. 
Cells from mice infected with H. pylori gave a similar pattern of expression, and results 
are not shown. (B and C) Cytokeratin staining of CD45(-)MHCII/Fas Ag(+) (B) and 
CD45(+) (C) populations confirms that the CD45 (-) MHCII/Fas Ag(+) are of an 
epithelial nature. (D) RT-PCR for expression of a panel of lineage specific genes. The 
CD45(-) population was sorted into MHCII/Fas Ag-expressing (top row) and non-
MHCII/Fas Ag-expressing cells (second row) populations. cDNA prepared from total 
mouse stomach was used for controls. Third row, positive control; fourth row, without 
reverse transcriptase, negative control. 
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 metaplastic cells (Fig. 3.3D).  
 
3. Gastric mucosal cells express MHCII in response to IFN-γ. 
 
In order to study MHCII/Fas Ag signal interactions, we turned to a tissue culture 
system. Rat gastric mucosal (RGM-1) cells in culture do not express MHCII or 
costimulatory molecules under normal culture conditions (Fig. 3.4A, lane 1). Upon 
exposure to IFN-γ, MHCII, invariant chain (Ii) and CIITA expression are markedly 
increased at both the mRNA (Fig. 3.4A, lane 2) and protein (Fig. 3.4B) levels. Control 
experiments were done without reverse transcriptase enzyme to exclude genomic DNA 
sequence amplification (Fig. 3.4A, lanes 3 and 4). RGM-1 cells cultured with IFN-γ for 
24 to 72 h elongate and develop an increased number of cytoplasmic projections (Fig. 
3.4C and D). RGM-1 cells express surface Fas Ag after exposure to the inflammatory 
cytokines IL-1β, TNF-α, and IFN-γ (85), similar to what is seen in vivo, further 
supporting the use of this cell line as a model for MHCII/Fas interaction in gastric 
mucosal cells. 
 
4. Gastric cell lines expressing MHCII have altered morphology and growth 
characteristics. 
 
In order to address potential interactions between MHCII and Fas Ag in gastric 
mucosal cells, while avoiding potentially confounding effects of exogenous IFN-γ, we 
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FIGURE 3.4 IFN-GAMMA REGULATES MHCII EXPRESSION IN GASTRIC 
MUCOSAL CELLS.
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FIGURE 3.4 IFN-γ  REGULATES MHCII EXPRESSION IN GASTRIC 
MUCOSAL CELLS. 
Rat gastric mucosal cells (RGM-1) were cultured in the absence or presence of 100 ng/ml 
rat IFN-γ for 24 to 72 h. (A) RT-PCR for MHCII, Ii (invariant chain), and CIITA (class II 
major histocompatibility complex transactivator) expression after 24 h in culture. 
GAPDH and S18 ribosomal message were used to standardize the blots. (B) Surface 
MHCII expression was confirmed by FACS analysis. (C) Cells grown for 72 h in control 
medium have a compact hexagonal shape (arrows). (D) Cells grown with 100 ng/ml IFN-
γ for 72 h are elongated with stellate projections (arrows). 
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 established cell lines stably expressing the MHCII complex and the Fas Ag receptor. 
FACS analysis confirmed surface expression of both the MHCII alpha and beta chains 
(Fig. 3.5A and B) and Fas Ag (Fig. 3.5C). Clones, which expressed high physiological 
levels (see Materials and Methods) of both receptors were chosen for further study. In 
culture, RGM-1 cells have a hexagonal shape and rarely show cell projections (Fig. 
3.5C). RGM-1 cells transfected with empty vector or those expressing high levels of Fas 
Ag alone did not differ in size, shape, or growth characteristics from the control cell line 
(data not shown). Interestingly, cell lines expressing MHCII alone or MHCII/Fas Ag 
(Fig. 3.5D) had a flattened, fusiform, spindle-shaped phenotype with long cytoplasmic 
“hummingbird” projections and were phenotypically indistinguishable from RGM-1 cells 
exposed to IFN-γ (Fig. 3.5D). There was no increase in spontaneous apoptosis or cell 
death in any of the cell lines. 
 
5. Gastric mucosal cells expressing MHCII are resistant to Fas-mediated cell 
signaling. 
 
In culture, RGM-1 cells express negligible Fas Ag surface receptor; have a low 
level of spontaneous apoptosis, and have a very small increase in apoptosis in response to 
Fas L (Fig. 3.6A and B). RGM-1 cells expressing MHCII on the cell surface also have a 
low baseline level of apoptosis, which is not increased, with the addition of Fas L (Fig. 
3.6C and D). In sharp contrast, RGM-1 cells expressing abundant Fas Ag on the cell 
surface rapidly undergo apoptosis in response to the addition of 25.0 ng/ml Fas L, with 
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FIGURE 3.5 MORPHOLOGICAL ALTERATIONS OF GASTRIC MUCOSAL CELLS 
EXPRESSING BOTH MHCII AND FAS AG.
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FIGURE 3.5 MORPHOLOGICAL ALTERATIONS OF GASTRIC MUCOSAL 
CELLS EXPRESSING BOTH MHCII AND FAS AG.  
RGM-1 cells were transfected with appropriate expression vectors. (A to C) Expression 
of alpha chain (A), beta chain (B), and Fas Ag (C) surface receptors was confirmed by 
FACS analysis. (D) Cellular morphology after 72 h in culture. Arrows show long stellate 
projections. 
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FIGURE 3.6 GASTRIC MUCOSAL CELLS EXPRESSING MHCII AND FAS AG ARE 
RESISTANT TO FAS L INDUCED APOPTOSIS. 
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FIGURE 3.6. GASTRIC MUCOSAL CELLS EXPRESSING MHCII AND FAS AG 
ARE RESISTANT TO FAS L INDUCED APOPTOSIS.  
Cells were exposed to control medium or medium containing 25 ng/ml Fas L for 4 h. (A 
and B) RGM-1 cells have a low basal level of apoptosis and do not undergo 
morphological changes of apoptosis when exposed to ligand. (C and D) Cells expressing 
MHCII do not undergo apoptosis under control conditions or upon exposure to Fas L. (E 
and F) Cells expressing Fas Ag do not undergo spontaneous apoptosis but show 
rounding, detachment, and blebbing (arrows) upon addition of ligand. (G and H) Cells 
with a higher level of Fas Ag expression as than in panels (E) and (F) but also expressing 
MHCII do not undergo spontaneous apoptosis and do not increase apoptosis in response 
to ligand. (I) Levels of apoptosis were quantitated using annexin V staining in cell lines 
with or without 25 ng/ml Fas ligand for 4 h as indicated. (J) Cells were grown under the 
same culture conditions as for panel (I) for 1 h, and caspase 8 activity was measured 
using the Caspase-8 Fluorometric Activity Assay kit. All experiments were repeated three 
times. Results in panels (I) and (J) are averages from three experiments ±1 standard 
deviation. 
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 38% ± 5% of cells being apoptotic at 4 h (Fig. 3.6E and F) and greater than 98% being 
apoptotic at 24 h (data not shown). Strikingly, cells expressing both MHCII and Fas Ag 
are completely resistant to Fas L-induced apoptosis (Fig. 3.6G and H). Dual-receptor- 
expressing cells did not undergo apoptosis in response to 25.0 ng/ml Fas L for 4 or 24 h 
(Fig. 3.6G and H; summarized in 3.6I) and showed no increase in caspase 8 activity (Fig. 
3.6J), suggesting that the block to signaling was upstream of caspase activation. Gastric 
mucosal cells can use the Fas Ag pathway for proliferative signaling at low receptor 
stimulation (due to low receptor abundance or low ligand level) (80, 85) and for both 
proliferative and apoptotic signaling at high receptor stimulation (80, 85, 124). We next 
tested whether Fas proliferative signaling was intact in cells, which coexpress MHCII and 
Fas Ag. Consistent with our previous reports, RGM-1 cells expressing low-abundance 
Fas receptor exposed to low-level Fas L (6.25 or 12.5 ng/ml) significantly increased 
proliferation (p <0.01) compared with cells exposed to control culture conditions. Cells 
expressing both MHCII and high levels of surface Fas Ag had no growth response to 
ligand. Dual-receptor-ex-pressing cells had very low baseline levels of proliferation as 
measured by [3H] thymidine incorporation, which did not change with the addition of 
6.25 to 25 ng/ml Fas L (Fig. 3.7), suggesting that all Fas-mediated growth signaling was 
interrupted in these cells. 
 
6. MHCII inhibits Fas signaling by preventing receptor aggregation. 
 
In order to determine the mechanism of Fas resistance, we first determined the 
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FIGURE 3.7 MHCII COEXPRESSION INHIBITS FAS-MEDIATED PROLIFERATIVE
SIGNALING.
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FIGURE 3.7 MHCII COEXPRESSION INHIBITS FAS-MEDIATED 
PROLIFERATIVE SIGNALING.  
RGM-1 cells expressing MHCII and Fas Ag or Fas Ag alone were cultured for 24 h in 
control medium or medium containing 6.25 to 25 ng/ml Fas ligand (as indicated), and 
proliferation was measured by [3H] Thymidine incorporation. Experiments were repeated 
three times, and results represent the averages ±1 standard deviation. 
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 point within the pathway where regulation likely occurred. Caspase 8 is not activated in 
dual-receptor-expressing cells; therefore, MHCII interferes with Fas signaling at or above 
the level of caspase 8 activation (Fig. 3.6J). Levels of the inhibitor FLIP were unchanged 
between cell lines (data not shown). Because of the alteration in cell morphology with 
MHCII, we addressed whether receptor aggregation was impaired. FLAG-tagged Fas L 
was used to immunoprecipitate DISCs (Fas L, Fas Ag, FADD, and FLICE) from Fas Ag 
expressing and Fas Ag/MHCII-expressing cell lines. After the addition of ligand to Fas 
Ag-expressing cells (Fig. 3.8A, lane 3), only signal-competent 250-kDa multimeric 
complexes were isolated (Fig. 3.8A, top gel). These bands were confirmed to be specific 
for DISCs by running an aliquot on a denaturing gel and blotting with Fas Ag (Fig. 3.8A, 
middle gel), which produced only a single 48-kDa band for each sample, or caspase 8 
(Fig. 3.8A, bottom gel). Strikingly, in cells expressing both Fas Ag and MHCII, a 
significant portion of receptors remained as 75-kDa monomeric complexes and failed to 
aggregate (Fig. 3.8A, lane 1); this failure to aggregate could not be overcome with either 
longer incubation times or higher levels of ligand (data not shown). Scant uncleaved 
caspase 8 (50 to 55 kDa) was recovered from these DISCs (Fig. 3.8A, third gel, lane 1). 
Inhibition of actin polymerization by CytoD completely restored receptor clustering, as 
only aggregated receptor complexes were recovered (Fig. 3.6A, lane 2). In addition, 
abundant caspase 8 was recovered in these DISCs and existed as both uncleaved (50- to 
55-kDa) and active (41- to 43-kDa) forms, comparable to that which was detected in Fas 
Ag-only expressing cells (lane 3). In the presence of CytoD, MHCII/Fas Ag-expressing 
cells lost their stellate cytoplasmic projections and assumed a more hexagonal shape, 
similar to wild-type control cells (data not shown). With the addition of ligand, caspase 8 
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FIGURE 3.8 MHCII INHIBITS FAS AG SIGNALING THROUGH AN ACTIN-
DEPENDENT INHIBITION OF RECEPTOR AGGREGATION.
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FIGURE 3.8 MHCII INHIBITS FAS AG SIGNALING THROUGH AN ACTIN-
DEPENDENT INHIBITION OF RECEPTOR AGGREGATION.  
(A) Cells were cultured with FLAG-tagged Fas L at 25 ng/ml for 15 min. DISCs were 
isolated from MHCII/Fas Ag-expressing cells (lane 1), MHCII/Fas Ag-expressing cells 
grown in the presence of cytochalasin D at 0.5 µg/ml to inhibit actin polymerization (lane 
2), or Fas Ag-expressing cells (lane 3). Proteins were run on a nonreducing gel and 
blotted with anti-Fas Ag antibody. Monomeric complexes are seen at 75 kDa, and 
aggregated complexes are seen at 250 kDa. Bands were confirmed to be specific for Fas 
aggregates by running an aliquot of the sample on a reducing gel and blotting for Fas Ag 
(middle gel) or caspase 8 (bottom gel). (B) Cell lines were grown in the presence or 
absence of Fas L at 25 ng/ml for 1 h as indicated, and caspase 8 activity was measured 
and is presented as relative fluorescent units. Bars represent averages from three 
experiments ±1standard deviations. (C) Control cells (empty vector) (top panel), Fas Ag-
expressing cells (middle panel), and MHCII/Fas Ag-expressing cells (bottom panel) were 
grown in the presence or absence of cytochalasin D, with or without Fas L at 25 ng/ml, 
for 4 h as indicated, and apoptosis was measured by annexin V staining. Each bar 
represents the average from three experiments ±1 standard deviation. 
88
 activation was restored to the same level as seen in cells expressing Fas Ag only (Fig. 
3.8B), and the addition of CytoD restored the Fas L-induced apoptotic response (Fig. 
3.8C) while not inducing an increase in spontaneous death in the absence of ligand. 
CytoD had no effect on the basal level or Fas L-mediated apoptosis in the parent RGM-1 
cell line or in cells expressing high levels of Fas Ag alone (Fig. 3.8C). 
 
Summary 
 
Dysregulation in the balance between proliferation and apoptosis is felt to 
underlie the development of cancer; it is not that inhibition of apoptosis per se is 
carcinogenic, but rather that inhibition of apoptosis in cells which otherwise would have 
been eliminated increases the likelihood of accumulating harmful genetic defects, leading 
to a proliferative advantage and the emergence of neoplastic clones (103, 125). In the 
setting of normal inflammation, that is, inflammation associated with acute injury and 
wound healing, environmental alteration due to chemokines and cytokines is a self-
limited event (125). With chronic inflammation, such as is seen with Helicobacter 
infection, there is constant exposure of the mucosa to cytokines and chemokines, leading 
to dysregulation of growth (19, 59, 60). Growth programs for repair and proliferation are 
activated, and apoptotic programs may be bypassed in an attempt to restore mucosal 
integrity. This sedition of the normal cell death and repair programs results in abnormal 
DNA replication and proliferation, pushing cells to acquire mutations (125). Because 
Fas-mediated apoptosis is a central feature of cell loss in Helicobacter infection (12, 19, 
59, 60, 62, 81, 85, 113, 115, 119, 120, 123, 126-129), alterations in the regulation of this 
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 pathway have great potential for contributing to the malignant process. Here we show 
that one mechanism of apoptosis escape in the inflamed stomach is through the 
acquisition of MHCII expression and its subsequent interaction with Fas Ag signaling 
cascade. Fas Ag signaling is well recognized as a mediator of gastric mucosal apoptosis 
and plays a central role in Helicobacter induced mucosal injury (81, 83, 114, 115, 127, 
128). In the face of inflammation, Fas Ag is highly expressed in numerous cell types 
within the gastric mucosa, including invading inflammatory cells and gastric epithelial 
cells, with the highest expression seen in chief and parietal cell compartments (114). 
Certainly, surface Fas Ag appears to be necessary for parietal cell loss and atrophy (113, 
114), which are early and progressive events in Helicobacter disease (81), culminating in 
gastric mucosal atrophy. In the setting of atrophy, there is peripheral stem cell failure and 
an influx of bone marrow-derived stem cells in an apparent reparative effort (123). These 
marrow-derived cells engraft and differentiate toward an incomplete gastric cell 
phenotype, forming the basis of metaplastic and dysplastic glands. While most cells 
expressing high receptor abundance (specifically parietal and chief cells) undergo 
apoptosis early in infection (59, 114), these metaplastic and dysplastic cell appear to be 
resistant to apoptotic signaling (86, 87). This phenotype of apoptosis resistance in the 
setting of high receptor abundance suggests that a mechanism other than receptor number 
is used to regulate susceptibility to Fas signaling events in these cells and may involve 
several points of regulation along the Fas signaling cascade. While much is known about 
Fas signaling in immune cells, much less is known about signaling regulation in other 
cell types. In general, Fas-mediated cell signaling events are controlled by an abundance 
of independent mechanisms, including but not limited to factors which alter the 
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 expression level and location of Fas Ag, availability of ligand, assembly and function of 
the DISC, and regulation of caspase activation and function. Integration of a wide variety 
of extracellular and intracellular events in the context of cell type specificity confers a 
high degree of flexibility to Fas L/Fas Ag signaling outcomes. We have previously shown 
that one level of regulation of the Fas pathway within the gastric mucosa is through 
modulation of receptor number. High levels of IL-1β, TNF- α, and IFN-γ, found in the 
infected gastric mucosa, regulate surface Fas Ag expression (85) and are associated with 
more severe diseases states (59, 60, 62), due in part to increased Fas signaling. 
Interestingly, this same environment that increases Fas Ag expression (most notably, 
elevated IFN-γ levels) regulates MHCII expression in gastric mucosal cells, albeit with 
different levels of protein expressed in different cell types. This differential expression of 
Fas Ag and MHCII within the gastric mucosa creates the potential for receptor interaction 
and variable signaling outcomes. MHCII is expressed in metaplastic and dysplastic tissue 
(unpublished observation) as well as in carcinoma (119, 130, 131), making a scenario of 
MHCII/Fas Ag receptor interaction plausible. As is true with other aspects of Fas 
signaling, the interaction between the MHCII complex and the Fas Ag pathway is cell 
type specific and appears to be unique to each situation studied. For example, in 
lymphoid cells, MHCII expression paradoxically increases Fas-mediated signaling in B-
lymphocytes, where MHCII expression is a cofactor in B-cell-mediated apoptosis 
through the production of “second messengers” (132) the identities of which are 
incompletely defined (133). Quite the opposite, MHCII ligation via interaction with T 
cells confers rapid Fas resistance in B cells (134) and in T cells, where CD4 and MHCII 
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 interactions are required for survival of resting CD4 cells; coexpression offers resistance 
against Fas-mediated apoptosis (135, 136). Immature dendritic cells, which express 
moderate levels of Fas surface receptor and low levels of or absent MHCII, are highly 
sensitive to Fas-mediated apoptosis. As these cells mature and express high levels of 
MHCII, they become fully resistant to Fas apoptotic signaling (136), while maintaining 
sensitivity to MHCII-induced apoptosis.  
H. pylori induced chronic inflammation may promote mechanisms to protect 
against Fas induced apoptosis. MHCII is upregulated on the surface of gastric epithelial 
cells when stimulated with IFN-γ in vitro or on the gastric cells in vivo. Indeed, we found 
a population of gastric cells that coexpress both, MHCII and Fas Ag. MHCII expression 
is inducing actin-dependent cytoskeletal changes that impair Fas Ag receptor aggregation 
and therefore, resistance to apoptosis.  
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CHAPTER IV. COINFECTION MODULATES INFLAMMATORY RESPONSES 
AND CLINICAL OUTCOME OF HELICOBACTER FELIS AND TOXOPLASMA 
GONDII INFECTIONS 
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 Introduction 
 
Chronic infections are the cause of considerable morbidity and mortality. Unlike 
acute infections, in which the “one microbe-one disease” concept can be applied, disease 
caused by chronic infectious organisms more likely represent interactions between the 
infecting organism(s) and a multitude of host and environmental factors including 
interaction with other infectious agents. Using a mouse model of infection we examined 
the interaction between Helicobacter felis and Toxoplasma gondii: two ubiquitous 
organisms that cause a spectrum of clinical disease. The host immune response is not able 
to eliminate H. pylori, and infection persists for the life of the host, setting up a situation 
whereby the gastric mucosa, which is normally devoid of inflammatory cells, becomes 
chronically inflamed(137). Cytokines present within the gastric mucosa are thought to 
determine the type and severity of damage. Neither a Th1 nor Th2 response eliminates 
the bacterium, however the two responses are associated with very different outcomes in 
terms of gastric mucosal disease.  
A Th1 cytokine pattern is associated with parietal cell loss, atrophy, metaplasia, 
dysplasia, and progression to adenocarcinoma, whereas a Th2 pattern is associated with a 
relative lack of architectural alterations and cell loss, and there is no progression of 
disease (64, 138-140). Although host genetics certainly play a role in determining the 
direction and vigor of the immune response, infections with other organisms that 
augment or suppress the Th1 response may potentially exacerbate or reduce disease 
severity, respectively. The “African enigma” (high rates of infection and low gastric 
cancer rates) has been explained in part by modification of the immune response by 
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 concurrent helminthic infection (65), which affects a “switch” in Th1/Th2 polarity and 
confers a degree of protection. In contrast to the protective effects of helminthic 
infection, we reasoned that chronic infections that evoke a predominant Th1 response 
(such as T. gondii) would modulate the immune response to accelerate Helicobacter 
disease.  
Toxoplasmosis is caused by the obligate intracellular protozoan parasite T. gondii. 
Infection is common in children and young adults and infection rates range from 10% to 
over 90% dependent upon many factors including climate, dietary habits, and animal 
exposure. T. gondii induces a strong IFN-γ response that limits the growth of parasites in 
peripheral tissues, and directs the transformation of parasites from the tachyzoite stage 
into dormant cysts. Dormant cysts are kept quiescent in chronic latent infection by a 
continued immune response (141). Impairment of this specific cell mediated response, as 
seen in immunocompromised patients, leads to a more aggressive acute infection or in the 
case of latent infection, reactivation of dormant cysts and reemergence of acute disease 
(142). In the absence of overt immunosuppression, it is not clear what factors if any 
influence the outcome of acute or chronic T. gondii infection. Although population based 
studies are sparse, there appears to be a positive correlation between T. gondii Ab 
production and gastric cancer (143-146), suggesting that T. gondii infection may 
influence the clinical outcome of Helicobacter infection.  
This study was initiated to examine the interaction between T. gondii and H. felis 
infection using the BALB/c mouse, a strain resistant to disease caused by both organisms. 
Coinfection with H. felis significantly blunted the IFN-γ response to T. gondii, allowing 
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 considerable tachyzoite replication, tissue damage, and increased mortality. Additionally, 
long-term coinfection leads to a prominent H. felis-specific Th1 response, blunting of the 
H. felis specific Th2 response and significant gastric mucosal damage. Collectively, these 
findings point to a dynamic interaction between immune responses to seemingly 
unrelated organisms with significant impact on disease outcomes. 
 
Results 
 
1. BALB/c mice infected with H. felis had higher mortality when challenged with 
T. gondii. 
 
The BALB/c strain of mice is easily infected with both T. gondii and H. felis, but 
it is considered a resistant host, as it does not develop clinical disease with either 
organism (147, 148). Control mice and mice infected with H. felis alone did not differ in 
weight, activity, or general well being at any time point of the experiment and there were 
no mortalities among mice within these groups. Only one mouse infected with T. gondii 
alone (n = 20) died on day 11; the remainder did not develop distress or evident disease. 
In sharp contrast, mice coinfected with H. felis and T. gondii became acutely ill as early 
as day 3 after T. gondii infection. Mice with established H. felis infection (n  = 20) 20 wk 
before T. gondii infection developed signs of dehydration, bloody stool, huddling, and 
decreased activity with 50% of the mice dying between day 7 and day 15. Of those that 
survived, recovery was evident by day 17, after which all remained well and without 
distress for the duration of the experiment. To assess the effects of acute H. felis 
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 infection, mice were infected with T. gondii first, and on days 5, 7, and 9 (the time of 
peak IFN-γ response to T. gondii) were infected with H. felis. Mortality in this group was 
less than in the chronically infected group, but substantially higher than T. gondii alone, 
with 25% mortality occurring between day 7 and day 11 (Fig. 4.1A). These mice 
appeared clinically similar to the T. gondii and chronically infected H. felis mice, 
although less severely affected, with dehydration, decreased activity, and huddling. There 
was complete recovery of survivors by day 17. 
 
2. Concomitant H. felis infection causes a blunted IFN-γ response to T. gondii and 
higher parasite loads. 
 
Host susceptibility to T. gondii infection is determined by the vigor of the immune 
response. Too strong an IFN-γ response induces a septic shock-like picture whereas an 
inadequate response allows tachyzoite replication and widespread tissue damage. 
BALB/c mice normally respond with modest IFN-γ induction; adequate to control 
tachyzoite replication yet low enough to avoid systemic complications. Control mice and 
those infected with H. felis alone did not have detectable peripheral IFN-γ levels (Fig. 
4.1B). With T. gondii infection alone, peripheral blood IFN-γ levels peaked between days 
3 and 11 and steadily declined thereafter to below the level of detection by 4 wk. Mice 
that were coinfected with H. felis and T. gondii had significantly lower IFN-γ levels when 
compared with mice infected with T. gondii alone and IFN-γ was most pronounced in 
mice that had a chronic H. felis infection at the time of T. gondii challenge. In the 
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FIGURE 4.1 CONCURRENT HELICOBACTER INFECTION BLUNTS THE IMMUNE 
RESPONSE TO T. GONDII AND INCREASES T. GONDII RELATED MORTALITY.
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FIGURE 4.1 CONCURRENT HELICOBACTER INFECTION BLUNTS THE 
IMMUNE RESPONSE TO T. GONDII INFECTION AND INCREASES T. GONDII 
RELATED MORTALITY.  
(A) Kaplan-Meier survival curves after T. gondii challenge in mice infected with H. felis 
or sham infected. Twenty mice in each group were followed for 20 wk after T. gondii 
infection. The experiment was repeated a second time (with 10 mice each) with similar 
results. Control ( ), H. felis ( ), T. gondii ( ), T. gondii + acute H. felis ( ) 
infection, T. gondii +chronic H. felis ( ) infection. (B) In a second cohort of mice, 
serum IFN-γ levels were determined by ELISA at 3, 11, and 15 days post T. gondii 
infection (n=5 for each group). Data from control mice and H. felis-infected mice were 
below the level of detection and data from these groups combined. After day 15, serum 
IFN-γ was below the level of detection in all groups. Results are reported as the mean ±1 
SD. The experiment was repeated a second time with similar results. 
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 surviving mice, IFN-γ levels steadily declined becoming undetectable after 4 wk and 
remained undetectable for the duration of the study in all groups. We next evaluated 
whether lower IFN-γ levels were associated with higher parasite replication, by 
examining the spleen parasite load in mice days 3 or 11 after infection. Control mice and 
mice infected with H. felis alone had undetectable T. gondii B1 gene expression, and no 
visible tachyzoites on H&E stained sections (Fig. 4.2A–C). Mice infected with T. gondii 
alone had moderate B1 gene expression in the spleen and occasional tachyzoites visible 
on histological section (Fig. 4.2, A, B, and D). In sharp contrast, mice that were 
chronically infected with H. felis before T. gondii challenge had a 3-fold increase in T. 
gondii B1 gene expression (Fig. 4.2A) and grossly visible tachyzoites in splenic tissue 
(Fig. 4.2E) accompanied by areas of infarction and necrosis.  
The small bowel of control mice and of mice infected with H. felis alone was 
unremarkable. Examination of the distal small bowel of T. gondii infected mice was 
grossly similar to control mice, with the exception of occasional prominent elevations on 
the serosal surface consistent with enlarged lymphoid aggregates. Gross examination of 
the luminal surface was within normal limits. Microscopically there was mild to 
moderate collections of acute inflammatory cells within the lamina propria of the ileum, 
preservation of architecture, and no visible tachyzoites (Fig. 4.2F). In sharp contrast, the 
small bowel of dual-infected mice had areas of gross necrosis, hemorrhage, and edema. 
Necropsy on those that were moribund or had died showed evidence of bowel perforation 
with peritonitis evidenced by free fluid in the peritoneal cavity, adherence of bowel loops 
to each other, and free fecal matter in the peritoneal cavity. Microscopically, there was 
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FIGURE 4.2 MICE WITH CONCURRENT H. FELIS INFECTION HAVE HIGHER 
PARASITE LOADS AND TISSUE DAMAGE WITH T. GONDII INFECTION.
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FIGURE 4.3 T. GONDII INFECTION ALTERS THE H. FELIS-SPECIFIC 
ANTIBODY RESPONSE. 
Serum levels of H. felis-specific IgG1 and IgG2a were measured by ELISA at 7 wk (A), 
20 or 40 wk (B) post-H. felis infection (n =10 for each group). Error bars represent 1 
SEM, * p =0.0012, **p =0.031, ***p =0.04. 
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 marked inflammation of the lamina propria, villus blunting, and architectural distortion. 
Visible tachyzoites were seen proliferating within cystic lesions (Fig. 4.2, G and H). At 
20 wk of T. gondii infection, the total T. gondii-specific serum IgG Ab response was 
significantly higher in those mice that had an established H. felis immune response before 
T. gondii challenge compared with those mice infected with T. gondii alone (Fig. 4.2I), 
however there were no differences in the ratio of IgG1 to IgG2a when subgroup analysis 
was performed (Fig. 4.2, J and K). 
 
3. T. gondii infection induces an H. felis–specific IgG2a/IgG1 isotype switch. 
 
H. felis infection altered the acute response to T. gondii by blunting the IFN-γ 
response and allowing uncontrolled parasite replication. We next addressed the impact of 
T. gondii infection on the H. felis-specific response, with the prediction that high levels of 
IFN-γ generated by T. gondii infection would induce a prominent and sustained bias 
toward a local gastric H felis-induced Th1 cytokine profile. We measured H. felis-specific 
IgG2a and IgG1 Abs at an early time point of infection (7 wk) and times representing 
chronic infection (after 20 wk coinfection) in mice that were infected with H. felis and T. 
gondii at the same time and in mice who had established H. felis infection at the time of 
T. gondii exposure. There was a significant increase in H. felis-specific IgG2a levels 
(p<0.0012), and a concomitant decrease in IgG1 Ab when T. gondii infection was present 
compared with the findings in H. felis infection alone. Ab were not detected in control 
mice, nor in mice infected with T. gondii alone (Fig. 4.3A). This response was 
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FIGURE 4.3 T. GONDII INFECTION ALTERS THE H. FELIS-SPECIFIC ANTIBODY  
RESPONSE.
T. gondii
H. felis
T. gondii + acute H. felis
Chronic H. felis + T. gondii
T. gondii
H. felis
T. gondii + acute H. felis
104
FIGURE 4.3 T. GONDII INFECTION ALTERS THE H. FELIS-SPECIFIC 
ANTIBODY RESPONSE. 
Serum levels of H. felis-specific IgG1 and IgG2a were measured by ELISA at 7 wk (A), 
20 or 40 wk (B) post-H. felis infection (n =10 for each group). Error bars represent 1 
SEM, * p =0.0012, **p =0.031, ***p =0.04. 
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 maintained for the duration of the experiment, with significant increases in anti-H. felis 
IgG2a levels maintained in the concurrently infected group ( p<0.031). Significantly, 
mice that had an established H. felis infection before T. gondii challenge, substantially 
increased production of IgG2a Ab (p<0.04), while maintaining the trend toward 
decreased IgG1 Ab production (Fig. 4.3B). 
 
4. T. gondii infection increases H. felis gastritis and mucosal damage. 
 
Mice infected with H. felis for 20 wk had mild corpus gastritis confined to the 
lesser curvature at the squamocolumnar junction, but were otherwise normal. The 
inflammation was characterized by a chronic inflammatory cell infiltrate composed 
mostly of lymphocytes appearing singly, or occasionally in small aggregates at the base 
of glands in the submucosa. There were no architectural alterations in the gastric mucosa, 
with preservation of gland structure, normal mucosal thickness and normal parietal cell 
mass (Fig. 4.4A). Mice infected with T. gondii alone for 20 wk had no alterations in the 
gastric mucosa. Specifically, there was little inflammation, preservation of mucosal 
thickness and no change in parietal or chief cell number (Fig. 4.4B). In contrast, mice 
infected with H. felis and T. gondii together had severe gastritis extending throughout the 
mucosa most severe in the corpus, but present in the antrum as well. Inflammation was 
characterized by a chronic inflammatory cell infiltrate composed mostly of lymphocytes 
extending throughout the thickness of the mucosa and forming discrete nodules in both 
the mucosal and submucosal areas. Some lymphoid aggregates were massive, distorting 
the overlying mucosa (Fig. 4.4C) and were grossly visible at the time of necropsy. 
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FIGURE 4.4 T. GONDII INFECTION ALTERS THE GASTRIC MUCOSAL RESPONSE 
TO HELICOBACTER INFECTION.
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FIGURE 4.4 T. GONDII INFECTION ALTERS THE GASTRIC MUCOSAL 
RESPONSE TO HELICOBACTER INFECTION.  
All sections are representative of findings at 20 wk. (A) H. felis infection in the BALB/c 
(group 2) mouse does not cause mucosal damage. Architecture is preserved, with 
occasional lymphocytes noted in the deep mucosa. (B) T. gondii infection alone does not 
cause gastric mucosal damage. The gastric mucosa of T. gondii-infected mice did not 
differ from control mice. (C) T. gondii infection concurrent with H. felis infection results 
in massive lymphocytic infiltrates in both the submucosa (arrow) and within the mucosa. 
Architectural distortion is prominent with loss of parietal and chief cells, antralization of 
glands and mucous cell metaplasia. Antralization and parietal cell loss is shown at higher 
power in (D). (E) Lesions were scored as outlined in Materials and Methods for 10 mice 
in each group. Number of symbols equals the number of mice achieving that score. 
Scores were compared using a two-tailed Mann-Whitney analysis of nonparametric data 
and p values are shown at top of each column. Magnification, X20 (A and B), X10 (C), 
and X40 (D). *p<0.003 – statistically significant. 
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 Infection with both H. felis and T. gondii was associated with considerable diffuse 
glandular epithelial atrophy, with extensive replacement of parietal cells and moderate 
antralization of the glands within the corpus (Fig. 4.4D). Lesion scores are presented in 
Fig. 4.4E. 
 
5. Dual infection alters level of H. felis colonization. 
 
H. felis infection was confirmed by serum Ab determination, histological 
detection of organism, and by DNA quantification in all mice experimentally infected. 
Organisms were not detected in those mice not specifically infected. H. felis colonization 
was highest in those mice infected with H. felis alone, compared with those mice 
coinfected with T. gondii (Fig. 4.5A). These findings are consistent with published 
reports of higher bacterial loads associated with Th2 responses and lower bacterial loads 
associated with a Th1 immune response (4). 
 
6. Gastric mucosal cytokine levels are altered in mice coinfected with T gondii 
compared with those infected with H. felis alone. 
 
In both human and mouse infection studies, the local cytokine environment 
predicts disease outcomes (201), with high IL-1β and low IL-10 predictive of severe 
disease in humans, and the combination of high IFN-γ levels and low IL-10 permissive 
for severe mucosal damage (61, 64, 149) in various mouse models. We therefore 
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FIGURE 4.5  CONCURRENT T. GONDII INFECTION SHIFTS THE LOCAL GASTRIC 
MUCOSAL CYTOKINE RESPONSE TO H. FELIS FROM A TH2 PROFILE TO A 
TH1 PROFILE.
A
B
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FIGURE 4.5 CONCURRENT T. GONDII INFECTION SHIFTS THE LOCAL 
GASTRIC MUCOSAL CYTOKINE RESPONSE TO H. FELIS FROM A TH2 
PROFILE TO A TH1 PROFILE.  
(A) Quantitative PCR for H. felis infection reported as number of bacteria (as a function 
of gene copy number) per microgram of total gastric tissue. Error bars represent 1 SD 
(n=10 for each group). (B) Quantitative PCR of IFN-γ, IL-12, IL-1β, IL-4, and IL-10 in 
the gastric fundic mucosa of H. felis-infected (7 and 20 wk infection time points 
combined) and H. felis/T. gondii-infected (7 and 20 wk of H. felis infection combined) 
mice. Results in the dual-infected mice (Helicobacter/T. gondii each 7 wk, 
Helicobacter/T. gondii each 20 wk, and Helicobacter 20 wk/T. gondii 7 wk) were 
indistinguishable from each other; therefore data from acute and chronic Helicobacter 
infection were combined. Each sample was run in triplicate, values differed by <1%, and 
an average for each mouse was used in calculation. Results are mean values +1SD 
(n=10). Experiment was performed two times with similar results. 
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 evaluated the gastric mucosal cytokine production using real-time PCR for IFN-γ, IL-12, 
IL-1β, IL-4, and IL-10. Proinflammatory cytokine expression in the gastric mucosa of 
BALB/c mice infected with H. felis alone did not differ from levels found in control mice 
(20 wk time point, n =10 for all groups). In sharp contrast, BALB/c mice infected with H. 
felis alone had markedly elevated IL-10 and IL-4 levels (Fig. 4.5B). These findings are 
consistent with the BALB/c phenotype as a Helicobacter resistant host. In sharp contrast, 
mice coinfected with T. gondii and H. felis had significant elevations in IFN-γ (5-fold), 
IL-12 (4-fold), and IL-1β (2-fold) compared with H. felis alone regardless of whether the 
mouse was infected with H. felis before, or after the time of T. gondii infection. IL-4 
expression (3-fold decrease) and IL-10 expression (5-fold decrease) were blunted relative 
to the robust response seen in the H. felis-infected mice (Fig. 4.5B). 
 
Summary 
 
Disease manifestations of chronic infections depend on a multitude of interacting 
factors specific to the host, the infecting organism and the environment. In most cases, a 
level of balance is reached whereby a continued immune response, while not able to fully 
eliminate an organism, keeps infection in check. The organism may then go undetected 
until reactivation of infection with suppression of this specific immune response (as 
occurs with Toxoplasmosis) or in some cases a chronic smoldering infection persists 
(such as is seen with H. pylori), which may show periodic flares of activity, or 
continually progress to debilitating disease. In the case of Helicobacter infection, clinical 
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 outcomes differ widely, with some patients infected but without obvious disease 
manifestations, whereas others develop severe manifestations such as gastroduodenal 
ulceration and gastric adenocarcinoma. The range in disease manifestations has not been 
fully explained by differences in bacterial factors or host genetics, but may be explained 
by interactions with other infectious agents modulating the organism-specific immune 
response. We infected mice with both T. gondii and H. felis and show the interplay 
between immune responses was not unilateral, but rather the immune response and 
clinical outcome to both organisms was affected. This immune modulation was durable 
resulting in both short-term morbidity and mortality due to T. gondii as well as severe 
chronic mucosal disease secondary to H. felis. 
The CD4 T cells within the adaptive immune response can be divided into two 
functional groups, Th1 and Th2 cells, based on the types of cytokines they produce and 
the immune responses they coordinate. Th1 cells produce IFN-γ, IL-2, and IL-12 and 
coordinate the cell-mediated immune response. Th2 cells predominantly produce IL-4, 
IL-5, and IL-10, and induce B cell activation. The direction of maturation of a naive T 
cell depends upon both the stimulus and the environment in which it is stimulated. High 
levels of IFN-γ at the time of T cell activation will promote a Th1 phenotype, and high 
levels of IL-4 will favor a Th2 phenotype. Although individual T cells can be thought of 
as Th1 or Th2 cells, assigning such a designation to the composite immune response is 
more complicated, and it should be viewed more correctly as falling on a continuum 
between the two responses, with the degree of polarization dependent on a variety of 
factors including properties of the infecting organism, host genetics, and environmental 
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 conditions. As such, there is the potential for manipulation by factors that nudge the 
response toward one or the other pole, with the possible effect of altering the disease 
outcome. Looking at mouse models of infection, the C57BL/6 mouse responds to H. felis 
with a Th1 immune response associated with considerable mucosal inflammation, 
atrophy of the fundic mucosa with loss of parietal and chief cells (59, 61, 62, 65, 81, 93), 
and the appearance of metaplastic changes progressing to dysplasia. The immune 
response and premalignant changes closely parallel the events preceding development of 
gastric adenocarcinoma in humans, making the mouse a powerful model in which to 
study helicobacter infection.  
In contrast to this susceptible mouse model, the BALB/c strain of mice develops a 
Th2 immune response to H. felis infection, minimal gastritis, and virtually no histological 
alterations despite dense colonization with bacteria (139). These two mouse strains 
represent the extreme poles of immune response to infection, providing models within 
which to determine the impact of modifiers on the immune response to Helicobacter and 
their subsequent effects on disease initiation and progression. To support the notion of 
coinfectious agents altering the outcome of disease, it has been shown that concurrent 
helminthic infection skews the Helicobacter specific immune response of the C57BL/6 
mouse toward a Th2 profile and protects against short-term disease (65). It is therefore 
conceivable that infectious or environmental influences may augment a Th1 response in a 
similar fashion, thereby promoting disease in an otherwise resistant host. The vast 
majority of individuals do not develop clinical disease with Helicobacter infection, 
suggesting a situation in which a few may be “pushed” toward disease rather than the 
majority protected from disease. Therefore, perhaps more compelling than protection, are 
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 situations that may increase disease severity. T. gondii infection is very common, with 
evidence of Ab production in every population studied, albeit at varying levels. Infection 
with T. gondii universally induces a strong Th1 response. We reasoned that if high levels 
of IFN-γ were present at the time the host was mounting an immune response to H. felis, 
the H. felis-specific response would shift toward a Th1 cytokine profile.  
We further reasoned that a Th1 cytokine profile in an otherwise “resistant” host 
would be associated with mucosal damage. Indeed, T. gondii infection at the time of 
Helicobacter infection effectively converts a resistant host to a susceptible host. 
Cytokines within the gastric mucosa show a dramatically altered pattern, with gastric 
IFN-γ levels comparable to those seen in the infected C57BL/6 mouse and a marked 
diminution in IL-10 levels. Both IFN-γ (64, 149) and IL-10 (61, 68) are pivotal in the 
gastric mucosal disease process secondary to Helicobacter and are felt to be essential 
factors in disease susceptibility in the mouse model as well as in human disease. Mice 
that were infected with both T. gondii and H. felis had a substantial increase in mucosal 
inflammation with mucosal hyperplasia, parietal and chief cell loss and mucous cell 
metaplasia, very similar to what is seen in the susceptible C57BL/6 mouse and in 
humans. It is interesting to note that although the mucosal changes were similar to those 
found in the infected C57BL/6, they were not identical and took longer to develop, 
suggesting differences between strains in addition to the immune response. For example, 
the marked antralization seen in the BALB/c (Fig. 4D) is not typically seen in the 
C57BL/6 model, but it is seen in human H. pylori infection (150). In humans, 
antralization is associated with increased proliferation; reduction in Bax expression and 
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 Bcl-2 overexpression implying that antralization may be an important histological marker 
for cancer risk (151, 152). This shift from a Th2- to a Th1-specific H. felis response is not 
confined to the gastric mucosal compartment, but is systemic. IgG subclass analysis is 
consistent with a sustained shift toward a Th1 response in all dual-infected groups. 
Perhaps most important is that mice with an established polarized H. felis response were 
equally susceptible to immune modulation by T. gondii, and the switch in Th1/Th2 
polarization was at least as great, if not greater than that seen with acute H. felis infection, 
suggesting there is an enormous window whereby factors may influence the outcome of 
chronic infections. T. gondii is a chronic infection and likely exerts continual pressure 
toward the H. felis Th1 response, which allows the response to be sustained. This raises 
the question of how other organisms may interact with the immune response to 
Helicobacter. The natural history of symptomatic Helicobacter infection in humans is 
one of active ulcers interspersed with various periods of remission. The trigger for this 
waxing and waning of disease is not known. 
Although we have not evaluated the effects of short-term infectious agents on 
Helicobacter immune response, it is tempting to speculate that acute infectious agents 
may exasperate H. pylori disease by nonsustained shifts in the immune response leading 
to disease “flares” that would theoretically abate as the acute infectious agent causing 
them was cleared. Alternatively, more sustained shifts in immune response may lead to 
more sustained changes such as metaplasia, dysplasia, and cancer. Without eradication 
therapy, Helicobacter infection exists for the life of the host, allowing the Helicobacter-
specific chronic inflammatory response to influence other infectious disease processes. 
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 Helicobacter infection significantly blunted the IFN-γ response to T. gondii and increased 
morbidity and mortality from T. gondii acutely. Although the effects of Helicobacter 
infection on the immune response to other organisms was not tested in this study, our 
findings suggest that the chronic immune response to Helicobacter may impact the host 
response to other infectious agents, implying an impact on both acute and chronic disease 
processes during the lifetime of the infected host. 
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CHAPTER V. T-BET KNOCKOUT PREVENTS HELICOBACTER FELIS-
INDUCED GASTRIC CANCER 
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 Introduction 
 
The link between chronic inflammation and cancer has been long recognized. 
Paradoxically, not all patients with chronic inflammation will develop cancer. Therefore, 
identifying immune response differences that predispose to cancer is paramount in 
identifying at-risk populations, and these differences may serve as therapeutic targets. 
Helicobacter infection causes chronic gastritis in all infected patients, although not all 
patients will develop clinical disease. Many infected patients will progress to gastric 
atrophy and mucous cell and intestinal metaplasia, while a smaller number of patients 
will develop dysplasia and <1% will develop gastric cancer. The incidence of gastric 
cancer ranges widely between countries (1, 153-155). Research into the mechanism by 
which H. pylori causes gastric disease has focused on three main areas: bacterial, 
environmental, and host genetic factors. The main body of research suggests that more 
virulent strains of bacteria and environmental factors that are associated with gastric 
cancer function via modulation or augmentation of inflammation within the gastric 
mucosa.  
Host genetic factors in turn dictate the intensity and the composition of the 
inflammatory response such that infected individuals with cytokine polymorphisms 
favoring a stronger proinflammatory response with elevated levels of TNF-α, IL1-β, and 
low IL-10 are more likely to develop more severe disease (67, 68). Studies using mouse 
models have been instrumental in defining the role of inflammation in Helicobacter 
disease progression and have clarified significantly the role of the adaptive immune 
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 response to mucosal damage. Mouse models allow controlled infection studies in 
genetically identical mice under restricted, regulated conditions. Different mouse strains 
have distinct immune responses to the bacterium (59, 61) and are very useful for studying 
various clinical manifestations of Helicobacter infection. H. felis infection in a 
genetically susceptible mouse strain, such as C57BL/6J, results in an acute inflammatory 
infiltrate into the gastric mucosa, which progresses to a chronic inflammatory response 
over several weeks (93, 102). During this time, parietal and chief cells are lost at least in 
part through Fas Ag/Fas L signaling (85). Once parietal cells are lost, the normal gastric 
gland architecture is replaced by a metaplastic mucous cell lineage followed by atrophy 
and intestinal metaplasia. By 15 months of H. felis infection, gastric adenocarcinoma 
develops in most mice (102). This pattern of mucosal alterations closely resembles the 
pattern and evolution of human gastric carcinoma (156).  
We have shown how H. felis infection in a mouse strain that is resistant to 
Helicobacter-induced gastric adenocarcinoma, such as the BALB/c, produces a very 
different mucosal immune response (61, 157) Mice become colonized by bacteria easily 
and often support higher bacterial loads than the C57BL/6J mice. Inflammation is 
initially submucosal with sparse intramucosal infiltrates, as is seen with infection in the 
C57BL/6J mouse; however, as H. felis infection progresses, lymphoid nodules are 
prominent and few mice may develop MALT (Mucosa-Associated Lymphoid Tissue) 
lymphoma. Strikingly, parietal and chief cells are largely preserved and atrophy does not 
develop. While the H. felis-infected BALB/c is a useful model of MALT lymphoma, it 
does not develop gastric adenocarcinoma. The major factor linked to the different 
outcomes of infection between a susceptible and resistant host is the immune response to 
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 H. felis. Th1 cytokines are associated with gastric adenocarcinoma, and a Th2 response is 
associated with relative resistance to gastric adenocarcinoma (59, 61). C57BL/6 mice 
tend to Th1 responses, while BALB/c mice usually polarize to Th2 responses. However, 
in addition to opposing immune response polarity, these two mouse strains are 
genetically different, and it is not clear how other genetic differences contribute to 
disease manifestations. 
Data from our laboratory as well as from those of others strongly supports that a 
vigorous Th1 response is required for disease to occur. IFN-γ infusions via osmotic pump 
into C57BL/6 mice for up to 4 wk is sufficient to induce inflammation with parietal cell 
loss and mucous cell and intestinal metaplasia, even in the absence of Helicobacter 
infection (64). With Helicobacter present, mucosal damage is greatly accelerated (64). 
Conversely, dampening a Th1 response greatly attenuates disease in the C57BL/6 mouse; 
however, it does not completely prevent mucosal damage (65). It is tempting to conclude 
that blocking the Th1 response in the C57BL/6 model is responsible for disease 
protection. However, the model used employed a helminthic infection to switch the 
immune response to Helicobacter infection, and direct effects of the helminth or the 
immune response to the helminth above and beyond the Th1/Th2 switch were not 
addressed. We have done similar immune manipulations in the BALB/c mice and have 
shown that overriding the usual Th2 response and forcing a Th1 cytokine pattern can alter 
disease progression, resulting in mucosal damage reminiscent of (but not identical to) 
damage in the C57BL/6 model (157) and CHAPTER IV. Taken together, these data 
suggest that manipulations within the C57BL/6 and the BALB/c model greatly alter 
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 inherent disease susceptibility, with a Th1 response necessary for disease progression. 
T-bet is a member of the T-box family of transcription factors, and it appears to 
regulate the commitment of Th cells to the Th1 lineage (158). It does so in part by 
transactivation of IFN-γ. Additionally, IFN-γ production is markedly impaired in NK 
cells from these mice. Strikingly, however, T-bet is not involved in controlling IFN-γ 
production in cytotoxic CD8+ T cells. The T-bet knockout (KO) mouse offers a model 
where Th1 responses can be directly assessed with minimal alterations of other immune 
functions, and without the effects of global cytokine deficiency seen in other transgenic 
models.  
Therefore, to definitively address the role of Th1 immune response in 
Helicobacter-induced disease, T-bet KO mice in the C57BL/6 background or their wild-
type littermates were infected with H. felis and followed for up to 15 mo for disease 
progression. Both groups maintained H. felis infection throughout the study. Analysis of 
mucosal cytokine patterns and H. felis-specific IgG subclass analysis confirmed a blunted 
Th1 response in the T-bet KO mice. Wild type mice progressed through tissue alterations 
of metaplasia, atrophy, and dysplasia to carcinoma, while the T-bet KO mice maintained 
parietal and chief cell populations and mucosal integrity and failed to develop 
adenocarcinoma. Our data clearly establish a link between IL1-β and TNF-α in the 
pathogenesis of Helicobacter-induced gastric adenocarcinoma. Parallel cytokine patterns 
in susceptible human populations suggest that differences in T-bet regulation may 
underlie susceptibility to gastric cancer in human populations.  
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Results 
 
1. Loss of T-bet does not alter the gastric mucosa in uninfected adult mice. 
 
We examined both male and female mice, five of each gender for each time point. 
Stomachs of uninfected (sham infected) mice were examined at 4 or 15 months after 
initiating the experiment (6–17 months of age). Stomachs of uninfected WT (wild type) 
and T-bet KO mice were grossly indistinguishable and were of similar weight. Gastric 
mucosal pH ranged from 1.0 to 2.0 and did not differ between the groups. Microscopic 
analysis did not reveal any differences in architecture between the two strains (Fig. 5.1A–
D) or any differences between genders. The mucosa was of similar thickness with a 
paucity of intramucosal and submucosal inflammatory cells. Numbers of parietal cells 
and their distribution within the fundus were similar between groups (WT, 16±1; T-bet, 
15±2 parietal cells/gland). A substantial portion of epithelial cell loss and parietal cell 
apoptosis that occurs during Helicobacter infection has been attributed to Fas Ag/FasL 
signaling (81, 84). Fas Ag is normally expressed at very low levels in gastric mucosal 
cells, and expression is preferentially up regulated in the parietal and chief cells in the 
presence of proinflammatory cytokines IL1-β and TNF-α (85). Invading inflammatory 
cells express both FasL and Fas Ag when activated, and FasL is necessary for Fas-
mediated apoptosis of gastric mucosal cells (89). Therefore, to begin our characterization 
of the T-bet KO mice, we characterized the baseline Fas Ag and FasL expression pattern 
123
FIGURE 5.1  HISTOLOGY OF UNINFECTED WILDTYPE AND T-BET KNOCKOUT 
MICE ARE SIMILAR.
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FIGURE 5.1 HISTOLOGY OF UNINFECTED WILDTYPE AND T-BET 
KNOCKOUT MICE ARE SIMILAR. 
H&E staining of WT C57BL/6 mouse (A, X4; B, X40) and T-bet KO mouse (C, X4; D, 
X40). Parietal cells (arrows) are large cells with pale pink cytoplasm and centrally 
located nuclei. Chief cells stain deeper purple and are seen at the gland base. Architecture 
is unchanged between the WT and T-bet KO mouse. Bar, 600 µm. Fas Ag 
immunohistochemistry in (E) WT mouse and (F) T-bet KO mouse. Arrow, positive 
staining inflammatory cells in connective tissue. 
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 within the gastric mucosa and inflammatory cell population. At baseline, in the absence 
of infection, Fas Ag is not detectable in gastric mucosal cells of either the WT or the T-
bet KO mice (Fig. 5.1, E and F). FasL was not detectable within the mucosa or 
submucosa of either strain (data not shown). Rare inflammatory cells were occasionally 
positive for Fas Ag (Fig. 5.1E, arrow). 
 
2. T-bet deficiency protects C57BL/6 mice from parietal cell loss by suppressing Th1 
immune response. 
 
At 4 mo of infection WT mice (n=10; 5 male, 5 female) have substantial 
submucosal (Fig. 5.2A, arrow) and intramucosal inflammatory infiltrates with near 
complete loss of parietal cells (Fig. 5.2B, arrow shows one remaining parietal cell in this 
field) and widespread mucous cell hyperplasia (Fig. 5.2C). The gastric mucosal pH 
ranged from 3 to 7 in the infected WT mice. Like the WT, T-bet KO mice (n=10; 5 male, 
5 female) developed widespread inflammatory infiltrates in both the mucosa and 
submucosa; however, unlike the WT, many T-bet KO mice had large lymphoid 
aggregates (Fig. 5.2D, arrows). The mucosal height did not differ between WT-infected 
and T-bet KO-infected mice (Fig. 5.2, A and D, bars). Remarkably, despite substantial 
inflammation, both male and female T-bet mice maintained their parietal cell population 
(Fig. 5.2, E and F, arrows) even in areas directly infiltrated with inflammatory cells (Fig. 
5.2F), and they maintained a gastric mucosal pH of 1–2. Studies from our laboratory and 
others reveal that Fas Ag-mediated apoptosis is responsible for the parietal cell dropout 
seen with Helicobacter infection (81, 84).  
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FIGURE 5.2 MUCOSAL SPARING IN T-BET KNOCKOUT MICE INFECTED 
WITH HELICOBACTER FELIS.
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FIGURE 5.2 MUCOSAL SPARING IN T-BET KNOCKOUT MICE INFECTED 
WITH HELICOBACTER FELIS.  
H&E staining of the fundic mucosa. Wild type (WT) mouse infected for 4 mo: (A) X4, 
arrow head depicts submucosal inflammation; (B) X40, arrow shows one rare remaining 
parietal amid markedly distorted gland architecture; (C) X40, submucosal and mucosal 
inflammation, mucous metaplasia, and antralization of the glands. T-bet KO infected 
mouse for 4 mo: (D) X4, large intramucosal and submucosal inflammatory infiltrates and 
lymphoid aggregates (arrow head); (E) preservation of architecture with numerous 
parietal cells (arrows) in areas with intramucosal inflammation; and (F) submucosal 
inflammation. Fas Ag immunohistochemistry of the fundic mucosa at 8 wk of infection in 
(G) WT mouse and (H) T-bet KO mouse. Bar, 600 µm.  
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 Therefore, we next determined the regulation Fas Ag expression in the mucosa 
with infection. Examination of a 2-months time point of infection, when parietal cells are 
present, revealed intense staining for Fas Ag throughout the parietal and chief cell 
population of the WT mice (Fig. 5.2G), but not in the T-bet KO mice (Fig. 5.2H). Few 
remaining parietal cells could be identified in the WT infected mouse at 4 months. Those 
present expressed surface Fas Ag by immunohistochemistry (data not shown), consistent 
with our previous reports of Fas Ag/FasL signaling playing a role in parietal cell loss 
during infection. FasL expression in inflammatory cells within the gastric mucosa did not 
differ between the WT and T-bet KO mice (data not shown). 
 
3. WT and T-bet KO mice maintain similar levels of H. felis bacterial colonization but 
have markedly different immunological responses to bacteria. 
 
We next examined H. felis bacterial colonization to determine whether differences 
in infection could account for the disparate mucosal damage seen. Uninfected mice did 
not have evidence of infection verifying their status as Helicobacter-free controls. 
Infected WT and T-bet mice had similar levels of bacteria detected by PCR, which were 
not statistically different (Fig. 5.3A; p>0.05). Despite similar bacterial loads, the immune 
response differed substantially with infected T-bet KO mice producing virtually no 
Helicobacter-specific IgG2c, resulting in a markedly blunted IgG2C/IgG1 ratio compared 
with WT mice, which had developed anti-Helicobacter IgG2c Ab (Fig. 5.3B, and C). We 
did not detect any differences in isotypic responses between male and female mice in 
either group, and therefore we combined the data for analysis. The gastric mucosa is 
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FIGURE 5.3 ALTERED IMMUNE RESPONSE IN T-BET KNOCKOUT MICE 
INFECTED WITH HELICOBACTER FELIS. 
(A) Bacterial load in WT (  ) and T-bet KO (  ) mice  and their infected counterparts 
WT + H. felis (  ) and T-bet KO + H. felis (  ) reported as the relative gene expression 
of H. felis FlaB, calculated using the 2-ΔΔCt method and reported as a ratio of fold increase 
in gene expression over the control value mouse β-actin gene, with uninfected mice set as 
a value of 1.  (B) Serum anti-H. felis antibodies assay. IgG2C/IgG1 ratio in infected T-bet 
KO (  ) and WT ( ) mice. (C) IgG subclass analysis. 
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 normally devoid of inflammatory cells. Any inflammatory cells within the gastric mucosa 
must come from circulating sources. We therefore analyzed Fas Ag and FasL expression 
on splenocytes from WT and T-bet KO mice. With activation, T-bet mice had a slight 
increase in Fas Ag expression (Fig. 5.4A) and similar FasL expression relative to WT 
mice (Fig. 5.4B). As predicted, T-bet mice compared with WT mice had a marked 
blunting of IFN-γ, with both a decrease in the number of cells positive for IFN-γ and the 
amount of IFN-γ secreted despite similar levels of activation (measured by CD69 
expression) (Fig. 5.4, C-E) and similar ratios of CD4 T cells (Fig. 5.4F).  
The cytokine milieu of the infected gastric mucosa is an amalgamation of 
cytokines from innate, adaptive, and mucosal responses. To assess the total cytokine 
environment, gastric mucosal strips from the squamocolumnar junction through the 
antrum at the lesser curvature were assayed by RT-PCR for select cytokines. The most 
dramatic differences between WT and T-bet KO mice were see in TNF-α, IL-1β, IL-12, 
and IL-13 expression, where the T-bet KO had markedly reduced levels, and in IL-10, 
where the T-bet KO mice had significantly increased levels relative to the WT mice. 
While IFN-γ was significantly decreased in the infected Tbet KO mice relative to the WT 
mice, substantial amounts of IFN-γ were still present (Fig. 5.5 A and B). IL-4 and IL-5 
levels were low in both the WT and T-bet KO mice and were not altered with infection. 
 
4. T-bet KO is protective against gastric cancer. 
 
We next evaluated the long-term effects of infection in the WT and T-bet KO 
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FIGURE 5.4 CHARACTERISTICS OF SPLENOCYTES FROM WILD TYPE AND 
T-BET KNOCKOUT MICE.
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FIGURE 5.4 CHARACTERISTICS OF SPLENOCYTES FROM WILD TYPE 
AND T-BET KNOCKOUT MICE.  
CD4+ cells were activated with anti-CD3 and anti-CD28 as indicated and assayed for (A) 
Fas Ag, (B) FasL, (C) IFN-γ expression, and (D) the activation marker CD69. (E) IFN-γ 
production was measured at 5 and 24 h of activation with anti-CD3 and anti-CD28 in 
culture. (F) The percentage of CD4+ cells did not differ between the WT and T-bet KO 
mice. 
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FIGURE 5.5 GASTRIC MUCOSAL CYTOKINE MILIEU IN WILD TYPE AND 
T-BET KNOCKOUT MICE.
A
B
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FIGURE 5.5 GASTRIC MUCOSAL CYTOKINE MILIEU IN WILD TYPE AND 
T-BET KNOCKOUT MICE.  
At 4 months after H. felis infection, gastric mucosa was assayed for cytokine expression 
as indicated and reported as fold increase over the lowest reported value in control mice. 
* p < 0.001; ** p < 0.02. 
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 mice. H. felis bacteria were detected by PCR in all mice, confirming that long-term 
infection was maintained in both genotypes.  
Inflammatory infiltrates were present in both groups, but they differed markedly, 
with WT mice maintaining intramucosal and submucosal diffuse infiltrates, and T-bet 
KO mice persisting with prominent lymphoid aggregates in the mucosa and submucosa. 
No mice developed MALT lymphoma. WT mice progressed through stages of 
metaplasia, dysplasia, and carcinoma in situ as previously documented (159) over a 
course of 15 months (Fig. 5.6, A and B). The gastric pH of the infected WT mice ranged 
from 4 to 7. T-bet KO mice maintained parietal cell populations and gastric pH of 2 or 
lower in all mice evaluated. They maintained architectural integrity, with only occasional 
metaplastic glands noted. Infected T-bet KO mice did not develop dysplasia or carcinoma 
in situ up to 15 mo of observed infection (Fig. 5.6, C and D; and summarized in Fig. 
5.6E). 
 
Summary 
 
Our WT and T-bet KO mouse models of Helicobacter infection recapitulate the 
cytokine environment seen in patients who are susceptible to the carcinogenic effects of 
Helicobacter infection (WT) and are apparently resistant to the carcinogenic effects of 
Helicobacter infection (T-bet KO). The striking aspect of this model is the composite 
mucosal cytokine milieu, contributed to by gastric mucosal cells, macrophages, CD8+T 
lymphocytes, and other resident cells. Together, these cells produce a cytokine 
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FIGURE 5.6 INFECTED WILD TYPE MICE DEVELOP GASTROINTESTINAL 
INTRAEPITHELIAL NEOPLASIA (GIN) AT 15 MONTHS, WHILE T-BET 
KNOCKOUT MICE ARE PROTECTED. 
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FIGURE 5.6 INFECTED WILD TYPE MICE DEVELOP GASTROINTESTINAL 
INTRAEPITHELIAL NEOPLASIA (GIN) AT 15 MONTHS, WHILE T-BET 
KNOCKOUT MICE ARE PROTECTED.  
Wild type mice and T-bet KO mice were infected with H. felis for 15 months.  (A) WT 
mice have persistent inflammation, glandular distortion with marked corpus metaplasia, 
parietal cell and chief cell loss, and GIN (X4). Gastric glands are seen herniating into the 
underlying tissue (arrow heads). (B) Severe gland distortion with branching, piling up of 
cells, marked cellular and nuclear atypia with nuclear stratification, and altered nuclear-
to-cytoplasmic ratio (X40). (C) T-bet KO mice have persistent inflammation 
(arrowheads) with sparing of parietal (arrows) and chief cell populations (X4); better seen 
in D (X60) of the boxed area in C. (E) Gastric injury scores are shown below the 
histology images. * p <0.02. 
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 environment that is difficult to predict based on the functions of T-bet alone. IFN-γ, while 
lower in the T-bet KO model, was still present at substantial levels within the mucosa, 
which was a surprising result.  
IFN-γ has been associated with parietal cell loss and mucous cell metaplasia in 
vivo (64, 160), but it is not significantly associated with Fas Ag regulation in vitro (85). 
Since Fas Ag mediated loss of parietal cells precedes metaplasia in the C57BL/6 model, 
this implies that IFN-γ may not be acting directly in vivo, and reinterpretation of these 
models may be needed. We suggest that TNF-α and IL-1β, which do directly regulate 
Fas Ag, are responsible for Fas Ag up-regulation and parietal cell loss in WT but not T-
bet KO mice. IL-4 and IL-5 production are inhibited by T-bet through both an INF-γ-
dependent and -independent mechanism (158, 161, 162) and one might expect increased 
levels of these two cytokines without T-bet; however, the composite mucosal 
environment does not reflect this, as neither cytokine was present at significant levels. 
Additionally, IL-13, which can be down-regulated by T-bet, independent of its effect on 
Th1/Th2 switch (163) would be expected to increase in the T-bet KO mouse; however, a 
significant paradoxical decrease in IL-13 was seen.  
Perhaps the most striking aspect of the gastric mucosal cytokine environment is 
the dramatic reduction of TNF-α and IL-1β levels in the face of architectural 
preservation. These two cytokines to date have shown the strongest and most consistent 
correlation with human H. pylori-induced gastric cancer risk, as well as risk for 
developing premalignant architectural changes (67, 68). Our working hypothesis is that 
the T-bet mediated immune response to Helicobacter results in elevated gastric mucosal 
140
 levels of IL-1β and TNF-α. IL-1β and TNF-α in turn mediate regulation and expression 
of cell surface Fas Ag and subsequent apoptosis of chief and parietal cells (81, 84, 85). 
Parietal cell loss is associated with decreased gastric acid secretion, which in turn may 
result in bacterial overgrowth of bowel flora in the stomach (164), although not all 
studies have confirmed this bacterial overgrowth (165). If present, bacterial overgrowth 
can further contribute to the antigenic stimulation within the stomach. Fas Ag - mediated 
signaling plays a central role in the development of gastric cancer through several 
mechanisms. Architectural changes result in cell-cell signaling defects (64, 156, 160), 
which are linked to altered differentiation and deregulated proliferation of gastric cells 
(220). Additionally, the chronic inflammatory environment favors the emergence of 
apoptotic resistant cell lineages (80, 87, 166-169).  
Fas Ag signaling in apoptotic resistant metaplastic and dysplastic gastric cells is 
diverted toward proliferative signaling via activation of Erk1/2-dependent pathways (91), 
thus allowing Fas Ag to act as a tumor promoter. T-bet orchestrates this complex immune 
environment. Knockout of this one critical immune regulator dramatically impacts all the 
pertinent signaling pathways associated with gastric cancer, suggesting that functional 
differences in T-bet activity may underlie human susceptibility to gastric cancer. 
In previously reported studies (170), T-bet KO mice infected with H. pylori did 
not develop gastric inflammation during the 24 wk of study, and they failed to develop 
any mucosal alterations, while transfer of CD4+ T-bet KO splenocytes into infected SCID 
recipients produced significant mucosal damage, similar to transfer of CD4+ WT 
splenocytes (59). H. pylori induces a less robust infection in mice than does H. felis, and 
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 it may account for the minimal inflammation noted in the WT mice and the lack of 
inflammation in the infected T-bet KO mice. SCID mice lack functional B and T cells. 
Transfer of T-bet KO CD4+ cells would replete only a subset of immune cells in the 
SCID model, which likely accounts for the differences in overall immune response and 
mucosal damage between these studies and our results, reported herein. 
Many of the severe outcomes of infectious diseases are a direct result of excessive 
or polarized immune activation. In the case of some pathogens, such as H. pylori, it is the 
immune reaction rather than the pathogen itself that is responsible for the majority of the 
disease process. In other situations such as inflammatory bowel disease, the inciting 
pathogen is not known but is postulated to be normal commensal bacteria that are 
eliciting an abnormal immune response. It is the immune response that leads to 
ulceration, fibrosis, and predisposition to cancer.  
More work has been done examining immune regulation within the small 
intestine and colon than has been done with the stomach, and therefore drawing from this 
knowledge may prove useful to advance our understanding of events in the stomach. 
Within the colon, T-bet has been identified as a master regulator of mucosal 
inflammation, and indeed our understanding of the role for T-bet in the colon has 
provided some understanding of perplexing inflammatory conditions. Inflammation 
within the intestine is normally tightly regulated; however, in a collection of diseases 
termed inflammatory bowel disease, this regulation is faulty and a chronic inflammatory 
state is perpetuated. While we think that inflammation is in response to luminal trigger, 
possibly bacterial, viral, or auto-antigens, the exact trigger has not been determined and is 
likely not the same in all patients. Animal models of disease have been instrumental in 
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 deciphering the alterations in mucosal immunity and have demonstrated that T-bet 
activity is pivotal in regulating Th1 predominant Crohn’s disease and Th2 predominant 
ulcerative colitis, where it acts to determine the balance of mucosal cytokines (171). 
These mouse models are very interesting because the mechanism of dysregulation of T-
bet (up-regulation or down-regulation of activity) leads to vastly different cytokine 
environments and mucosal damage patterns.  
Despite the substantial cytokine differences and mucosal outcomes in the mouse 
model, the point of alteration is identical in both models of inflammatory bowel disease 
offering a potential clinically relevant target for correction of disease. Inflammatory 
diseases of the stomach share similarities with inflammatory diseases of the small 
intestine and colon. Infection with H. pylori is associated with a mild asymptomatic 
gastritis in most patients. Approximately 20% of those infected will develop 
gastroduodenal ulcer disease while significantly fewer (0.01–3%) will develop gastric 
adenocarcinoma (154, 155), and even fewer will develop MALT lymphoma. Similar to 
inflammatory bowel disease caused by opposite immune response in humans, gastric 
cancer secondary to H. pylori infection is associated with opposite immune responses; 
adenocarcinoma is linked to Th1 cytokines, and MALT lymphoma is linked to Th2 
cytokines in people. The widely varying prevalence of gastric adenocarcinoma between 
patient populations has been attributed to differences in bacterial strains, dietary and 
environmental cofactors (172), and genetic differences dictating the intensity of the Th1 
cytokine response (67, 68). To date, these genetic differences in cytokine response have 
been investigated at the level of individual cytokine regulation. Work in mouse models 
using a variety of techniques including infection in Th1 predominant (C57BL/6) and Th2 
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 predominant (BALB/c) strains, manipulation of immune responses through concurrent 
infections, and use of various cytokine knockout and transgenic models fully support a 
dependence on a Th1 immune response for adenocarcinoma; however, the dominant 
cytokine responsible is not clear. Manipulation of individual cytokines such as IFN-γ (64, 
160) and IL-1β (173) creates artificial immune environments that result in mucosal 
damage and share several features of clinical disease, but lack others, suggesting that 
there are pieces of the puzzle that we still need to fit in place.  
In a Chinese population study, Schistosoma japonicum infection concurrent with 
H. pylori infection is associated with alterations in IgG responses to H. pylori along with 
less gastric atrophy, suggesting that coinfection alters the immune response of the host to 
a more favorable outcome (174). Additionally, several African populations have 
paradoxically low gastric cancer rates despite high infection rates with virulent strains of 
H. pylori. Because of these findings, animal studies have been designed in an attempt to 
recapitulate the coinfection status of human populations. For example, when the 
C57BL/6 susceptible strain of mice were infected with both a helminth and Helicobacter, 
the specific Helicobacter immune response was skewed toward a Th2 response, and mice 
were seemingly protected from mucosal damage (65). This effect was not sustained, 
suggesting that continual ongoing infection with Th2 skewing organisms or an inherent 
propensity to respond to Helicobacter infection with a blunted Th1 response would be 
needed for long-term effects. Also, in our laboratory we attempted to coerce the BALB/c 
mouse toward a Th1 response with concurrent Toxoplasma gondii infection resulted in a 
similar, but not identical, pattern of mucosal injury when compared with the C57BL/6 
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 mouse (66) and CHAPTER III. These studies have raised the question of whether other 
genetic factors are at play, or if results are related to an incomplete recreation of the 
cytokine pattern using these artificial experimental models.  
The search in humans for a genetic basis of disease has led to some startling and 
profound findings, which served as the impetus for this study. Population-based studies 
assessed genetic polymorphisms in cytokine genes in populations at risk for gastric 
cancer. Polymorphisms resulting in higher levels of the proinflammatory cytokines IL-1β 
or TNF-α and lower levels of the antiinflammatory IL-10 were strongly associated with a 
dramatic increase in H. pylori-related noncardia gastric cancer (67, 68). There was an 
additive effect seen with multiple polymorphisms, conveying the highest risk to patients 
with the most proinflammatory profile. The original landmark studies by El-Omar and 
colleagues (77,78) analyzed Caucasian populations. Attempts to reproduce these findings 
in other populations have met with mixed results (175). Although disappointing, this is 
not at all surprising given the genetic diversity of patients and the varied genetic 
mechanisms available to modulate the host immune response. The conflicting results in 
non-Caucasian populations should be viewed as a challenge to broaden our search for 
additional regulators of the immune response important for gastric inflammatory disease 
outcome. Our findings strongly support a central role for T-bet regulation of the immune 
response associated with gastric cancer risk, and differences in T-bet regulation among 
patients may account for a portion of this risk. 
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CHAPTER VI. CXCR4/SDF-1 MEDIATED HOMING OF MESENCHYMAL 
STEM CELLS TO THE INJURED GASTRIC MUCOSA 
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Introduction 
 
The link between infection, chronic inflammation, and cancer has long been 
recognized (176), a prime example being infection with Helicobacter pylori and gastric 
cancer (93, 97). Chronic gastric inflammation, which develops as a consequence of H. 
pylori, leads over time to repetitive injury and repair resulting in hyperproliferation, an 
increased rate of mitotic error, and progression to adenocarcinoma. The same 
inflammatory environment that favors the development of cancer has also been linked to 
homing and engraftment in peripheral tissue by bone marrow derived cells (BMDCs).  
In the last decade, there are at least 22 publications, which confirm how a bone 
marrow derived stem cell is responsible not only for marrow reconstitution, but also for 
nonhematopoietic tissue homing, engraftment and differentiation (76, 77, 177-194). But 
which cells from bone marrow are able to differentiate across embryonic lineages? 
BMDCs plasticity experiments were done with whole bone marrow, hematopoietic stem 
cells (HSC) or mesenchymal stem cells (MSC), or all of the above in combinations. The 
analysis of the plasticity mechanisms found that differentiation was a more common 
phenomenon then cellular fusion, even though the cell fusion was not analyzed in all 
mentioned above publications.  
Finally, how do these cells get there? Most of the models where plasticity was 
analyzed employed a form of injury or inflammation of peripheral tissue (toxins, 
radiation, infections, organ resection, etc.), which made the case for secreted factors, like 
SDF-1 (stromal derived factor 1) and SCF (stem cell factor) to have a role in homing, 
147
 since bone marrow derived cells reside at a distant site from the periphery. This may 
occur where tissue injury induces excessive apoptosis that overwhelms or compromises 
the supply of endogenous tissue stem cells (195). Evidence suggests that BMDCs use 
CXCR4/SDF-1 axis for cell trafficking (196, 197). Various tissues respond to cellular 
damage such as irradiation, hypoxia, chronic inflammation or toxic agents by increasing 
their secretion of SDF-1 (198-200). The known receptor for SDF-1 is CXCR4. 
CXCR4, a G-protein-coupled seven span trans-membrane receptor, is expressed 
on the surface of many stem cells. CXCR4 is responsible for regulating trafficking of 
normal hematopoietic stem cells and their mobilization and homing to the bone marrow 
(197, 201, 202). Furthermore, it is thought that CXCR4/SDF-1 is used during 
embryogenesis for appropriate cell migration (203). It is well known that hematopoietic 
stem cells (HSC) depend upon an SDF-1 gradient to home back to the marrow cavity for 
circulation. Indeed, agents used to mobilize bone marrow cells for transplant purposes 
propose do so by disrupting the CXCR4/SDF-1 axis (204, 205). In a similar manner, 
successful engraftment of the bone marrow transplant relies heavily on an intact 
CXCR4/SDF-1 signaling axis. Inflammatory tissues produce elevated levels of SDF-1, 
which act as the lure for CXCR4-expressing marrow cells to home to these sites (127). 
CXCR4 signaling occurs by dissociation of the Gβγ subunit from the GTP bound Gα. Gα 
will inhibit the adenylate cyclase function, therefore resulting in a reduction of cyclic 
AMP (cAMP) levels (206, 207) when stimulated by SDF-1. 
Similar to their non-malignant stem cell counterparts, many cancer cells express 
CXCR4. Like the hematopoietic stem cells, it is believed that cancer stem cells use the 
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 CXCR4 receptor to mobilize, invade and metastasize (205), further supporting the notion 
that cancer stem cells derive from a tissue stem cell source and utilize inflammatory 
environments for growth and movement. If we look closely at the function of the CXCR4 
receptor on normal or malignant cells, we see that it is multi-factorial and modulated by 
several components of the inflammatory environment.  
Although the mechanism and extent of subsequent BMDCs differentiation is not 
established (208), it is clear that engrafting cells rely on external environmental cues for 
the orderly inactivation of growth programs and progression of appropriate differentiation 
(76, 77, 209). However, there is little information on the long-term consequences of 
recruiting pluripotent cells to areas of chronic inflammation where signals for cell growth 
and differentiation may be altered.  
To investigate the role of BMDCs in the metaplasia/dysplasia/carcinoma 
progression associated with inflammation, we employed models of short-term 
inflammation and chronic inflammation in the C57BL/6 mouse model. We postulate that 
CXCR4/SDF-1 axis might be the key mechanism for recruiting the MSC into a chronic 
inflammation zone, like Helicobacter induced mucosal damage of the stomach.  
To determine the role of BMDCs in acute inflammation, we used an acute alcohol 
model. This is clinically relevant and it is easily reproduced in a mouse model. Topical 
experimental instillation of alcohol into stomach by gavaging induces local damage and 
inflammation in the first 30 minutes after application. Ethanol directly and dose-
dependently impairs the mucosal barrier, induces the release of inflammatory cytokines 
and vasoactive substances; these lead to ischemia and mucosal damage (210).  
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Results 
 
1. Engraftment of Rosa26 marrow-derived cells into the mouse stomach after H. felis 
infection. 
To investigate if BMDCs will engraft into the mouse stomach during an 
Helicobacter infection we used lethally eradiated C57BL/6 mice, which were 
transplanted with bone marrow from C57BL/6JGtrosa26 (ROSA26) transgenic mice, 
expressing a nonmammalian beta-galactosidase enzyme or from control wild-type 
littermates. Engraftment of ROSA26 marrow-derived cells was tracked with X-
galactosidase (Xgal) staining.  
X-gal staining (blue) was not detected in negative control mice: wild-type 
noninfected mice (Fig. 6.1A) or wild-type infected mice (Fig. 6.1C). Uninfected ROSA26 
transplanted mice did not demonstrate any BMDCs engraftment into gastric glands (Fig. 
6.1B). Although acute (3 weeks) H. felis infection of ROSA 26 mice was associated with 
intense bone marrow–derived inflammation, it did not produce major architectural 
destruction and was not sufficient stimulus for stomach repopulation with BMDCs. In 
this model, gastric mucosal apoptosis increases at 6 to 8 weeks after inoculation (93) and, 
consistent with this, β-galactosidase–positive (blue-staining) glands appeared after this 
peak of apoptosis. Looking into the long-term consequences of inflammation, these cells 
were initially detected at 20 weeks of infection, but their numbers increased dramatically 
with the length of time of infection, such that 90% of the gastric mucosa at the 
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FIGURE 6.1 ENGRAFTMENT OF ROSA26 MARROW-DERIVED CELLS INTO THE 
MOUSE STOMACH  AFTER H. FELIS INFECTION.
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H. felis, 30 weeks
uninfected
H. felis, 30 weeks
H. felis infected mice
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FIGURE 6.1 ENGRAFTMENT OF ROSA26 MARROW-DERIVED CELLS INTO 
THE MOUSE STOMACH AFTER H. FELIS INFECTION.  
(A and C) Xgal staining (blue) of C57BL/6 mouse transplanted with wild-type marrow 
and (A) mock infected or (C) infected with H. felis for 30 weeks. (B and D) C57BL/6 
mouse transplanted with ROSA26 marrow and (B) mock infected or (D) infected with H. 
felis for 30 weeks. (E) Wild-type mouse with chronic H. felis infection shows TFF2 (red) 
staining and is X-gal negative (blue). (F) In the infected ROSA26 transplanted mouse, 
BMDCs are positive for both beta-galactosidase (blue) and TFF2 (red). (G) Dysplastic 
glands in the infected ROSA26 mouse express abundant beta-galactosidase activity. (H) 
Mitotic activity in BMD epithelial cells demonstrated by coexpression of cytoplasmic 
beta-galactosidase activity (short arrows; blue) and chromosomal BrdU incorporation 
(long arrows; brown). 10-mm frozen sections. Magnification: [(A) to (G)], 60X; (H), 
100X. 
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 squamocolumnar junction was replaced with cells derived from donor marrow at 52 
weeks after infection (Fig. 6.1D).  
With a chronic Helicobacter infection, a second proliferative zone forms deeper 
within the gastric mucosa, giving rise to metaplasia (146). This zone is designated SPEM 
(spasmolytic expressing metaplasia) because it expresses the trefoil factor 2 (TFF2), also 
known as spasmolytic polypeptide (211, 212). In chronically infected wild-type mice, 
TFF2 (red staining) is prominent in deep antral and fundic glands (Fig. 6.1E). In mice 
transplanted with ROSA26 marrow and infected with H. felis, TFF2 expression is seen 
within blue β-galactosidase–positive BMDCs (Fig. 6.1F). Histological alterations were 
similar in infected WT and ROSA26-transplanted mice, with both showing equivalent 
metaplasia and dysplasia. Of the few parietal cells or chief cells that persisted in the 
infected stomach, none were beta-galactosidase positive, which indicates that under these 
experimental conditions of H. felis infection, marrow cells do not differentiate toward the 
parietal or chief cell phenotype. Epithelial dysplasia increased in severity over time, and 
by one year after inoculation resulted in carcinoma or high-grade gastrointestinal 
intraepithelial neoplasia (GIN) (213). In the mouse model of Helicobacter mediated 
gastric cancer, dysplasia is considered a direct precursor of gastric adenocarcinoma and is 
found both at the squamocolumnar junction and at the antral-pyloric junction (214, 215). 
In this H. felis model, the majority of dysplastic glands stained blue with X-gal (Fig. 
6.1G), and many BMDCs within the epithelium, were bromodeoxyuridine (BrdU) 
positive (Fig. 6.1H), which demonstrates active proliferation as occurs in neoplasia.  
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2. β-Galactosidase immunohistochemistry (IHC) and immunofluorescence (IF) of 
stomachs from C57BL/6 mice transplanted with Rosa26 marrow and infected with H. 
felis.  
 
To further confirm the presence of β-galactosidase, we used 
immunohistochemistry (IHC) for bacterial β-galactosidase. Gastric tissue from wild-type 
mice did not stain for β-galactosidase (Fig. 6.2, A and C), whereas all observed 
intraepithelial neoplasia in the 52- week infected mice were β-galactosidase positive (Fig. 
6.2, B and D; brown intracellular staining), which proves that these cells arose from 
donor marrow and strongly suggests an inherent vulnerability of this population to 
malignant progression. Bone marrow–derived GIN displayed features consistent with this 
histological diagnosis (213), including elongation and branching, crowding and distortion 
of gland structures, presence of hyperchromatic nuclei, pronounced cellular and nuclear 
atypia, and loss of polarity.  
To further test if the β-galactosidase positive cells are indeed epithelial cells, but 
not donor bone-marrow derived lymphocytes a double-label immunofluorescence 
staining revealed that the β-galactosidase–positive cells (red) within deep gastric glands 
were also pan-cytokeratin positive (green; merged seen as yellow) (Fig. 6.2F and fig. 
6.3D). CD45 expression (red; 6.3 J and N) was specifically restricted to donor derived 
infiltrating leukocytes (red; fig. 6.3K; merged yellow; 6.3L). These studies confirmed 
that the marrow-derived cells had differentiated to a gastric epithelial phenotype, ruling 
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FIGURE 6.2 BETA-GALACTOSIDASE IMMUNOHISTOCHEMISTRY (IHC) OF 
STOMACHS FROM C57BL/6 MICE TRANSPLANTED WITH ROSA26 MARROW.
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FIGURE 6.2 BETA-GALACTOSIDASE IMMUNOHISTOCHEMISTRY (IHC) OF 
STOMACHS FROM C57BL/6 MICE TRANSPLANTED WITH ROSA26 
MARROW. 
(A and C) Mock-infected mice do not demonstrate any BMDC engraftment, as evidenced 
by lack of beta-galactosidase staining. (B and D) H. felis – infected mice have substantial 
architectural distortion and betagalactosidase – positive (brown) GIN. Fluorescence IHC 
for cytokeratin (green) and betagalactosidase (red). (E) Glands within GIN from an 
infected mouse transplanted with wildtype marrow do not express betagalactosidase. (F) 
Glands within GIN from an infected mouse transplanted with ROSA26 marrow 
demonstrate beta-galactosidase expression (red), colocalized with cytokeratin (green) to 
form yellow, confirming epithelial differentiation of integrated BMDC. Occasional 
mononuclear leukocytes are betagalactosidase positive (red) and cytokeratin negative. 
Scale bars, 400 mm [(A) and (B)], 160 mm [(C) and (D)], 40 mm [(E) and (F)]. 
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FIGURE 6.3 IDENTIFICATION OF MARROW DERIVED CELLS IN THE GASTRIC 
MUCOSA USING IMMUNOFLUORESCENCE (IF).
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FIGURE 6.3 IDENTIFICATION OF MARROW DERIVED CELLS IN THE 
GASTRIC MUCOSA USING IMMUNOFLUORESCENSE (IF). 
Mice transplanted with ROSA26 (A-D and I-L) or WT (E-H and M-P) marrow were 
infected with Helicobacter felis for 52 weeks. Nuclear morphology is similar (DAPI 
staining, first panel-blue) in all groups. Gastric mucosal cells stain for cytokeratin 
(second panel- green) in both the ROSA26 (B) and the WT (F) transplanted mouse. Beta-
galactosidase expression (third panel- red) within gastric gland units is only seen in the 
mouse transplanted with ROSA26 (C) and not WT (G) marrow. In the merged panels 
(last column) the mouse transplanted with ROSA26 marrow (D) demonstrates 
colocalization of beta-galactosidase (red) with cytokeratin (green) producing yellow 
while (H). WT mice do not co-localize signals. Infiltrating inflammatory cells are CD45 
positive (green) in mice transplanted with ROSA26 (J) or WT (N) marrow. 
Betagalactosidase (red) is only expressed in ROSA26 (K) derived leukocytes, and is not 
found in WT (O) transplanted mice. Merged CD45 (green) and beta-galactosidase (red) 
are seen as yellow (L) in the ROSA transplant mice, and this merged signal is absent in 
WT mice (P). 
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 out the unlikely possibility that the observed staining pattern was due to lymphocytes 
(CD45+) intercalating into the gland structure.  
 
3. Engrafted BMDCs contain the LacZ/Neo fusion gene. 
 
Although these analyses directly showed β-galactosidase enzyme activity (X-gal 
staining) and protein abundance (IHC), we further evaluated BMDCs within the 
epithelium for the lacZ/Neo fusion gene specific to donor cells from the ROSA26 mouse. 
Laser capture microdissection was used to capture and isolate entire X-gal–positive 
glands from chronically H. felis–infected ROSA26 and wild-type transplanted mice (Fig. 
6.4, A and B). This was followed by a polymerase chain reaction (PCR) with specific 
lacZ/Neo fusion gene primers, followed by sequence analysis verified these cells to be of 
donor origin (Fig. 6.4C, lanes 1, 2 and 4). Water control of the PCR reaction was 
negative (Fig. 6.4C, lane 5).  
 
4. Gastric mucosal cells sorted and analyzed by flow cytometry. 
 
As a further additional test to prove for bone marrow origin of the gastric 
epithelial cells, we used a completely independent model of labeled bone marrow 
reconstitution. Female C57BL/6 mice were lethally irradiated, transplanted with bone 
marrow from male transgenic mice expressing chicken β-actin-EGFP (enhanced green 
fluorescent protein), and then infected with H. felis for 15 to 16 months. Dispersed gastric 
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FIGURE 6.4. ENGRAFTED BMDC CONTAIN THE LACZ/NEO FUSION GENE.
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FIGURE 6.4 ENGRAFTED BMDC CONTAIN THE LACZ/NEO FUSION GENE. 
Laser capture microdissection was used to isolate beta-galactosidase positive gastric 
glands (A- boxes 1 and 2) or beta-galactosidase positive infiltrating leukocytes (A-box 4) 
from a mouse transplanted with ROSA26 marrow. As a negative control, we used a 
captured gastric gland from a mouse transplanted with WT marrow (B- box 3). (C) PCR 
for the LacZ/Neo fusion gene and GAPDH show that the LacZ/Neo expression is specific 
to engrafted cells. The numbers correspond to the boxes in panels (A) and (B). Lane 5 is 
a water control. 
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 mucosal cells from these mice were sorted by flow cytometry (Fig. 6.5A) into 
GFP+/CD45+ (P4) – donor derived leukocytes, GFP+/CD45– (P5) – donor derived 
epithelial cells, and GFP–/CD45– (P6) populations – host derived epithelial cells, 
subsequently stained for pan-cytokeratin, and also analyzed by fluorescent in situ 
hybridization (FISH) for X and Y chromosomes. The CD45– populations were 
consistently positive for pan-cytokeratin (Fig. 6.5, D and F), which indicates their 
epithelial nature, whereas CD45+ cells were negative for this marker (Fig. 6.5B) – 
indicating their nonepithelial lineage. GFP–/CD45– cells contained two X chromosomes 
(Fig. 6.5G), which confirms them to be of host origin, whereas all GFP+ cells were 
consistently positive for both X and Y chromosomes by FISH (Fig. 6.5, C and E), which 
demonstrates that they are of donor bone marrow origin.  
 
5. Tumor cells are GFP positive, Y chromosome positive and coexpress cytokeratin.  
 
Analysis of tissue sections from the female mice transplanted with bone marrow 
from male transgenic mice expressing chicken β-actin-EGFP (Fig. 6.6) demonstrated that 
tumor cells were GFP positive (brown stain) (Fig. 6.6B and C) and Y chromosome 
positive (green signal) and expressed cytokeratin (red signal) (Fig. 6.6E and F). FISH for 
Y chromosome is negative in the female-to-female transplant animal (cytokeratin; red) 
(Fig. 6.6D). These studies, using two independent markers (GFP and Y chromosome), in 
addition to the β-galactosidase marker, confirmed that in Helicobacter-infected mice, 
bone marrow– derived cells could give rise to gastric epithelial cancer.  
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FIGURE 6.5 GASTRIC MUCOSAL CELLS SORTED AND ANALYZED BY FLOW 
CYTOMETRY.
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FIGURE 6.5 GASTRIC MUCOSAL CELLS SORTED AND ANALYZED BY 
FLOW CYTOMETRY (FACS). 
(A) FACS sorting of gastric mucosal cells from long-term H. felis – infected female mice 
transplanted with male GFP+ bone marrow. Three populations were sorted and 
characterized further. (B) The population sorted, as GFP+/CD45+ (P4) does not stain for 
cytokeratin (hematoxylin counterstained). (C) X (red) and Y (green) FISH confirms that 
the GFP+/CD45+ (P4) population is made up of donor-derived leukocytes. (D) The 
population sorted as GFP+/CD45– (P5) is made up of donor derived engrafted gastric 
mucosal cells that stain for cytokeratin (brown) and (E) contain both X and Y-
chromosomes by FISH. (F) GFP–/CD45– cells (P6) are cytokeratin positive and (G) 
contain two X chromosomes, confirming that they are host-derived gastric epithelial 
cells. 
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FIGURE 6.6 TUMOR CELLS ARE GFP POSITIVE, Y CHROMOSOME POSITIVE 
AND EXPRESSED CYTOKERATIN.
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FIGURE 6.6 TUMOR CELLS ARE GFP POSITIVE, Y CHROMOSOME 
POSITIVE AND EXPRESSED CYTOKERATIN. 
(A) Female wild-type mouse transplanted with female wild-type marrow does not stain 
for GFP by IHC. (B and C) Female mouse transplanted with male GFP marrow shows 
positive IHC staining for GFP (brown staining) in tumor cells. (D) FISH for Y 
chromosome (green) is negative in the female-to-female transplant (cytokeratin; red). (E 
and F) Tumors from male-to-female transplants show numerous Y-chromosomes (green) 
within the nuclei (black) of cytokeratin-positive (red) cells. 
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6. BMDCs did not fuse with gastric epithelium after engraftment. 
 
Cell-to-cell fusion, where an engrafting cell merges with a preexisting 
differentiated target cell, is another way towards multilineage plasticity. The resulting 
tetraploid cell could be one nucleated (if nuclear fusion occurred) or binucleated, if it did 
not. However, a reductive division may then follow, which could result in a mixed 
nucleus-cytoplasm combination. 
Using three methods, we next addressed whether fusion occurred between 
BMDCs and the gastric epithelium. First, we examined histological sections containing 
bone marrow–derived epithelial cells and found that cells contained only a single 
nucleus; no binucleate cells were seen. Second, we used fluorescence activated cell 
sorting (FACS) of propidium iodide–stained cells to determine DNA content in wild-type 
tissues, early infection prior to engraftment, and BMDCs carcinoma, and did not 
demonstrate any difference between these groups (Fig. 6.7). Third, in female mice 
transplanted with male GFP transgenic marrow, we evaluated 10,000 GFP+/CD45– 
pancytokeratin+ FACS-sorted gastric cells, using FISH, and showed a single X and a 
single Y chromosome in all cells examined (Fig. 6.5E). These studies strongly suggest 
that stable fusion did not occur. In our initial reconstitution studies, whole bone marrow 
was used to minimize cell manipulation, which can alter growth potential and behavior of 
stem cells (77, 208).  
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FIGURE 6.7 FURTHER EVIDENCE THAT STABLE FUSION IS NOT THE MECHANISM 
BY WHICH BMDC DIFFERENTIATE TO GASTRIC MUCOSAL CELLS, METAPLASIA, 
DYSPLASIA OR EARLY CANCER.
IMMUNOHISTOCHEMISTRY FOR X-GAL (BROWN)
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FIGURE 6.7 FURTHER EVIDENCE THAT STABLE FUSION IS NOT THE 
MECHANISM, BY WHICH BMDC DIFFERENTIATES TO GASTRIC 
MUCOSAL CELLS, METAPLASIA, DYSPLASIA OR EARLY CANCER. 
(A) DNA content and gastric mucosal histology from a one-year-old male WT mouse 
without Helicobacter infection (B) WT transplanted with ROSA26 marrow and infected 
for 12 weeks or (C) 52 weeks. Single cell preparations were prepared from the gastric 
mucosa and analyzed by FACS for DNA content. The number of >2N cells was not 
different between groups. Histology confirms the presence of a single nucleus in each 
mucosal cell. In long term infected mice (C) GIN is seen in the H&E section, with the 
majority of mucosa at the squamocolumnar junction along the lesser curvature replaced 
by BMDC (brown staining- IHC for beta-galactosidase, bottom panel). Only single nuclei 
are seen in these BMD-gastric epithelial cells. 
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7. Mesenchymal stem cells, but not the hematopoietic stem cells, acquired a gastric 
mucosal phenotype when exposed to primary epithelial cell cultures. 
 
To identify the population of cells within the bone marrow responsible for gastric 
mucosal engraftment, we cultured hematopoietic stem cells (HSC) (lineage depleted, 
RhodullHodull) or adherent mesenchymal stem cell (MSC) populations in Transwell culture 
plates in contact with the soluble components of control medium or culture medium from 
primary gastric epithelial cell cultures. Neither HSC nor MSC populations expressed 
epithelial markers (TFF2 or KRT1-19 – keratin 1-19) at the time of isolation or after 
culture with control medium. MSC cultures, but not HSC cultures, showed a marked up-
regulation of both KRT1-19 and TFF2 at 24 and 48 hours when exposed to the soluble 
components of gastric epithelial tissue, which demonstrates that MSC (but not HSC) 
acquired a gastric mucosal cell–gene expression pattern without cell-to-cell contact or 
fusion (Fig. 6.8).  
 
8. Acute alcohol and H. felis induced inflammation promote a significant upregulation 
of stromal derived factor 1 (SDF-1) in the stomach. 
 
Next, we wanted to test if the components of the CXCR4/SDF-1 axis have a role 
to play in the stem cell mobilization towards an inflamed stomach mucosa. To do this we 
performed real time RT-PCR analysis on whole gastric mucosa from H. felis–infected 
C57BL/6 mice (6 and 12 months after infection), which showed a substantial up-
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FIGURE 6.8 THE GASTRIC MUCOSA PROMOTES DIFFERENTIATION OF 
MESENCHYMAL STEM CELLS TOWARD AN EPITHELIAL CELL PHENOTYPE.
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FIGURE 6.8 THE GASTRIC MUCOSA PROMOTES DIFFERENTIATION OF 
MESENCHYMAL STEM CELLS (MSC) TOWARD AN EPITHELIAL CELL 
PHENOTYPE. 
Hematopoietic stem cells (HSC) or MSC were cultured in control medium or with the 
soluble components of a primary gastric mucosal cell culture followed by RT-PCR after 
48-hours. Lane 1: Negative water control. Lane 2: Positive control- RNA isolated from 
the gastric mucosa from an infected male mouse KRT1-19 (epithelial cell cytokeratin), 
CD45 (from infiltrating leukocytes), and TFF2 (metaplastic cell lineage marker) are all 
expressed. Lane 3: Mesenchymal stem cells cultured in the presence of gastric mucosa do 
not express CD45 but do express both KRT1-19 and TFF2. MSC do not express these 
epithelial cell markers under control conditions (lane 4). Lane 5- Lineage depleted 
Rhodull, Hodull (HSC) cells express CD45, but do not express KRT1-19 or TFF2 when 
exposed to gastric mucosal environment or with control medium (lane 6). Loading 
quantity was standardized with GAPDH. 
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 regulation of SDF-1 and CXCR4 compared with uninfected age-matched controls (Fig 
6.9A and B). Immunohistochemistry performed on the stomach tissue confirms the 
presence of CXCR4 on the dysplastic epithelial glands in an infected animal (Fig 6.9 C 
and D). Recent evidence suggests that SDF-1/CXC4 axis plays an important role not only 
in mobilization of the bone marrow cells, but also in tumor cell growth, mobilization and 
metastasis (216-219).  
We were also able to confirm the upregulation of these two factors in an acute 
inflammation model using ethanol. Acute alcohol injury in mice induces up to 9 fold 
SDF-1 upregulation in the stomach (Fig. 6.10A) and a severe inflammation score (2.5) 
for epithelial lesion changes, after giving mice 3 doses of alcohol (Fig. 6.10B and D). 
Histological analysis shows diffuse mucosal ulceration and severe lymphocytic 
infiltration in the stomach, which looked hemorrhagic on gross examination. Therefore, 
the acute alcohol injury model could be used to study the homing properties of the 
BMDCs. 
 
9. Red fluorescent protein (RFP) positive mesenchymal stem cells (MSC) home in the 
stomach and differentiate into gastric epithelial cells. 
 
Our laboratory had developed several culture adapted mesenchymal stem cell 
lines from a male C57BL/6J mouse by continuous propagation of its total bone marrow in 
tissue culture (220). With each passage, cells that were attached to the plate and became 
confluent were analyzed for their ability to form foci or grow in soft agar, proving if they 
underwent transformation. FACS analysis of our MSC showed that they were CD44 
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FIGURE 6.9 SDF-1 AND CXCR4 UPREGULATION IN THE STOMACH AFTER 
HELICOBACTER INFECTION.
C D
SDF-1 expression in the stomach 
control 6 months 12 months-10
0
10
20
30
40
  H. felis 
fo
ld
 in
 g
en
e 
ex
pr
es
si
on
CXCR4 expression in the stomach
control 6 months 12 months
-100
0
100
200
300
  H. felis 
fo
ld
 in
 g
en
e 
ex
pr
es
si
on
A B
IMMUNOHISTOCHEMISTRY FOR CXCR4 IN THE STOMACH
CONTROL, 60X H. FELIS INFECTION, 6 MONTHS, 60X
C D
p<0.05
p<0.05
p<0.05
p<0.05
174
FIGURE 6.9 SDF-1 AND CXCR4 UPREGULATION IN THE STOMACH AFTER 
HELICOBACTER INFECTION.  
Gene expression is determined using real-time RT-PCR on total RNA from the stomachs 
of mice. Gene expression is represented in folds increase of gene expression over control 
group (1 fold), using β-actin as an internal control. (A) SDF-1 (B) CXCR4 
Immunohistochemistry for CXCR4; (C) control mouse; (D) gastric mucosa of a mouse 
infected with H. felis for 6 months (arrow points a positive (brown) stained cell). 
Magnification, 60x. Counterstaining with hematoxylin. 
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control mouse; 40x alcohol, 96 hours; 40x
FIGURE 6.10 ACUTE ALCOHOL INJURY CAUSES SEVERE INFLAMMATION AND 
SDF-1 UPREGULATION IN THE STOMACH
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FIGURE 6.10 ACUTE ALCOHOL INJURY CAUSES SEVERE 
INFLAMMATION AND SDF-1 UPREGULATION IN THE STOMACH.  
(A) SDF-1 expression was determined using real-time RT-PCR on total RNA from the 
stomachs of mice. Control mice did not receive an alcohol dose. Alcohol (5 gm/kg) was 
given once at 24h, 48 h, 72h and 96h respectively. Expression is represented in folds 
increase of gene expression over control group (1 fold). *p<0.001. (B) Mucosa injury 
scoring in the stomach at the same time points as in (A), based on analysis of 
inflammation, epithelial lesion changes and mucosa thickness (edema). *p<0.05. (C) 
Normal histology of a control mouse. (D) Histology of mouse stomach exposed to 
alcohol for 96 hours. Magnification, 40X. N=5. 
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 positive and CD45 negative, as known in literature. After 12 months of culture we were 
able to isolate a MSC colony that had a fibroblast - like phenotype, which was not 
different from the fresh cultured MSC. When our MSC were tested for lineage-specific 
markers, like cytokeratin, desmin, CD31, S100, etc., the results showed that they are not 
committed to any lineage differentiation. In order to be able to keep track of these cells in 
vivo, they were stably transfected with RFP and GFP constructs. When injected 
subcutaneously into mice, our RFP positive MSC were able to grow into subcutaneous 
tumors that had a natural appearance of fibrosarcoma. Moreover, our cells were able to 
transdifferentiate into fat, bone, cartilage, epithelial and endothelial cell lineages of the 
host mouse, after receiving a subcutaneous injection with cells, proving their functional 
plasticity was preserved. By injecting these cells subcutaneously we are mimicking a 
continuous influx of MSC into the host. An intravenous injection of these cells results in 
a low frequency engraftment of the skin, GI tract, mesentery and genitourinary tract 
(220).  
We have used these cells to study the homing of MSC into the stomach in a 
setting of chronic inflammation induced by Helicobacter infection. Our MSC are useful 
for this purpose because they resemble freshly cultured MSC, are not committed to 
differentiated lineages and preserved their plasticity in vivo.   
RFP labeled MSC (MSC-RFP+) were injected subcutaneously into mice infected 
with H. felis for four months. The transdifferentiation of MSC into epithelial gastric cells 
occurred along with differentiation into submucosal non-epithelial cells, which was 
evaluated by direct fluorescence for RFP on frozen section (Fig. 6.11D and H), FISH for 
Y chromosome (green) costained with immunofluorescence for cytokeratin (red) (Fig. 
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FIGURE 6.11. RED FLUORESCENT POSITIVE (RFP) POSITIVE MESENCHYMAL 
STEM CELLS (MSC) HOME AND DIFFERENTIATE INTO GASTRIC EPITHELIAL 
CELLS.
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FIGURE 6.11 RED FLUORESCENT PROTEIN (RFP) POSITIVE 
MESENCHYMAL STEM CELLS (MSC) HOME IN THE STOMACH AND 
DIFFERENTIATE INTO GASTRIC EPITHELIAL CELLS. 
Immunohistochemistry for RFP on stomach tissue. (A) Mouse infected with H. felis for 6 
months, but not injected with MSC; (B) Infected with H. felis for 6 months that was 
injected with RFP positive MSC. Positive RFP immunohistochemistry staining is seen on 
stomach tissue (brown color). Counterstaining was done with hematoxylin.  
Direct fluorescence on stomach tissue. (C) Negative for RFP of a mouse infected with H. 
felis for 6 months, but was not injected with MSC. (D) Positive for RFP on a mouse 
infected with H. felis for 6 months, which was injected with MSC. Counterstaining done 
with DAPI, cell nuclei are stained with blue.  
FISH for Y chromosome. (E) Male mouse stomach. Y chromosome is stained in green, 
seen in most of the glandular cells. (F) Female mouse stomach is negative control for Y. 
Y chromosome staining is not seen in any of the in any of the glandular cells. Nuclei 
stained with DAPI in blue and cytokeratin stained in red. (G) Female mouse stomach 
infected with H. felis for 6 months and injected with MSC (male). Arrows point to Y 
positive cells in the glandular structures of the stomach. (H) Female mouse stomach 
infected with H. felis for 6 months and injected with MSC. Arrows point to Y positive 
cells in the submucosa of the stomach. These cells are not epithelial in origin, therefore 
negative for cytokeratin (red). Magnification, A and B (40X); C, D, E, F, G, H (60X).  
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 6.11G and H) and immunohistochemistry for RFP on paraffin sections (Fig 6.11B). 
Control infected mice that did not receive injected cells were negative for RFP by 
immunohistochemistry (Fig 6.11A) and Y chromosome (Fig 6.11F). These results prove 
the ability of the MSC to home and transdifferentiate into stomach mucosal cells of both, 
epithelial and nonepithelial lineages. 
 
10. MSC express a functional CXCR4, which is knocked down after their transfection 
with short hairpin CXCR4 constructs. 
 
In order to assess the role of the SDF-1/CXCR4 axis in the pathogenesis of 
Helicobacter induced disease we knocked expression of CXCR4 down, by transfecting 
our MSC-RFP+ cells with short hairpin RNA for CXCR4 or its scramble control. Total of 
three different RNAi clones were used and, transfection efficiency was assessed using 
GFP fluorescence, which they encode.  
FACS analysis of the MSC-RFP+ shows that they express CXCR4 (Fig. 6.12G, 
blue histogram), also conformed by western blotting (Fig. 6.12H, lane 1).  
MSC-RFP+ cells were transfected with shScramble construct (control vector, 
named shScramble cells) or sequentially with shCXCR4 clone 1, 2, and 3 (called from 
here on shCXCR4 cells) constructs. Fluorescent microscopy of live cells confirmed that 
both cells lines were efficiently transfected with GFP and preserved their RFP positivity 
in vitro (Fig. 6.12B, C, E and F). Western blot analysis of the same cell lines, shows the 
strongest CXCR4 down regulation of the MSC transfected with all three clones of 
shCXCR4 (Fig. 6.12G, last lane).  
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FIGURE 6.12 MSC EXPRESS A FUNCTIONAL CXCR4, WHICH IS KNOCKED DOWN 
AFTER THEIR TRANSFECTION WITH SHORT HAIRPIN CXCR4 CONSTRUCTS. 
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FIGURE 6.12 MSC EXPRESS A FUNCTIONAL CXCR4, WHICH IS KNOCKED 
DOWN AFTER THEIR TRANSFECTION WITH SHORT HAIRPIN CXCR4 
CONSTRUCTS. 
(A) shScramble MSC viewed under light microscopy, they are RFP positive (B) and 
acquired a GFP signal (C) after their cotransfection with the shScramble plasmid. (D) 
shCXCR4 MSC cells viewed under light microscopy, without any morphological 
changes observed, they preserved their RFP positivity (E) and gained a GFP signal (F) 
after a cotransfection with three different clones of shCXCR4. (G) WB for CXCR4 on 
total protein extracts from shScramble cells, MSC transfected with shCXCR4 clone1, 
shCXCR4 clone 1 and 2, and shCXCR4 clone1 and 2 and 3. β-actin was used as a 
loading control for each sample. Magnification, 20X.  
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11. SDF-1 stimulated MSC reduce their cAMP levels and promote their migration in a 
Transwell system. 
 
SDF-1 stimulation of CXCR4 results in activation of Gi protein, which will inhibit 
the adenylate cyclase function, therefore resulting in a reduction of cyclic AMP (cAMP) 
levels in the cell. Stimulation of MSC-shScramble cells resulted in downregulation of 
cAMP by almost 50%, which was statistically significant (p<0.00006) (Fig 6.13A). On 
the other hand, the knock down CXCR4 cell line had a statistically insignificant change 
in cAMP levels (p<0.23), which confirms its inability to trigger CXCR4 signaling (Fig. 
6.13A). 
Measuring MSC migration through a Transwell system towards a SDF-1 gradient 
in vitro further tested CXCR4 functionality. An overnight stimulation of MSC-
shScramble cells with 100ng/ml of SDF-1 resulted in a 200% increase in migration 
through the membrane when compared to migration of nonstimulated cells, which occurs 
by gravity (Fig. 6.13B and C). When shCXCR4 cells were stimulated in the same 
conditions, there were no changes in migration conforming a nonfunctional CXCR4 
receptor (Fig. 6.13B and C). Therefore, CXCR4 knockdown MSC (shCXCR4 cells) 
could be used as a “loss of function” model for addressing gastric mucosal homing. 
 
12. MSC homing in acute gastric inflammation is dependent on CXCR4 activity 
 
In order to study homing of MSC to the gastric mucosa, we employed an acute 
injury model which allowed us to precisely time the injection of circulating cells with the 
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FIGURE 6.13 shCXCR4 EFFECTIVELY BLOCKS CXCR4-SDF-1 MEDIATED
cAMP REDUCTION AND PREEVENTS CELL MIGRATION. 
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FIGURE 6.13 shCXCR4 EFFECTIVELY BLOCKS CXCR4-SDF-1 MEDIATED 
cAMP REDUCTION AND PREVENTS CELL MIGRATION  
shCXCR4 or shScramble MSC were stimulated with 100ng/ml of SDF-1 for 10 min and 
cAMP was measured by ELISA. 
 (A) shScramble cells down regulated cAMP by almost 50%, which was statistically 
significant; (* p<0.00006). shCXCR4 cells decreased cAMP concentration by less then 
30%, but failed to reach a statistical significance. (p<0.23). shCXCR4 or shScramble 
MSC were stimulated with 100ng/ml of SDF-1 for 12 hours and migrated cells were 
counted by Giemsa staining on the bottom of the plate.  
(B) shScramble cells were able to migrate by almost 200% of its nonstimulated control. 
(* p<0.05). shCXCR4 failed to migrate under the same conditions. (p>0.05). (C) 
shScramble and shCXCR4 cells counted on the bottom of the plate. Magnification 20X. 
All experiments repeated 3 times. 
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availability of adequate SDF-1 levels. Mice were given ethanol at a dose of 5mg/kg of 
mouse body weight by oral gavage every 24h 4 times. The control group was given PBS 
of the same volume (200 µl). Because SDF-1 levels peaked at 72 hours after the first 
injection (Fig. 6.10B and D), we chose to give intravenously via a tail vein 1 million of 
either shScramble or shCXCR4 cells at 6 hours before the 3rd dose of ethanol. Animals 
were sacrificed 12h after the cells were injected. Cells with a functional CXCR4 
(shScramble cells) were recovered in the gastric mucosa using PCR for RFP (alcohol 
group - 5.6 folds (p<0.05) and no alcohol group - 4.3 folds (p<0.05), while the cells with 
a nonfunctional CXCR4 (shCXCR4 cells) failed to produce a positive PCR. Control 
mice, with or without alcohol administration, did not have any RFP expression (Fig. 
6.14A).  
Gastric mucosa was also evaluated by direct fluorescence microscopy for RFP.  
The results supported the findings in the RFP PCR experiment. That is, mice that were 
injected with shScramble cells had RFP positive cells in the gastric mucosa, while 
shCXCR4 injected cells were not found by direct fluorescence in the mice stomach (Fig. 
6.14B, C, D and E). We did not look into the phenotype of the homed MSC in the 
stomach, since more then 12 hours are needed for these cells to differentiate into 
epithelial lineages. 
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FIGURE 6.14 MSC REQUIRE A FUNCTIONAL CXCR4 RECEPTOR FOR HOMING
IN THE GASTRIC MUCOSA.
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FIGURE 6.14 MSC REQUIRE A FUNCTIONAL CXCR4 RECEPTOR FOR 
HOMING IN THE GASTRIC MUCOSA.  
Real time PCR for RFP on total stomach DNA: (A) Positive signal was detected in the 
shScramble groups, with or without alcohol. (*p<0.05) and (**p>0.05). N=3-5 animals 
per group. Statistical analysis was done using a nonparametric analysis (Mann-Whitney 
test). Direct fluorescence for RFP: (B) Positive cells (red) in the stomach mucosa of mice 
injected with shScramble cells and alcohol. (C) Positive cells (red) in the stomach 
mucosa of mice injected with shScramble cells, without alcohol. (D) and (C) no RFP 
cells detected.  
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Summary 
 
The ability of BMDCs to differentiate into different embryonic lineages 
(ectoderm, mesoderm and endoderm) is supported by an overwhelming amount of 
publications (76, 77, 177-194). The inflammation of peripheral tissue, where the adult 
stem cells reside, causes an overexpression of inflammatory mediators (chemokines, 
cytokines) resulting in failure of the adult stem cell population. It is believed that the 
bone marrow’s role is to repopulate the adult tissues with new progenitors, thus 
mediating a repair and a reconstruction process. It is unclear what would happen to the 
stem cell fate when exposed continuously to a chronic inflammatory environment.  
The theory of cancer stem cells implies that many tumors rise from a stem cell, 
which is able to differentiate into all cell types of the tumor and self-renew, just like a 
tissue stem cell. Because cancer is considered to be a disease of unregulated self-renewal, 
the understanding of stem cell self-renewal may facilitate our understanding of cancer 
cell proliferation. Cancer stem cells along with the normal stem cells share self-renewal 
ability; one may extrapolate that cancer stem cells and normal stem cells use the same 
pathways and regulation mechanisms to control cell division. Indeed, the Notch and Wnt 
signaling pathways regulate normal stem cell self-renewal, and are also implicated in 
carcinogenesis. 
Here, I use H. pylori infection to explore the interaction of the inflammatory 
environment within the gastric tissue with a stem cell, emphasizing on how the gastric 
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 stem cell responds to inflammation. We believe that in response to chronic Helicobacter 
infection MSC can home to and engraft into the gastric mucosa, contributing over time to 
metaplasia, dysplasia, and cancer. We now recognize that a peripherally located stem cell 
(rather than a terminally differentiated cell) is the target of transformation; this may be 
the cancer stem cell or tumor-initiating cell that is responsible for cancer growth.  
CXCR4/SDF-1 axis is an important tool used by MSC for homing. MSC not only 
express CXCR4, but also respond with migration and internal signaling when stimulated 
by SDF-1. Here, we showed how a functional CXCR4 is necessary for homing of MSC 
into the gastric mucosa, while the loss of function does not result in homing.  
Next, we are going to test if homing is a CXCR4 dependent process in the setting 
of chronic Helicobacter infection using ore mouse model. We are going to infect mice 
with H. felis and inject them with shScramble or shCXCR4 cells, and then analyze their 
stomachs at different time points (2, 4, 6, 12 months) for engraftment and differentiation 
of MSC into epithelial cancer cells of the stomach. Based on our preliminary conclusions 
drawn from the homing experiment with alcohol-induced inflammation, we hypothesis 
that CXCR4-SDF-1 axis is indeed necessary for MSC to initiate the gastric 
adenocarcinoma in our mouse model of disease.  
The concept that epithelial cancers can arise from BMDCs greatly alters our 
overall understanding of cancer initiation and progression and has broad implications for 
the development of anticancer therapies. The focus of anticancer cure, based on our 
findings, has to focus also on treating chronic inflammation, eliminate the causes of 
chronic inflammation and preventing a normal stem cell become a cancer stem cell.  
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CHAPTER VII. DISCUSSION 
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 The host immune response plays a critical role in determining disease 
manifestations of chronic infections. Inadequate immune response may fail to control 
infection, although in other cases the specific immune response may be the cause of 
tissue damage and disease. More than one organism infects the majority of patients with 
chronic infections, yet the interaction between multiple active infections is not known, 
nor is the impact on disease outcome clear. Using the BALB/c strain of mice, we showed 
that Toxoplasma gondii infection in a host infected with Helicobacter felis alters the 
natural outcome of T. gondii infection, allowing uncontrolled tachyzoite replication and 
severe organ damage. In addition, infection with T. gondii alters the specific H. felis 
immune response, converting a previously resistant host to a susceptible phenotype. 
Dual-infected mice had developed a skewed immune response towards a Th1 phenotype. 
These changes were associated with severe gastric mucosal inflammation, parietal cell 
loss, atrophy, and metaplastic cell changes. These data demonstrate the profound 
interactions between the immune response to unrelated organisms, and suggest these 
types of interactions may impact clinical disease.  
The interaction between different microbes in the same host has an important 
implication for the human pathology. The prime example is the HIV (human 
immunodeficiency virus) infection and other viruses, like Hepatitis C or B, Epstein Bar 
virus (EBV), cytomegalovirus virus (CMV), and human T-cell lymphotropic virus. It is 
well known that coinfection with hepatitis C virus (HCV) and HIV is associated with 
increased HCV replication and a more rapid progression to severe liver disease, including 
the development of cirrhosis and hepatocellular carcinoma (221). Coinfection of HIV and 
EBV leads to a higher risk of developing lymphoma in humans. The coinfection of 
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 helminthes and viruses has a great deal of importance as well. Furze et al. have described 
how the coinfection with Trichinella spiralis ameliorates the clinical picture of influenza 
virus (222); on the other hand ascaridosis protects against cerebral and blood-stage 
malaria (223, 224). It is very important to be aware of all coinfections that affect the 
human body as this may lead to improved clinical outcomes when treating against one 
pathogen. 
To further elucidate the role of Th1 cytokines and their regulation in Helicobacter 
induced inflammation, we used C57BL/6 mice to identify T-bet as a central regulator of 
the cytokine environment during infection. Despite sustained infection, T-bet KO mice 
responded with a blunted Th1 response associated with preservation of parietal and chief 
cells and protection from the development of gastric cancer. Unexpectedly, T-bet KO 
mice develop a gastric environment that would not be expected based on the phenotype 
of T-bet KO CD4 cells alone, but also to NK cells, that produce a non T-bet dependent 
IFNγ. Activity of T-bet modulates the expression of the key gastric mucosal cytokines 
(IFNγ, TNF-α and IL-1β) associated with gastric cancer and may be a target for therapy 
to restore immune balance clinically in patients at risk for gastric cancer. Studying the 
presence of single nucleotide polymorphisms (SNP) (225) in the human T-bet gene may 
provide additional clues in determining how host genetics influences the disease 
outcome. 
There is evidence that Fas signaling may have a role in proliferation, and in some 
cases function as an oncogene (80). Because gastric mucosal cells acquire many 
characteristics of immune cells during Helicobacter infection, including cytokine 
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 production (226) and the capacity to present antigens (227), we addressed whether cells 
within the infected gastric epithelium possess MHCII/Fas Ag interactions similar to those 
found in lymphocytes and/or dendritic cells. We showed that MHCII molecules inhibit 
Fas-mediated signaling in gastric mucosal cells through inhibition of receptor aggregation 
and prevention of downstream caspase activation by an actin cytoskeleton-dependent 
mechanism. Under conditions of self-limited inflammation, MHCII expression by gastric 
mucosal cells may be beneficial. Indeed, presentation of antigens by gastric mucosal cells 
and binding of Helicobacter organisms directly to the MHCII complex (120, 123) have 
been reported and potentially play a role in coordinating the local immune response to 
infection. However, the immune response is ineffective, and failure to eliminate the 
organism results in a continued inflammatory state. Under these conditions, MHCII 
expression may become detrimental. The inhibition of apoptosis due to MHCII 
involvement may be one mechanism by which abnormal clones of cells avoid apoptosis 
and may help explain the progression of the metaplastic cell lineage to adenocarcinoma. 
Retrospective studies suggest that differences in patient susceptibility to gastric cancer 
may be linked to the MHC locus [for example, expression of the MHC DQA1*0102 
allele is associated with a decreased risk of intestinal-type gastric adenocarcinoma (228)], 
offering the exciting possibility of further identifying the genetic compositions of patients 
most at risk for gastric cancer and offering targeted intervention based on these signaling 
alterations. 
While it is widely accepted that the cancer stem cell derives from a peripheral 
tissue stem cell pool, there is accumulating evidence from mouse and human studies that 
mobilized pluripotent stem cells originating in the bone marrow may seed distant sites of 
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 injury and act as the cancer stem cell (127, 220, 229-233), and may contribute to tumor 
stroma as fibroblasts, myofibroblasts and endothelial cells (234-238), and provide crucial 
signals to the tumor stem cells. The pressing questions therefore remain. What is it about 
the inflammatory environment that encourages the malignant growth of peripheral organ 
stem cells? What are the environmental factors, which call in circulating pluripotent stem 
cells, allowing them to become established within injured tissue? 
 Within the bone marrow are at least two populations of stem cells, hematopoietic 
and mesenchymal stem cells.  The hematopoietic stem cell is responsible for producing 
all the formed elements of the blood.  The mesenchymal stem cell was originally 
recognized as essential for the production of stromal support cells necessary for 
hematopoiesis, and later recognized as having tri-lineage potential, with the ability to 
differentiate to bone, cartilage and fat.  More recently the mesenchymal stem cell has 
been shown to possess the plasticity to differentiate down most all cell lineages in the 
body and participate in tissue restoration and healing as epithelial cells as well as stromal 
cells.  Under normal physiologic conditions, multiple types of epithelial cells have been 
shown to be derived from bone marrow cells including epithelium of the lung, 
gastrointestinal tract and skin (76). Single bone marrow derived stem cells have been 
shown experimentally to expand within the host and transdifferentiate into diverse 
epithelial lineages.  These data strongly support the existence of a single pluripotent stem 
cell rather than multiple committed progenitor cells as the cell of origin (173).  
Within the gastrointestinal tract, isolated BM-derived epithelial cells in the gastric 
pits of the stomach, the small intestinal villi, the colonic crypt, and rarely in the 
esophagus appear as single differentiated epithelial cells, and do not appear to engraft 
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 into the stem cell niche.  These cells can be recovered months after transplantation so it 
appears that either the cells are long lived, or engraftment is an ongoing process. Their 
role within the peripheral tissue is not clear.   Human studies, which take advantage of 
patients receiving gender-mismatched organs/marrow, also demonstrate this phenomenon 
on BMDCs residing in the peripheral tissues as tissue specific cells.  In these studies, 
BMDCs have been found in increased numbers within the inflamed epithelium, and the 
level of engraftment correlates to some degree with the level of graft verses host disease 
present (239, 240). 
 To evaluate BMDCs activity in an inflammatory model, we used the well-
described H. felis/C57BL/6 mouse model of gastric inflammation and injury (97, 102). 
The C57BL/6 model of Helicobacter felis induced gastric cancer is ideal to address this 
question because C57BL/6 mice do not develop gastric cancer under control conditions, 
but they reliably develop cancer with Helicobacter felis infection (127, 174). The process 
and pathological changes within the stomach recapitulate human disease, where gastric 
cancer in the absence of Helicobacter infection is unusual, while longstanding infection 
carries a significant (up to 1-3%) risk of gastric cancer (17) making this a very useful 
animal model. For these studies, C57BL/6 mice transplanted with marked bone marrow 
were infected with Helicobacter felis, and evaluated at various time points for the 
presence of BMDCs within the gastric mucosa. Engraftment of BMDCs and of culture 
adapted MSC within the mucosa, and differentiation to an epithelial cell phenotype first 
becomes evident at about 20 weeks of infection, corresponding with the appearance of 
metaplastic cell lineages. As time progresses, the number of BMDCs-glands increases 
dramatically suggesting both an expansion of resident BMDCs through proliferation, 
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 and/or the recruitment of additional cells (127). Based on these studies, we believe long-
standing inflammation and inflammatory mediated damage is required for BMDCs 
engraftment within the gastric epithelium. Long standing inflammation and tissue 
remodeling is associated with premalignant and malignant conditions, further suggesting 
to us that this environment may be driving the transformation of the BMDCs within 
inflamed sites.  
In addition to epithelial cells within the tumor, BMDCs also comprise a subset of 
cells within the tumor stroma and within seemingly uninvolved epithelium and 
subepithelial spaces adjacent to the tumors. Adipocytes, fibroblast, endothelial cells and 
myofibroblasts derived from bone marrow precursors can be found in areas adjacent to 
dysplasia and neoplasia.   
For as many questions these studies answer, there are more that are raised, and 
remain to be answered. The data from the H. felis induced gastric cancer model implies 
that BMDCs are recruited to the inflamed tissue and there, transform. We do not yet 
know if BMDCs in the tissue regain access to the circulation setting up a scenario where 
environmental influences at one site could affect the BMDCs, which then could grow at a 
different site. If this were the case, it could be imagined that BMDCs that carry mutations 
could home to and engraft into peripheral tissues possibly resulting in malignancy in a 
shorter time frame, or with a more aggressive phenotype (Fig 7.1). Additional work in the 
animal model is needed to address these points.  
 The next dilemma that our hypothesis is facing is, what are mechanisms by which 
the BMDCs are able to mobilize and attach at the “inflammatory niche”? It is known 
from literature that CXCR4/SDF-1 axis is one of the most important tools used by 
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FIGURE 7.1 THE PROPOSED MODEL OF GASSTRIC CANCER DERIVED 
FROM CXCR4 POSITIVE MESENCHYMAL STEM CELLS.  
Mesenchymal stem cells from bone marrow, which are positive for CXCR4, enter the 
circulation and engraft in the inflamed peripheral tissue that secret SDF1 within the stem 
cell niche. If inflammation is not chronic and short lived, these cells will aid with the 
local repair by transdifferentiation into a terminally differentiated stomach mucosa cell. If 
the inflammation perpetuates and becomes chronic, either an already mutated MSC or a 
locally mutated stem cell acquires a mutagenic phenotype, giving rise to neoplasia. The 
later process is also dependent on the CXCR4/SDF-1 axis.  
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 mesenchymal stem cells to navigate through to a targeted destination, like an 
inflammatory site. MSC express CXCR4 physiologically, allowing them to migrate in 
vivo and in vitro. Using an acute alcohol injury model in mice we were able to conform 
that a functional CXCR4 receptor is necessary for homing of MSC into the gastric 
mucosa. The “CXCR4 loss of function” model was not tested in our Helicobacter model 
of inflammation, but we expect that homing, followed by engraftment of MSC in the 
stomach would be at least diminished. While the CXCR4/SDF-1 axis seems to be an 
important part of the homing process, it may not be the only tool that is used by the stem 
cells.  
Recently, more molecules that facilitate the mobilization of MSC were described. 
A role for galanin in mesenchymal stem cells migration, probably through activation of 
the GalR2 (galanin receptor-2) receptor, was described by Louridas et. al (241). MSC 
express both, galanin and its receptors; they are able to mobilize in response to galanin in 
vitro using a “wound assay” and in vivo, by homing in the bone marrow of a galanin 
transgenic mouse.  
Zisa et al. have described how intramuscular VEGF is inducing recruitment of 
stem cells into the heart and skeletal muscle hence reducing the cardiomyopathy in a 
hamster model of heart failure (242). Their results show that VEGF was able to recruit 
also CXCR4 positive progenitors along with c-kit positive cells. There may be a 
correlation between the VEGF and CXCR4-SDF-1 axis in homing of MSC?  
Hoxa3 is a transcription factor that is known to promote angiogenesis during 
tissue repair and accelerates cutaneous healing in vivo. Mace et al. group have 
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 demonstrated how a skin wound that overexpresses Hoxa3 attracts more bone marrow 
derived cells and improves the rate of healing in mice (243).  
Matrix metalloproteinase one (MMP1) and its cognate receptor PAR1 were 
studied by Ho et al. and determined that MMP1/PAR1 axis is an important mean for 
MSC mobilization towards a glioma tumor microenvironment in vivo and in vitro (244). 
Their model resembles our model of gastric cancer environment attracting in stem cells 
for repair. 
The field of cancer biology has undergone significant shifts in recent years, with a 
focus on identifying and understanding the cancer stem cell.  The evolving picture is one 
of a rare group of cells within a tumor with a surface marker profile and gene expression 
pattern unique to its role as a stem cell. A body of work suggests that the cancer stem cell 
may arise from the bone marrow; however, more work is needed to determine if this 
notion can be extrapolated to other models of cancer.  In addition the importance of 
BMDCs in human cancer needs to be clarified. Characterizing and developing markers 
for the BMDCs subpopulations that can contribute to solid tumors is of major importance 
to facilitate early detection in patients and to develop targeted therapies aimed at the 
cancer stem cell.  It seems likely that some solid tumors may be derived from resident 
tissue stem cells rather than circulating BMDCs, with the environment, genetic make up 
of the host and other factors dictating the cell that undergoes transformation.  It is 
extremely important for these two paradigms to be understood- in their similarities, as 
well as their differences. The possible role of cell fusion by BMDCs has yet to be fully 
elucidated and research in this area will likely provide novel and exciting insights into the 
complexity of the relationship of the BMDCs and peripheral tissues. Additionally, the 
202
 concept of an aberrant stem cell niche and its role in contributing to cancer development 
from BMDCs will need further clarification. Prevention and/or reversibility of 
preneoplastic lesions (for example by eradication of H. pylori) are clearly worth 
addressing further in the Helicobacter mouse model and can be considered in the context 
of the biology of stem cell differentiation.    
Finally, the precise relationship of chronic inflammation to BMDCs needs further 
investigation. One suspects that future studies will reveal the involvement of many cell 
types and specific factors – including cytokines, chemokines, hypoxia and oxidative 
stress – in the mobilization, recruitment, engraftment, and progression of stem cells 
toward cancer. Understanding these mechanisms offers the exciting hope of new 
approaches to cancer treatment. 
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